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Abstract
The development of a new Lewis acid catalyzed sigmatropic reaction is described.
This process, termed the allenoate-Claisen rearrangement, involves the metal-catalyzed
condensation of an allenic ester with a tertiary allylic amine.  The zwitterionic
intermediate resulting from this condensation undergoes facile [3,3] bond reorganization
to provide b-amino-a,b,e,z-unsaturated-g,d-disubstituted ester products.  The allenoate-
Claisen reaction has been demonstrated to allow for the production of a diverse range of
Claisen adducts in high yield and with very high diastereoselectivities.  Perhaps most
notably, this process is amenable to the rapid generation of quaternary carbon
stereogenicity with nearly complete stereocontrol.
Investigations of an enantioselective catalytic variant of the allenoate-Claisen
rearrangement have been initiated.  Enantioselectivities of up to 49% have been achieved
with the use of a titanium bis(binaphthyl) catalyst and a bidentate chelating allenic
partner.  The effects of solvent and method of catalyst preparation on enantioselectivity
are described.
Progress towards the total synthesis of the briarane diterpene, erythrolide E, has
been made.  Using acyl-Claisen methodology developed in the MacMillan laboratories,
both key fragments of the erythrolide framework have been prepared in racemic fashion.
In addition, a highly enantioselective route to the core fragment has been developed using
an enantioselective organocatalytic Diels-Alder reaction and Ireland-Claisen
methodology.
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1CHAPTER 1
The Claisen Rearrangement
Introduction
The Claisen rearrangement stands as one of the most powerful known methods for
the generation of complex organic architecture.1  Originally disclosed as the [3,3]-
sigmatropic reorganization of allyl-aryl or allyl-vinyl ethers,2 the term Claisen
rearrangement has subsequently expanded to include any such process involving a 1,5-
diene possessing a heteroatom in the 3-position (Figure 1).  Thus, in addition to the
traditional formulation in which X = O, aza-Claisen3 (X = N), thio-Claisen4 (X = S), and
even metallo-Claisen5 (X = M) rearrangements are well known.
Figure 1. The Claisen rearrangement.
The utility of the Claisen rearrangement lies in the highly predictable manner in
which complex stereochemical motifs may be generated from relatively simple
precursors.  This predictability is a consequence of the propensity of Claisen substrates to
proceed through highly ordered six-membered transition states (Figure 2).  As such, the
diastereomeric identity of Claisen rearrangement products is typically controlled by
judicious choice of reactant olefin geometry.
Figure 2. Highly ordered six-membered transition state.
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In general, the actual sigmatropic event is facile, often occurring at or just above
ambient temperatures.  Given this fact, Claisen rearrangement reports often focus on
novel strategies to prepare the requisite allyl vinyl component in a geometrically defined
manner.  Indeed, it is the manner of substrate preparation that has traditionally defined
the numerous Claisen variants.
Claisen Variants
One of the earliest reported methods for the preparation of allyl vinyl ether
Claisen substrates was the mercury-catalyzed interchange of allylic alcohols with alkyl
vinyl ethers (Figure 3).6  Once formed, simple allyl vinyl ethers typically require elevated
temperatures to undergo rearrangement.  Though it allows for straightforward access to
an otherwise challenging functionality, the toxicity and low yields associated with
mercury transetherification have limited the use of this procedure.
Figure 3. Mercury-catalyzed preparation of Claisen substrates.
Numerous alternative methods have been reported to access the allyl vinyl ether
motif.  An important entry in this context is the olefination of ester or lactone carbonyls
with the Tebbe reagent (Figure 4).7  As an example, Paquette has successfully applied
this strategy to the synthesis of precapnelladiene.
3
Figure 4. Allyl vinyl ether preparation via Tebbe olefination.
Very recently, Buchwald reported the facile preparation of allyl vinyl ethers via
copper-catalyzed coupling of allylic alcohols with vinyl iodides (Figure 5).8  The
resulting coupling products undergo in situ rearrangement to provide Claisen products in
good yields.  Of particular note was the application of this methodology to the
preparation of a range of adducts (i.e., 1) incorporating vicinal quaternary carbon centers
with high diastereoselectivities.
Figure 5. Domino Cu-catalyzed coupling / Claisen rearrangement.
Another clever strategy for accessing the allyl vinyl ether motif was recently
reported by Stoltz and May.9  Their protocol entails a tandem process in which a-allyloxy
N-aziridinyl imines 2 are first converted via rhodium-catalyzed Bamford-Stevens reaction
to allyl vinyl ethers 4, which subsequently undergo thermal Claisen rearrangement to
4
furnish complex aldehyde products 3.  Importantly, the Bamford-Stevens reaction
provides difficult to access (Z)-enol ethers with high stereoselectivity.
Figure 6. Tandem Rh-catalyzed Bamford-Stevens / Claisen rearrangement.
The common feature of these simple allyl vinyl ether Claisen rearrangements is
the relatively high temperatures (100 to >200 °C) required to effect the pericyclic event.
This fact, coupled with the higher degree of difficulty in accessing these substrates has
led to a less widespread reliance on these traditional Claisen variants as compared to
certain other, charge-accelerated protocols.
In 1940, as an alternative strategy for vinyl ether formation, Carroll reported the
[3,3]-sigmatropic reaction of allylic b-ketoesters, a process now generally known as the
Carroll-Claisen rearrangement (Figure 7).10  In this process, preparation of the vinyl
component of the Claisen substrate is greatly simplified, resulting from enol (or enolate)
tautomerization of the ketoester.  Upon rearrangement, the resulting b-ketoacid typically
undergoes decarboxylation to yield a g,d-unsaturated ketone (5).
5
Figure 7. Carroll-Claisen rearrangement.
Another significant advancement in Claisen technology came with a report by
Eschenmoser and coworkers in 1964 who found that condensation of allylic alcohols with
amide acetals results in the formation of an N,O-ketene acetals (Figure 8).11  These
acetals subsequently undergo facile in situ rearrangement to provide amide Claisen
products.
Figure 8. Eschenmoser-Claisen rearrangement.
In related work, Johnson found that treatment of allylic alcohols with ortho-esters
and trace weak acid (such as propionic acid) results in the formation of ketene acetals
(Figure 9).12  Analogous to the Eschenmoser protocol, these Johnson ortho-ester
intermediates undergo Claisen rearrangement to yield ester products.  In contrast,
however, the Johnson protocol does not generally provide geometrically defined ketene
acetals, thereby limiting the utility of this protocol for the generation of a-stereogenicity.
6
An exception to this limitation comes with the use of cyclic orthoesters, which of course
provide complete control over olefin geometry (Figure 9).13
Figure 9. Johnson ortho ester rearrangement.
Perhaps the most significant advancement in the area of Claisen technology has
come from the report by Ireland in 1972 that silyl ketene acetals readily undergo
sigmatropic rearrangement at or below room temperature (Figure 10).14  The silyl ketene
acetals are typically generated at low temperature (–78 °C) by enolization of allylic esters
with amide bases followed by silylative trapping.  Simple warming of these intermediates
to ambient temperature is often enough to facilitate rearrangement.
Figure 10. Ireland-Claisen rearrangement.
7
The utility of this protocol lies in the fact that silyl ketene acetal olefin geometry
(6 or 7), and thus relative product stereochemistry (8 or 9), can be dictated by judicious
choice of enolization conditions.  This stereochemical control, coupled with exceedingly
mild reaction conditions, has led to the extraordinarily broad application of the Ireland-
Claisen rearrangement to complex molecular synthesis.  A recent example of such is the
application to the synthesis of the Taxol skeleton reported by Magnus and Westwood
(Figure 11).15  Remarkably, this transformation provides rearrangement product 10 in
good yield despite the highly congested nature of the Claisen transition state.
Figure 11. Application of the Ireland-Claisen to the synthesis of the Taxol skeleton.
In a somewhat related process, the Reformatsky-Claisen reaction involves
sigmatropic bond reorganization of ester enolates generated from zinc dehalogenation of
allylic a-halo esters (Figure 12).16  The primary significance of this protocol is that it
occurs under essentially neutral conditions.
Figure 12. Reformatsky-Claisen rearrangement.
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Bellus and Malherbe reported a Claisen protocol involving the addition of allyl
ethers to ketenes (Figure 13).17  The resulting zwitterionic intermediates 11 undergo rapid
bond reorganization to yield charge-neutral ester products 12.  Although the authors
reported that this ketene Claisen protocol was effective only with highly electrophilic
ketenes, careful analysis of their report reveals that only those reactions involving ketenes
generated by in situ zinc dehalogenation were productive.  This raises the notion that
successful ketene-Claisen rearrangements might have involved activation by ZnCl2.
Recognition of this possibility led to the development in the MacMillan laboratories of a
Lewis acid catalyzed acyl-Claisen reaction (vide infra).
Figure 13. Bellus-Malherbe ketene-Claisen rearrangement.
The zwitterionic nature of the ketene-Claisen intermediate underscores an
important principle of charge-acceleration of the Claisen rearrangement.  Specifically a
substrate that incorporates positive charge at the 3 position18 and/or negative charge at the
2a position19 of the 1,5-diene undergoes rearrangement more readily than a charge-neutral
substrate (Figure 14).  These accelerating effects are usually attributed to a more
advanced X(3)–C(4) bond breaking in the sigmatropic transition state.  In this context,
the Claisen rearrangement can be regarded as an intramolecular SN2¢ reaction between the
“nucleophilic” vinyl component and the “electrophilic” allyl component.
9
Figure 14. Charge acceleration of the Claisen rearrangement.
Although negative charge at the 2a position is usually manifested as an oxygen
anion, Denmark and Harmata have reported two carbanion-accelerated Claisen protocols
(Figure 15).20,21  In one method, deprotonation of a pendant 2-sulfonylmethyl group
results in Claisen rearrangement of allyl vinyl ether 13 to provide b-ketosulfone product
14 in high yield and high diastereoselectivity (Eq. 1).20  In a similar manner, asymmetric
induction was achieved by deprotonation and subsequent anion-accelerated
rearrangement of chiral phosphorinane 15 (Eq. 2).21  In both cases, orbital alignment of
the carbanionic carbon and the vinyl pi-system in the transition state is presumed.
Figure 15. Carbanion-accelerated Claisen rearrangements.
Stereocontrol of the Claisen Rearrangement
Besides the actual formation of bonds, the true power of the Claisen
rearrangement lies in its ability to readily and predictably generate complex
10
stereochemical architecture.  As noted earlier, Claisen rearrangements proceed through
highly ordered six-membered transition states to produce as many as two stereocenters,
often with high levels of stereoselectivity.
Analogous to the conformations of cyclohexyl rings, Claisen transition states may
be chair-like or boat-like depending on substrate identity.  Theses two conformationally
distinct transition states lead to diastereomerically divergent products.  Not surprisingly,
olefin geometry is intimately linked to product stereochemistry.
As demonstrated in Figure 16, if the allyl and vinyl olefins of the Claisen
substrate are both trans (17) or both cis (18), then a chair-like transition state will produce
a product (19) with syn configuration.  Alternatively, if the geometry of the olefinic
components differ (20 or 21), then the anti product (22) will result from the chair-like
transition state.  In each case, a boat transition state produces the opposite diastereomer
(in Figure 16, only relative stereochemistry is implied).
Figure 16. Sterechemical consequence of olefin geometry of Claisen reactants.
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In reality, with acyclic substrates the chair-like transition state is nearly always
preferred, a consequence of energetic minimization of torsional and transannular
interactions.1d  In contrast, Claisen rearrangements in which the allyl component is
confined in a ring system often proceed through a boat-like transition state.1d
This conformational reversal is usually a result of an unfavorable interaction in
the chair-like transition state 25 of the vinylic component with the allylic ring structure
(Figure 17).  Reaction through the boat-like conformation 26 avoids this interaction, and,
indeed, boat selectivity can be quite high (e.g., greater than 9:1 in Figure 17).  Such
preference, however, is not a rigid rule and may vary from case to case.
Figure 17. Boat-like transition state preference for cyclic substrates.
Another consequence of the highly ordered nature of Claisen transition states is
that the transfer of stereochemistry from reactants to products is highly conservative.1d
The most straightforward case to consider in this context is for a substrate that
incorporates stereogenicity at C(4) (Figure 18).  The rearrangement of substrates such as
27 could potentially proceed through either of two chair-like transition states, 28 or 29.
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One of these (28), however, is highly disfavored due to a pseudo-1,3-diaxial intereaction.
Thus transition state 29, which orients the C(4) substituent in a pseudo-equatorial
position, is favored and hence dictates the product stereochemistry.  A process such as
this is termed “self-immolative” because the controlling stereocenter is destroyed in the
reaction.  Incidentally, another consequence of equatorial preference is that Claisen
rearrangements of substrates with C(4) substitution give rise to products containing E-
olefins (31).
Figure 18. Transfer of stereochemistry in the Claisen rearrangement.
Numerous investigations have focused on the influence of stereogenic substitution
at other positions of the 1,5-diene framework.1g  These studies have led to a wide array of
substrate and auxiliary-controlled methods for control of the absolute stereochemistry of
Claisen products.
In contrast, relatively few strategies have been reported for asymmetric control of
the Claisen rearrangement using an external chiral reagent.1g,h  This paucity is particularly
surprising in light of the inherent synthetic power of the Claisen rearrangement coupled
with the explosive interest in the field of enantioselective catalysis over the last several
decades.  Indeed, while several notable stoichiometric methods for enantioselective
13
Lewis acid promotion of the Claisen rearrangement have been developed, to date only
one enantioselective catalytic protocol has been reported.22
Corey has reported the first enantioselective promotion of the Claisen
rearrangement of allylic ester enolates using a stilbenediamine-derived boron catalyst 35
(Figure 19).23  With this method, both anti (33) and syn (34) Claisen products can be
obtained with high enantioselectivity simply by altering enolization conditions.  While
the Corey procedure has been proven to be synthetically useful,23b,c this method suffers
from extraordinary long reaction times (2 weeks) and an inherent need for stoichiometric
amounts of the chiral promoter.
Figure 19. Corey’s enantioselective Claisen rearrangement.
In 1995, Yamamoto disclosed a method for the enantioselective promotion of the
Claisen rearrangement of allyl vinyl ethers 36 using chiral aluminum alkoxides (Figure
20).24  By employing stoichiometric amounts of the tris(binaphthyl)aluminum derivatives
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38 or 39, cationic acceleration of the Claisen rearrangement of a limited substrate range
can be achieved to provide Claisen products 37 in good to excellent yield and with
generally modest enantioselectivity.
Figure 20. Yamamoto’s cation-accelerated enantioselective Claisen rearrangement.
The first, and to date only, successful enantioselective catalytic Claisen
rearrangement was described by Hiersemann in 2001 (Figure 21).22  With this protocol, 5-
10 mol% of copper bisoxazoline complex 42  effectively catalyzes the Claisen
rearrangement of a-allyloxy alkenoate esters 40 to yield a-keto Claisen adducts 41 in
very high yields and with modest enantioselectivities.  Organizational control is
undoubtedly bolstered by the bidentate nature of the reactant.  Although the Hiersemann
method represents a milestone in the Claisen rearrangement field, the modest
enantioselectivities and rather specific substrates associated with this protocol leave much
room for improvement.
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Figure 21. Hiersemann’s enantioselective catalytic Claisen rearrangement.
There has been an ongoing program in the MacMillan group aimed at the
development of a broadly useful enantioselective Claisen rearrangement.  In this context,
a new sigmatropic variant, the acyl-Claisen rearrangement, was developed as a platform
to achieve this goal.
The Acyl-Claisen Rearrangement
In 1999, the MacMillan group reported the development of the acyl-Claisen
rearrangement.25  In this process, the reaction of allyl morpholines 43 and acid chlorides
44 in the presence of catalytic amounts of Lewis acid and a tertiary amine base produces
amide Claisen adducts 45 in high yields and with excellent diastereoselectivities (Figure
22).
Figure 22. The acyl-Claisen rearrangement.
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The inspiration for this work came from the recognition that the ketene-Claisen
developed by Bellus and Mallherbe might be a Lewis acid-dependent process (see Figure
12).17  It was reasoned that Lewis acid activated ketene (47) should be susceptible to
addition of a tertiary allylic amine 43 (Figure 23).  The resulting zwitterionic acyl-
ammonium intermediate 48 should be suitably disposed to undergo facile bond
reorganization.  The product of this reorganization, a neutral amide (49), should readily
dissociate from the Lewis acid to provide the Claisen product 45 and thereby allow for
catalyst turnover.
Figure 23. Catalytic cycle of the acyl-Claisen rearrangement.
This hypothesis was successfully realized with the development of the broadly
useful acyl-Claisen rearrangement.25  As can be seen in Table 1, a diverse range of allyl
amine and acid chloride components can be utilitized in this transformation.  Products
thus obtained incorporate with high diastereoselectivity a wide variety of functionality,
including alkyl, aryl, chloro, alkoxy, thio, and amino substituents (entries 1-7).   In
addition, the acyl-Claisen has been demonstrated to be highly effective for the generation
of quaternary carbon centers in both cyclic and acyclic settings (entries 8 and 9).
17
Table 1. Substrate scope of the acyl-Claisen rearrangement.
18
Importantly, relative product stereochemistry can be dictated by proper choice of
olefin geometry of the allyl amine component.  Thus, while trans allyl amines give rise to
syn Claisen products (entries 1-3, 5, 6, 8, and 9), anti adducts may be obtained with the
use of cis isomers (entries 4 and 7).
Two enantioselective variants of the acyl-Claisen rearrangement have
subsequently been developed by Yoon in the MacMillan group.27,28  The first method
entails the reaction of allyl amines with a-benzyloxyacetyl chloride, promoted by three
equivalents of magnesium bisoxazoline complex 50.27  As represented in Table 2,
significant variety of the allyl component can be tolerated, providing access to Claisen
products in high yields, diastereoselectivities, and enantioselectivities.  At least one
contributing factor to the requirement of multiple equivalents of chiral promoter is
thought to be a chloride–iodide metathesis reaction of complex 50, which renders this
promoter ineffective.25b
A second generation enantioselective acyl-Claisen strategy has been developed by
Yoon and Kim for the reaction of allyl amines with propionyl chloride (Table 3).25b, 28  In
this protocol, two equivalents of the stilbene diamine-derived boron complex 51 are
capable of providing acyl-Claisen products in good yield and with high levels of enantio-
and diastereoselectivity.  As with the first generation system, however, the use of
substoichiometric quantities of promoter 5 1  results in drastically reduced
enantioenrichment, again presumably due in part to inhibition of the Lewis acid by
chloride ion.25b
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Table 2. First generation enantioselective acyl-Claisen rearrangement.
The acyl-Claisen rearrangement represents a powerful new technology for the
generation of highly complex organic architecture in an operationally trivial manner.
Within the MacMillan group, this reaction has led to many fruitful avenues of research,
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including two new enantioselective Claisen variants.  Yet the goal of achieving an
enantioselective catalytic Claisen rearrangement has remained elusive.
To further our pursuit of this goal, we have investigated another novel Claisen
methodology that possesses several attractive features in common with the acyl-Claisen
reaction, yet offers significant alternatives in regard to bond construction and
enantioselective catalysis.  We have termed this new reaction the allenoate-Claisen
rearrangement.
Table 3. Second generation enantioselective acyl-Claisen rearrangement.
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CHAPTER 2
Development of the Lewis Acid Catalyzed Allenoate-Claisen Rearrangement1
Chapter 1 describes the development of a new Lewis acid catalyzed sigmatropic
rearrangement termed the acyl-Claisen rearrangement.2  This chapter details our
investigations of a conceptually related protocol that we have termed the allenoate-
Claisen rearrangement.
Reaction Design
Numerous mechanistic attributes render the acyl-Claisen rearrangement2 a highly
useful synthetic process.  Prominent among these are (1) zwitterionic charge-acceleration
of the sigmatropic event, (2) subsequent internal charge quenching, and (3) operationally
trivial formation of the vinyl-heteroatom bond (Figure 1).  Indeed, it was in pondering
this last point that led to a consideration of whether analogous Claisen intermediates
might be accessed via addition of allyl amines to cumulenic partners other than ketenes.
Such alternatives would be expected to retain the above-mentioned positive
characteristics while offering powerful new possibilities for bond construction and
asymmetric catalysis.
In this context we recognized that allenic esters 1 might be subject to Lewis acid-
activated 1,4-conjugate addition of allylic amines  2 (Figure 2).  This type of coupling
would result in a zwitterionic complex 3, which would be suitably predisposed to
undergo carbanion-accelerated Claisen rearrangement to provide b-amino-a,b,e,z-
unsaturated-g,d-disubstituted ester products 4.
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Aside from the inherent synthetic utility of vinylogous carbamate Claisen
products,3 the proposed process would benefit from the advantage of employing stable,
isolable allenic substrates rather than ketenes.  As such, the use of exogenous tertiary
amine base and the subsequent generation of stoichiometric quantities of ammonium
chloride as dictated by the acyl-Claisen protocol would be forgone.4  Moreover, variation
of the nature of the allenic carbonyl (ester, amide, imide, etc.) should provide a
tremendous breadth of functional handles with which to explore asymmetric catalysis.
Figure 1. Salient features of the acyl-Claisen reaction.
Results and Discussion
To facilitate our studies, we began by preparing the requisite allenic esters
according to the procedure of Lang and Hansen.5  In a straightforward manner, ester
phosphoranylidenes 5 and acid chlorides 6 react in the presence of triethylamine to
provide ester allene products 1 (Scheme 1).  The operative reaction in this process is a
Wittig olefination of in situ-generated ketene 7.  Although this protocol is invariably low-
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yielding (<50% yield), the operational simplicity and ready availability of starting
materials served to make this our exclusive preparation of choice.
Figure 2. Proposed catalytic cycle for the allenoate-Claisen rearrangement.
Our studies began with investigation of the reaction of benzyl 2,3-pentadienoate
(8) and cinnamyl pyrrolidine (9) (Table 1).  We were gratified to find that the production
of Claisen adduct 10 was efficiently catalyzed by 5-10 mol% of a broad range of Lewis
acids including, notably, AlCl3, Cu(OTf)2, FeCl3, and Zn(OTf)2.  Importantly, high levels
of reaction efficiency and diastereocontrol were observed in all metal-mediated cases
(entries 2–9, 81–95% yields, >98:2 syn:anti), while rearrangement adducts were not
detected in the absence of Lewis acid (entry 1).  The superior catalytic efficiency
exhibited by Zn(OTf)2 prompted us to select this metal salt for further exploration.
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Scheme 1. Preparation of allenic esters.
Our investigations into the scope of the allyl pyrrolidine component are
summarized in Table 2.  Allyl substituents of varying steric demand (R1 = H, Me, iPr, and
Ph, entries 1 and 3-5) can be incorporated in high yields and with high levels of
stereocontrol (80-97% yield, >94:6 syn:anti).  Importantly, in accord with established
Claisen protocols,6 the relative sense of stereoinduction can be dictated by appropriate
choice of olefin geometry in the allyl component.  Thus, while trans-allylic amines give
rise to syn Claisen adducts with high levels of stereoselection (entries 1, 3, and 4, >94:6
syn:anti), the anti-Claisen products may be obtained with equally high selectivity by
employing cis-allylic amines (entry 2, <2:98 syn:anti).
Table 1. Lewis acid catalyzed allenoate–Claisen rearrangement.
aProduct ratios determined by 1H NMR analysis. b NX2 = pyrrolidine.
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Table 2. Catalyzed allenoate–Claisen rearrangement between benzyl 2,3-pentadienoate
and representative allyl pyrrolidines.
             aNX2 = N-pyrrolidine,  bRatios determined by GLC or 1H NMR
         analysis.  cRelative configurations assigned by X-ray analysis.
Significant structural variation of the allenoate component is also well tolerated
(Table 3).  Substituents of disparate size and electronics (R2 = H, allyl, iPr, Cl, and Ph,
entries 1-6) may be incorporated in high yields (84-96%) and with high
diastereoselectivities (≥93:7 syn:anti).  Importantly, g-amino substitution can be achieved
by employing a phthalimido-substituted allenic ester (entry 7, 75% yield, 91:9 syn:anti).
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Table 3. Catalyzed allenoate–Claisen rearrangement between allyl pyrrolidines and
representative allenic esters.
aNX2 = N-pyrrolidine. bProduct ratios determined by GLC or 1H
NMR analysis.  cRelative configurations assigned by X-ray
analysis.
We were very mindful of the beneficial synthetic consequences that might be
derived from the incorporation of oxygenation in an allenoate-Claisen product.  This type
of functionality, however, proved much more problematic to achieve.  The primary
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difficulty arose in the preparation of a g-oxy allenic ester 12.  Despite the suggestion of
successful reaction by thin layer chromatography (TLC),7 only complex mixtures of
products were isolated when most a-oxy acid chlorides 11 were employed in the Lang
and Hansen procedure (Table 4).5  Indeed, only with the use of a-acetoxyacetyl chloride
could any of the desired Claisen substrate be isolated in very low yield.  It is not difficult
to imagine several destructive pathways that an amphiphilic molecule such as 12 might
follow.
Table 4. Preparation of a g-oxy substituted allenic ester.
Although preparation of useful quantities of an oxygenated allenic ester was
possible, the performance of this substrate in the allenoate-Claisen reaction proved
problematic (Scheme 2).  When allene 14 was added to a mixture of amine 13 and Lewis
acid, TLC analysis indicated the presence of numerous species.  Upon workup and
purification, only a 29% yield of Claisen adduct 15 was obtained.  It was hypothesized
that Lewis acid mediated oligomerization of the allene was a significant contributing
factor to the poor reaction efficiency, although syringe pump addition of the allene did
not lead to any improvement in yield whatsoever.
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Scheme 2. Allenoate-Claisen rearrangement of a g-oxy substituted allenic ester.
It seems apparent that the allenoate-Claisen rearrangement is not inherently
unamenable to incorporation of oxygen substitution.  Indeed, these results suggest that
identification of a suitably stable oxyallene would readily facilitate this formulation.  As
evidence of this claim, one might note the successful reaction of the amino-substituted
allene shown in entry 7 of Table 3.  Although a similar instability of this heteroatom-
substituted allene might be expected, incorporation of the nitrogen atom as an imide
functionality reduces its electron donating ability to a sufficient extent that the desired
reactivity is possible.
In addition to variation of the allyl moiety, it was found that alteration of the
amine component was possible, although a significant correlation of substrate
nucleophilicity to reaction efficiency was observed (Table 5).  While pyrrolidino
substitution seemed to be optimal both in terms of reaction rate and overall yield (entry
1), the dimethylamino substrate required a similar reaction time (entry 2).  The yield in
this case, however, was inexplicably reduced.  The less nucleophilic cinnamyl piperidine
was effective but required significantly longer reaction time (entry 3), while morpholino
substitution reduced the nucleophilicity of the substrate to such an extent that higher
catalyst loading (20 mol%) and much longer reaction time (48 h) was required to obtain
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even a modest yield (entry 4).  Dibenzyl cinnamyl amine provided no Claisen product
whatsoever under the conditions screened (entry 5).
Table 5. Catalyzed allenoate-Claisen rearrangement between representative cinnamyl
amines and benzyl 2,3-pentadienoate.
aProduct ratios determined by 1H NMR analysis.  bRelative
configurations assigned by X-ray analysis.  cReaction performed
with 20 mol% Lewis acid.
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To further demonstrate the proficiency of the allenoate-Claisen reaction in
generating complex stereochemical architecture, we examined the formation of
quaternary carbon centers via the rearrangement of g-disubstituted allyl amines (Scheme
3).8  Reaction of 3-methylcinnamyl pyrrolidine (16) with allenic ester 8 proceeded in the
presence of 10 mol% Lewis acid to provide the Claisen adduct 17 in high yield and with
high diastereocontrol (Eq. 1).  Notably, this product incorporates a synthetically
challenging benzylic quaternary carbon center.9  Further, reaction of the same allene with
isomeric substrates geranyl (18) and neryl pyrrolidine (19) in the presence only 5 mol%
catalyst provided in high yield the Claisen adducts 20 and 21 in which the relative
stereochemistry was completely dictated by the olefin geometry of the allylic amine
substrates (eqs. 2 and 3). The complete differentiation of sterically similar substituents
through transition state-controlled p-facial discrimination is noteworthy.
Scheme 3. Facile generation of quaternary carbon centers.
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One subject that has thus far avoided note is that of enamine olefin geometry.
Although depicted as E-isomers, allenoate-Claisen products are often isolated as a
mixture of E (22) and Z (23) congeners (Table 6).  Vinylogous carbamates are well-
known to exist preferentially as E-isomers as a result of more efficient pi-delocalization in
this configuration.10  Sufficient steric bulk at the g-position, however, can override this
electronic preference to afford a mixture of products.  As one can see from Table 6, the
situation seems to be more complex than this, and apparently the product ratio is
dependent on a number of steric and electronic factors.
Table 6. Enamine olefin isomeric ratio of selected allenoate-Claisen products.a
a Product ratio was determined by 1H NMR analysis.
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Not surprisingly, the presence of two olefin isomers significantly complicates the
determination of the diastereomeric ratio of the Claisen adducts.  As such, we required a
method to remove this complication.  With some experimentation, it was found that
hydrodeamination of the reaction products could be effected by a simple two-step
procedure (Scheme 4).3g
First, selective reduction of the enamine moiety of both isomers 22 and 23 can be
accomplished using standard reductive amination conditions [Na(CN)BH3, TFA].  Then,
treatment of the resulting amine with mCPBA results in N-oxidation and subsequent
facile b-elimination to provide the a,b,e,z-unsaturated ester product 24 as a single E-
olefin isomer.  In addition to allowing for a straightforward determination of
diastereoselection, this deamination procedure is unarguably a synthetically useful
procedure in its own right, particularly when coupled with the allenoate-Claisen
rearrangement.
Scheme 4. Hydrodeamination of allenoate-Claisen products.
Another factor that served to complicate product isolation was the discovery that
silica gel effects the hydrolysis of allenoate-Claisen products to the corresponding b-keto
esters 26 (Scheme 5).11  The susceptibility of substrates to this hydrolysis reaction was
found to have a high correlation to the steric size of the g and d substituents.  Thus
adducts unsubstituted at either position undergo rapid hydrolysis upon exposure to silica
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gel.  Subtituents of modest size (i.e., methyl) at both positions render the Claisen
substrate mildly susceptible to this reaction, while adducts that incorporate larger
substitution patterns such as a phenyl ring at either position or a quaternary carbon center
do not undergo any observable hydrolysis.  Although b-ketoesters are highly valuable
synthetic building blocks, this procedure provides a less than optimal means of access
because extended exposure to silica gel results in g-epimerization of the ketoester
products.
Scheme 5. Silica gel-promoted hydrolysis of allenoate-Claisen products.
Limitations of the Methodology
Despite allowing for access to adducts bearing a wide scope of functionality, there
are certain substitution patterns with which the allenoate-Claisen reaction has thus far not
proven to be compatible.  For example, attempted reaction of a-substituted allenic ester
27 resulted in no observed product 29 (Scheme 6).  This result is easily rationalized by
examination of the zwitterionic coupling intermediate 28.  If one assumes pi-orbital
alignment to be a requisite condition for carbanion-acceleration of the sigmatropic
event,13 one can readily see that Claisen rearrangement of intermediate 28 will be highly
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disfavored due to a severe A1,3–interaction between the a-methyl group and the g-
substituent (or between the a-methyl group and the quaternary ammonium moiety).
Scheme 6. Attempted allenoate-Claisen rearrangement of an a-substituted allenic ester.
Not surprisingly, g-disubstituted allenic ester 30 was also unreactive in the
allenoate-Claisen reaction (Scheme 7).  This lack of reactivity is attributed to steric
blocking of both pi* orbitals by the methyl groups (see structure 31), thereby precluding
amine addition.
Scheme 7. Attempted Claisen rearrangement of a g-disubstituted allenic ester.
Finally, as alluded to previously, the allenoate-Claisen reaction displays a certain
sensitivity to the nucleophilicity of the amine component (Figure 3).  As such, allyl
amines that possess highly electron-withdrawing substituents such as chloro or ester
groups do not readily participate in this process.  As mentioned, dibenzyl cinnamyl amine
is also ineffective in the Claisen process, which is most readily attributed to the electron-
withdrawing nature of the benzyl substituents.  It is unclear to what extent these reactivity
39
issues might be overcome with the use of more forcing conditions such as catalyst
variation, higher concentration, or heating.
Figure 3. Non-productive, weakly nucleophilic allylic amine components.
Concluding Remarks
We have developed a powerful new Lewis acid catalyzed variant of the Claisen
rearrangement.  This process employs simple allylic amines and allenic esters for the
rapid generation of highly functionalized b-amino-a,b,e,z-unsaturated-g,d-disubstituted
ester products.  Importantly, the allenoate-Claisen rearrangement allows for the
stereoselective incorporation of a broad range of carbogenic and heteroatom substituents.
Further, it has been found that relative product stereochemistry is strongly dictated by the
geometric configuration of the allyl component.  This protocol has proven to be
particularly efficient for the production of quaternary carbon centers in a highly
stereodefined manner.  We feel confident that the operational simplicity and broad
catalytic susceptibility of this chemistry provide a promising platform for the
development of a highly enantioselective catalytic Claisen rearrangement.
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Experimental Section
General Information.  All reactions were performed using oven-dried glassware under
an atmosphere of dry argon.  Non-aqueous reagents were transferred under argon by
syringe.  Organic solutions were concentrated under reduced pressure using a Buchi
rotary evaporator.  Methylene chloride was distilled from CaH2 or filtered through a
column charged with Al2O3 (solvent purification system) immediately prior to use.
Tetrahydrofuran and diethyl ether were distilled from sodium benzophenone ketyl
immediately prior to use.  Acid chlorides were distilled immediately prior to use.  Allenic
esters were prepared according to the procedure of Lang and Hansen.1  All other
commercial reagents were used as provided.  Air sensitive solids were dispensed in an
inert atmosphere glovebox.  Chromatographic purification of products was accomplished
using forced-flow chromatography on ICN 60 32-64 mesh silica gel 63 according to the
method of Still.2  Thin-layer chromatography (TLC) was performed on EM Reagents
0.25 mm silica gel 60-F plates.  Visualization of the developed chromatogram was
performed by fluorescence quenching, or KMnO4 or p-anisaldehyde stain.
1H and 13C NMR were recorded on Mercury 300 (300 MHz and 75 MHz) as
noted, and are internally referenced to residual protio solvent signals.  Data for 1H NMR
are reported as follows:  chemical shift (d ppm), multiplicity (s = singlet, brs = broad
singlet, d = doublet, t = triplet, q = quartet, m = multiplet), integration, coupling constant
(Hz) and assignment.  Data for 13C NMR are reported in terms of chemical shift.  IR
spectra were recorded on a Perkin-Elmer 1600 Series spectrometer using NaCl salt plates,
and reported in terms of frequency of absorption (cm-1).  Mass spectra were obtained
                                                 
1 Lang, R. W.; Hansen, H.-J. Org. Syn 1984, 62, 202.
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from the UC Irvine Mass Spectral Facility.  Gas chromatography was performed on
Hewlett-Packard 6890 Series gas chromatograph equipped with split-mode capillary
injection system and flame ionization detector using a C&C Column Technologies CC-
1701 (30 m x 0.25 mm).
General Procedure A:  The allylic amine and the allenic ester in CH2Cl2 were added
sequentially to a 2 dram vial containing Zn(OTf)2.  The resulting solution was stirred
until the allenic ester was completely consumed (0.25-24 h) as determined by TLC (20%
EtOAc:hexanes).  The solution was diluted with an equal volume of Et2O and flushed
through a short (8 x 30 mm) silica gel plug with an additional equal volume of Et2O.  The
combined filtrates were concentrated and the resulting crude residue was purified by
silica gel chromatography to afford the title compounds.
General Procedure B:  The b-amino-a,b-unsaturated ester was taken up in 5%
EtOAc:hexanes and silica gel was added.  The resulting slurry was stirred until the
starting material was completely consumed as determined by TLC (10% EtOAc:hexanes,
p-anisaldehyde stain.)  The slurry was filtered through a cotton plug and the silica gel was
flushed with ether.  The combined filtrates were concentrated to afford the pure b-keto
esters products.
                                                                                                                                                  
2 Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923.
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General Procedure C:  The b -amino-a,b-unsaturated esters were hydrodeaminated
according to the procedure of Brown.3  The b-amino-a,b-unsaturated ester (0.1 mmol) in
THF (0.25 mL) was added to 9-BBN in a 2-dram vial, and the solution was stirred for 3h.
Solvent was removed in vacuo and MeOH (0.5 mL) was added.  The vial was heated
briefly with a heat gun and then left at room temperature for 0.5h.  Solvent was removed
in vacuo and the resulting residue was dissolved in pentane (2 mL), washed with 1N HCl
(0.5 mL) and H2O (0.5 mL), dried (Na2SO4) and concentrated.  The resulting residue was
purified by silica gel chromatography to provide the a,b-unsaturated ester product.
General Procedure D:  To the b-amino-a,b-unsaturated ester (0.2 mmol) in MeOH (3
mL) was added NaCNBH3 (0.2 g, 3.2 mmol) followed by trifluoroacetic acid (0.3 mL).
After 0.5 h the solution was basified to pH 12 with 1N NaOH, extracted with Et2O (3 x 1
mL), dried (Na2SO4) and concentrated.  The crude residue was taken up in THF (1 mL)
and mCPBA (0.2 g, 1.2 mmol) was added.  After 15 min the solution was diluted with
Et2O (2 mL) and washed with H2O (3 x 1 mL), 20% Na2S2O3 (1 mL), and 1N NaOH (2
mL), dried (Na2SO4) and concentrated.  The crude residue was purified by silica gel
chromatography to provide the a,b-unsaturated ester product.
Benzyl (E)-4,6-Dimethyl-3-pyrrolidinohepta-2,6-dienoate:  Prepared according to
general procedure A from methallyl pyrrolidine (144 mg, 1.14 mmol), benzyl penta-2,3-
dienoate (108 mg, 0.58 mmol), and Zn(OTf)2 (20 mg, 0.06 mmol).  1H NMR (300 MHz,
CDCl3) d 7.29-7.39 (m, 5H, ArH), 5.08 (s, 2H, CH2Ph), 4.73 (d, J = 1.5 Hz, 1H, CH2=C),
                                                 
3 Singaram, B.; Rangaishenvi, M. V.; Brown, H. C.; Goralski, C. T.; et al. J. Org. Chem. 1991, 56, 1543.
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4.71 (s, 1H, CH 2=C), 4.48 (s, 1H, NC=CH), 3.34 (brs, 4H,
N(CH2CH2)2), 2.83 (brs, 1H, CHCH3), 2.31 (brm, 2H,
C(CH3)CH2), 1.88 (m, 4H, N(CH2CH2)2), 1.77 (s, 3H,
CH2=CCH3), 1.21 (brs, 3H, CHCH3); LRMS (CI) m/z 313 (M)+;
HRMS (CI) exact mass calc’d for (C20H27NO2) requires m/z
313.2042, found m/z 313.2037.
The yield was determined by enamine hydrolysis according to procedure B using
2 mL solvent and 0.8 g silica gel to provide the b-keto ester as a colorless oil in 80%
yield (120 mg, 0.46 mmol).  IR (thin film) 3072, 3034, 2972, 2936, 1746, 1714, 1649,
1623, 1456, 1376, 1310, 1262, 1225, 1154 cm-1; 1H NMR (300 MHz, CDCl3) d 7.34-7.36
(m, 5H, ArH), 5.17 (s, 2, CH2Ph), 4.78 (s, 1H CH2=C), 4.68 (s, 1H CH2=C), 3.54 (s, 2H,
C(O)CH2), 2.82 (dq, J = 7.2, 14.4, 1H, CH3CH ), 2.39 (dd, J = 6.0, 14.1 Hz, 1H,
C(CH3)CH2), 2.00 (dd, J = 8.3, 14.3 Hz, 1H, C(CH3)CH2), 1.68 (s, 3H, CH2=CCH3), 1.08
(d, 3H, J = 7.2 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) d 205.8, 167.2, 142.5, 135.6,
128.8, 128.6, 128.5, 113.1, 67.3, 48.1, 44.8, 41.0, 22.5, 16.2; LRMS (CI) m/z 261 (MH)+;
HRMS (CI) exact mass calc’d for (C16H21O3) requires m/z 261.1490, found m/z 261.1500.
Benzyl (2E,4R*,5S*)-4-Methyl-5-phenyl-3-pyrrolidinohepta-2,6-dienoate:  Prepared
according to general procedure A from cinnamyl pyrrolidine (216
mg, 1.15 mmol), benzyl penta-2,3-dienoate (108 mg, 0.57
mmol), and Zn(OTf)2 (20 mg, 0.06 mmol).  The crude residue
was purified by silica gel chromatography (10% EtOAc:hexanes)
to afford the title compound as a light yellow oil in 97% yield (208 mg, 0.55 mmol), 94:6
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syn:anti, 3:1 E:Z.  Syn, E isomer:  IR (thin film) 3062, 3029, 2972, 2873, 1676, 1560,
1455, 1400, 1345, 1128 cm-1; 1H NMR (300 MHz, CDCl3) d 7.29-7.43 (m, 10H, ArH),
6.07 (ddd, J = 9.8, 9.8, 17.1, 1H, CH2=CH), 5.44 (dq, J = 7.7, 11.6, 1H, CHCH3), 5.19 (d,
J = 12.6 Hz, 1H, CH2Ph), 5.12 (d, J = 12.6 Hz, 1H, CH2Ph), 4.90 (d, J = 7.8 Hz, 1H,
CH2=CH), 4.85 (s, 1H, CH2=CH), 4.59 (s, 1H, NC=CH ), 3.39-3.48 (m, 4H,
N(CH2CH2)2), 1.88-1.93 (m, 4H, N(CH2CH2)2), 1.01 (d, 3H, CH3); 13C NMR (75 MHz,
CDCl3) d 169.1, 167.3, 166.9, 165.4, 143.7, 141.5, 141.1, 138.0, 129.0, 128.8, 128.7,
128.6, 128.6, 128.3, 128.2, 128.1, 127.8, 127.7, 126.7, 126.5, 115.7, 114.0, 85.9, 84.1,
64.8, 64.7, 55.2, 51.1, 50.0, 49.6, 43.5, 37.1, 25.7, 25.6, 16.4, 15.1; LRMS (CI) m/z 375
(M)+; HRMS (CI) exact mass calc’d for (C25H29NO2) requires m/z 375.2198, found m/z
375.2199.
The diastereomer ratio was determined by derivitization of the product to benzyl
(2E,4R*,5R*)-4-methyl-5-phenylhepta-2,6-dienoate according to general procedure C
and analysis by 1H NMR.  1H NMR (300 MHz, CDCl3) d 7.15-7.39 (m, 10H, ArH), 7.00
(dd, J = 8.2, 15.4 Hz, 1H, CH=CHCO2), 5.90-6.01 (m, 1H, CH2=CH), 5.86 (d, J = 15.4
Hz, 1H, CH=CHCO2), 5.19 (s, 2H, CH2Ph), 5.10 (d, J = 9.9 Hz, 1H, CH2=CH), 5.01 (d, J
= 17.6 Hz, 1H, CH2=CH), 3.17 (dd, J = 8.2, 8.5 Hz, 1H, PhCH), 2.69 (dd, J = 6.6, 8.5
Hz, 1H, CHCH3), 0.93 (d, J = 6.6 Hz, 3H, CH3); LRMS (CI) m/z 307.2 (MH)+; HRMS
(CI) exact mass calc’d for (C21H23O2) requires m/z 307.1698, found m/z 307.1695.
Benzyl (2E , 4R*,5S*)-4,5-Dimethyl-3-pyrrolidinohepta-2,6-dienoate:  Prepared
according to general procedure A from (E)-crotyl pyrrolidine (144 mg, 1.14 mmol),
benzyl penta-2,3-dienoate (108 mg, 0.58 mmol), and Zn(OTf)2 (20 mg, 0.06 mmol) to
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provide the crude enamine, >98:2 syn:anti.  1H NMR (300 MHz,
CDCl3) d 7.24-7.39 (m, 5H, ArH), 5.67-5.76 (m, 1H, CH2=CH),
5.11 (d, J = 12.9 Hz, 1H, CH 2Ph), 5.08 (d, J = 13.2 Hz, 1H,
CH2Ph), 4.74-4.94 (m, 3H, CH2=CH and CCHCH3), 4.47 (s, 1H,
N C = C H ), 3.31 (brs, 4H, N(CH 2CH2)2), 2.35 (m, 1H,
CH2=CHCH), 1.84 (brs, 4H, N(CH2CH2)2), 1.22 (brs, 3H, CCHCH3), 1.12 (d, J = 5.4 Hz,
3H, CH2=CHCHCH3); LRMS (CI) m/z 313 (M)+; HRMS (CI) exact mass calc’d for
(C20H27NO2) requires m/z 313.2042, found m/z 313.2044.
The yield was determined by enamine hydrolysis according to procedure B using
3 mL solvent and 1.5 g silica gel to provide the beta keto ester as a colorless oil in 95%
yield (142 mg, 0.55 mmol).  IR (thin film) 3068, 3034, 2974, 1746, 1713, 1641, 1456,
1419, 1377, 1307, 1222, 1152 cm-1; 1H NMR (300 MHz, CDCl3) d 7.33-7.36 (m, 5H,
ArH), 5.71 (ddd, J = 7.1, 10.6, 16.9 Hz, 1H, CH2=CH), 5.16 (s, 2H, CH2Ph), 4.97-5.05
(m, 2H, CH 2=CH), 3.51 (s, 2H, C(O)CH 2), 2.44-2.65 (m, 2H, CH2=CHCH and
CCHCH3), 1.04 (d, J  = 7.1 Hz, 3H, CCHCH 3), 0.96 (d, J  = 7.1 Hz, 3H,
CH2=CHCHCH3); 13C NMR (75 MHz, CDCl3) d 205.7, 167.2, 141.5, 135.6, 128.8, 128.6,
128.5, 115.0, 67.3, 51.7, 49.0, 39.7, 16.0, 12.8; LRMS (CI) m/z 261 (MH)+; HRMS (CI)
exact mass calc’d for (C16H21O3) requires m/z 261.1493, found m/z 261.1490.
The diastereomer ratio was determined by derivitization of the product to benzyl
(2E,4R*,5R*)-4,5-dimethylhepta-2,6-dienoate according to general procedure C and
analysis by 1H NMR.  1H NMR (300 MHz, CDCl3) d 7.33-7.39 (m, 5H, ArH), 6.98 (dd, J
= 7.8, 15.9 Hz, 1H, CH=CHCO2), 5.84 (dd, J = 1.2, 15.9 Hz, 1H, CH=CHCO2), 5.64-
5.76 (m, 1H, CH2=CH), 5.18 (s, 2H, CH2Ph), 5.03 (s, 1H, CH2=CH), 4.97-5.03 (m, 1H,
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CH2=CH), 2.18-2.37 (m, 2H, 2CH3CH), 1.07 (d, J = 6.6 Hz, 3H, CH3), 0.99 (d, J = 7.2
Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) d 166.7, 153.4, 141.4, 136.3, 128.7, 128.4,
128.4, 120.6, 114.9, 66.4, 42.7, 41.8, 17.2, 16.5; LRMS (CI) m/z 244.2 (M)+; HRMS (CI)
exact mass calc’d for (C16H20O2) requires m/z 244.1463, found m/z 244.1469.
Benzyl (2E,4R*,5R*)-4,5-Dimethyl-3-pyrrolidinohepta-2,6-dienoate:    Prepared
according to general procedure A from (Z)-crotyl pyrrolidine
(144 mg, 1.14 mmol), benzyl penta-2,3-dienoate (108 mg, 0.58
mmol), and Zn(OTf)2 (20 mg, 0.06 mmol) to provide the crude
enamine, <2:98 syn:anti.  1H NMR (300 MHz, CDCl3) d 7.25-
7.39 (m, 5H, ArH ), 5.63-5.78 (m, 1H, CH2=CH), 4.97-5.14 (m, 4H, CH 2Ph and
CH2=CH), 4.55 (s, 1H, NC=CH), 3.33-3.37 (m, 4H, N(CH2CH2)2), 1.88 (brs, 4H,
N(CH2CH2)2), 1.15 (d, J  = 7.2 Hz, 3H, CCHCH 3), 0.95 (d, J  = 6.6 Hz, 3H,
CH2=CHCHCH3); LRMS (CI) m/z  313 (M)+; HRMS (CI) exact mass calc’d for
(C20H27NO2) requires m/z 313.2042, found m/z 313.2035.   
The yield was determined by enamine hydrolysis according to procedure B using
3 mL solvent and 1.5 g silica gel to provide the beta keto ester as a colorless oil in 94%
yield (140 mg, 0.54 mmol).  IR (thin film) 3068, 3035, 2973, 1746, 1713, 1642, 1456,
1419, 1376, 1313, 1223, 1160 cm-1; 1H NMR (300 MHz, CDCl3) d 7.34-7.38 (m, 5H,
ArH), 5.55-5.67 (m, 1H, CH2=CH), 5.18 (s, 2H, CH 2Ph), 5.05 (d, J = 4.9 Hz, 1H,
CH2=CH), 5.00 (s, 1H, CH2=CH), 3.53 (s, 2H, C(O)CH2), 2.44-2.55 (m, 2H, CCHCH3
and CH2=CHCHCH3), 1.04 (d, J = 6.6 Hz, 3H, CCHCH3), 0.99 (d, J = 6.6 Hz, 3H,
CH2=CHCHCH3); 13C NMR (75 MHz, CDCl3) d 205.8, 167.1, 140.4, 135.6, 128.8, 128.6,
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128.6, 115.7, 67.3, 51.9, 48.9, 40.5, 18.7, 14.2; LRMS (CI) m/z 260.2 (M)+; HRMS (CI)
exact mass calc’d for (C16H20O3) requires m/z 260.1412, found m/z 260.1404.
The diastereomer ratio was determined by derivitization of the product to benzyl
(2E,4R*,5S*)-4,5-dimethylhepta-2,6-dienoate according to general procedure C and
analysis by 1H NMR.  1H NMR (300 MHz, CDCl3) d 7.33-7.39 (m, 5H, ArH), 6.94 (dd, J
= 8.0, 15.7 Hz, 1H, CH=CHCO2), 5.83 (d, J = 15.3 Hz, 1H, CH=CHCO2), 5.61-5.73 (m,
1H, CH2=CH), 5.18 (s, 2H, CH2Ph), 5.02 (s, 1H, CH2=CH), 4.97-4.99 (m, 1H, CH2=CH),
2.12-2.28 (m, 2H, 2CH3CH), 1.01 (d, J = 6.6 Hz, 3H, CH3), 0.97 (d, J = 7.2 Hz, 3H,
CH3); LRMS (CI) m/z 245.2 (MH)+; HRMS (CI) exact mass calc’d for (C16H21O2)
requires m/z 245.1541, found m/z 245.1544.
Benzy l  (2E/Z,4R*,5S*)-4,5-Dimethyl-5-phenyl-3-pyrrolidinohepta-2,6-dienoate:
Prepared according to general procedure A from (E)-3-methyl
cinnamyl pyrrolidine (69 mg, 0.34 mmol), benzyl penta-2,3-
dienoate (54 mg, 0.29 mmol), and Zn(OTf)2 (10 mg, 0.03 mmol).
The crude residue was purified by silica gel chromatography
(10% EtOAc:hexanes) to afford the title compound as a light yellow oil in 90% yield
(100 mg, 0.26 mmol), 97:3 syn:anti, 40:60 E:Z.  Syn isomer:  IR (thin film) 3087, 3060,
3031, 2974, 2877, 1747, 1678, 1558, 1496, 1454, 1398, 1378, 1344, 1327, 1263, 1162,
1131, 1089, 1026, 919 cm-1; 1H NMR (300 MHz, CDCl3) d 7.19-7.49 (m, 10H, ArH),
6.41 (dd, J = 10.4, 16.5 Hz, 1H, CH2=CH, E isomer), 6.32 (dd, J = 10.2, 16.8 Hz, 1H,
CH2=CH Z isomer), 5.50 (q, J = 7.7 Hz, 1H, CHC H3 E isomer), 5.03-4.82 (m, 4H,
CH2Ph and CH2=CH), 4.67 (s, 1H, NC=CH E isomer), 4.61 (s, 1H, NC=CH Z isomer),
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3.44-3.52 (m, 2H, NCH2 Z isomer), 3.12-3.24 (m, 3H, NCH2 and CHCH3 Z isomer),
2.96-3.03 (m, 2H, NCH2 E isomer), 2.78-2.85 (m, 2H, NCH2 E isomer), 1.59-1.81 (m,
4H, N(CH2CH2)2) (E and Z isomer), 1.56 (s, 3H, CCH3) (E isomer), 1.53 (s, 3H, CCH3)
(Z isomer), 1.14 (d, J = 7.7 Hz, 3H, CHCH3) (E isomer), 0.97 (d, J = 7.1 Hz, 3H, CHCH3
Z isomer); 13C NMR (75 MHz, CDCl3) d 168.9, 166.0, 164.1, 163.5, 147.1, 145.9, 145.6,
144.5, 138.2, 138.0, 129.0, 128.8, 128.6, 128.6, 128.4, 128.3, 128.1, 128.1, 128.0, 127.8,
127.7, 127.7, 126.5, 126.2, 114.0. 112.8, 88.8, 84.9, 64.8, 64.7, 52.1, 50.5, 48.5, 48.4,
46.3, 40.5, 26.4, 25.8, 25.5, 25.1, 23.4, 22.0, 16.7, 14.5; LRMS (CI) m/z 388 (MH)+;
HRMS (CI) exact mass calc’d for (C26H30NO2) requires m/z 388.2277, found m/z
388.2264.
The diastereomer ratio was determined by derivitization of the product to benzyl
(2E,4R*,5R*)-4,5-dimethyl-5-phenylhepta-2,6-dienoate according to general procedure C
and analysis by GLC with a CC-1701 column (100 °C, 20 °C/min gradient), tr 16.1 and
16.2 min.  1H NMR (300 MHz, CDCl3) d 7.18-7.41 (m, 10H, ArH), 7.01 (dd, J = 7.1,
15.9 Hz, 1H, CH=CHCO2), 5.84 (d, J = 15.9 Hz, 1H, CH=CHCO2), 5.19 (dd, J = 1.1,
11.0 Hz, 1H, CH2=CH), 5.16 (s, 2H, CH2Ph), 5.05 (d, J = 17.0 Hz, 1H, CH2=CH), 2.90
(dq, J = 6.6, 7.1 Hz, 1H, CHCH3), 1.38 (s, 3H, CCH3), 0.91 (d, J = 6.6 Hz, 3H, CHCH3);
13C NMR (75 MHz, CDCl3) d 166.5, 152.2, 146.2, 144.4, 136.3, 128.7, 128.4, 128.3,
128.3, 126.9, 121.5, 114.3, 66.3, 47.7, 45.1, 21.4, 14.6; LRMS (CI) m/z 321.2 (MH)+;
HRMS (CI) exact mass calc’d for (C22H25O2) requires m/z 321.1854, found m/z 321.1852.
B e n z y l  ( 2E,4R*,5S*)-5-Isopropyl-4-methyl-3-pyrrolidinohepta-2,6-dienoate:
Prepared according to general procedure A from (E)-4-methyl-2-pentenyl pyrrolidine
51
(176 mg, 1.15 mmol), benzyl penta-2,3-dienoate (108 mg, 0.57
mmol), and Zn(OTf)2 (20 mg, 0.06 mmol) to provide the crude
enamine as a yellow oil in 81% yield (159 mg, 0.47 mmol),
>98:2 syn:anti, 5:1 E:Z.  Syn, E isomer:  IR (thin film) 3067,
3032, 2961, 2873, 1742, 1678, 1560, 1455, 1424, 1400, 1345,
1310, 1258, 1129, 1060, 1026 cm-1; 1H NMR (300 MHz, CDCl3) d 7.24-7.40 (m, 5H,
ArH), 5.60 (ddd, J = 10.2, 10.2, 17.3 Hz, 1H, CH2=CH), 5.03-5.18 (m, 3H, CNCHCH3
and CH2Ph), 4.92 (dd, J = 2.2, 10.2 Hz, 1H, CH2=CH), 4.79 (dd, J = 2.2, 17.0 Hz, 1H,
CH2=CH), 4.44 (s, 1H, NC=CH), 3.24-3.35 (m, 4H, N(CH2)2), 2.09 (ddd, J = 2.5, 10.7,
10.7 Hz, 1H, (CH3)2CHCH), 1.80-1.98 (m, 5H, (CH3)2CH and N(CH2CH2)2), 1.22 (d, J =
7.1 Hz, 3H, CNCHCH3), 0.94 (d, J = 7.1 Hz, 3H, (CH3)2CH), 0.89 (d, J = 6.6 Hz, 3H,
(CH3)2CH); 13C NMR (75 MHz, CDCl3) d 168.9, 166.6, 137.9, 128.5, 128.1, 115.5, 84.7,
64.5, 53.8, 49.7, 33.2, 28.6, 25.5, 22.5, 16.5, 16.4; LRMS (CI) m/z 342.2 (MH)+; HRMS
(CI) exact mass calc’d for (C22H33NO2) requires m/z 342.2432, found m/z 342.2434.
The diastereomer ratio was determined by derivitization of the product to benzyl
(2E,4R*,5R*)-5-isopropyl-4-methylhepta-2,6-dienoate according to general procedure C
and analysis by 1H NMR.  1H NMR (300 MHz, CDCl3) d 7.29-7.40 (m, 5H, ArH), 6.95
(dd, J = 8.4, 15.8 Hz, 1H, CH=CHCO2), 5.83 (dd, J = 1.1, 15.6 Hz, 1H, CH=CHCO2),
5.46 (ddd, J = 10.1, 10.1, 17.0 Hz, 1H, CH2=CH), 5.18 (s, 2H, CH2Ph), 5.09 (dd, J = 2.2,
10.1 Hz, 1H, CH 2=CH), 4.94 (dd, 2.2, 16.7 Hz, 1H, CH 2=CH), 2.53-2.64 (m, 1H,
CHCH=CH), 1.62-1.74 (m, 2H, iPr-CH and CH(CH3)2), 1.02 (d, J = 7.0 Hz, 3H, CH3),
0.92 (d, J = 6.1 Hz, 3H, CH3), 0.82 (d, J = 6.6 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3)
d 166.7, 153.1, 137.5, 136.3, 128.7, 128.4, 128.3, 120.6, 117.8, 66.3, 57.1, 37.6, 28.9,
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21.5, 20.2, 18.7; LRMS (CI) m/z 273.2 (MH)+; HRMS (CI) exact mass calc’d for
(C18H25O2) requires m/z 273.1854, found m/z 273.1850.
B e n z y l  ( 2E,4R*,5S*)-3-Dimethylamino-4-methyl-5-phenylhepta-2,6-dienoate:
Prepared according to general procedure A from (E)-cinnamyl-
N,N-dimethylamine (185 mg, 1.15 mmol), benzyl penta-2,3-
dienoate (108 mg, 0.57 mmol), and Zn(OTf)2 (20 mg, 0.06
mmol).  The crude residue was purified by silica gel
chromatography (5% EtOAc:hexanes) to provide the title compound as white needles in
81% yield (162 mg, 0.46 mmol), 94:6 syn:anti, 6:1 E:Z.  Syn, E isomer IR (thin film)
3063, 3029, 2971, 2936, 1678, 1569, 1494, 1454, 1397, 1372, 1316, 1130, 1041, 1024
cm-1; 1H NMR (300 MHz, CDCl3) d 7.22-7.43 (m, 10H, ArH), 6.03 (ddd, J = 9.4, 9.4,
17.7 Hz, 1H, CH2=CH), 5.46 (dq, J = 7.0, 11.6 Hz, 1H, CHCH3), 5.18 (d, J = 9.2 Hz, 1H,
CH2Ph), 5.13 (d, J = 9.2 Hz, 1H, CH2Ph), 4.86-4.93 (m, 2H, CH2=CH), 4.66 (s, 1H,
NC=CH), 3.47 (dd, J = 10.3, 10.5 Hz, 1H, CHPh), 3.00 (s, 6H, N(CH3)2), 1.02 (d, J = 7.5
Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) d 169.0, 167.9, 143.7, 141.5, 137.8, 129.0,
128.7, 128.3, 128.2, 127.9, 126.8, 114.1, 87.0, 64.9, 55.9, 41.9, 36.5, 16.8; LRMS (CI)
m/z 350.2 (MH)+; HRMS (CI) exact mass calc’d for (C22H28NO2) requires m/z 350.2120,
found m/z 350.2114.
The diastereomer ratio was determined by derivitization of the product to benzyl
(2E,4R*,5S*)-4-methyl-5-phenylhepta-2,6-dienoate according to general procedure C and
analysis by 1H NMR.
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Benzyl (2E,4R*,5S*)-3-Piperidino-4-methyl-5-phenylhepta-2,6-dienoate:  Prepared
according to general procedure A from (E)-cinnamyl piperidine
(232 mg, 1.15 mmol), benzyl penta-2,3-dienoate (108 mg, 0.57
mmol), and Zn(OTf)2 (20 mg, 0.06 mmol).  The crude residue
was purified by silica gel chromatography (5% EtOAc:hexanes)
to provide the title compound as a yellow oil in 87% yield (194 mg, 0.50 mmol), 94:6
syn:anti, 6:1 E:Z.  Syn, E isomer:  IR (thin film) 3062, 3029, 2936, 2856, 1746, 1683,
1565, 1494, 1454, 1396, 1360, 1253, 1233, 1145, 1124, 1080, 1022 cm-1; 1H NMR (300
MHz, CDCl3) d 7.18-7.45 (m, 10H, ArH), 5.99-6.11 (m, 1H, CH2=CH), 5.36 (brs, 1H,
CHCH3), 5.17 (s, 2H, CH2Ph), 4.88-4.94 (m, 3H, CH2=CH and NC=CH), 3.41-3.47 (m,
1H, PhCH), 3.29-3.31 (m, 4H, N(CH3)2), 1.64 (brs, 6H, piperdine), 1.01 (d, J = 7.5 Hz,
3H, CH3); 13C NMR (75 MHz, CDCl3) d 170.0, 166.5, 143.8, 141.6, 137.7, 128.9, 128.7,
128.4, 128.3, 127.9, 126.7, 114.5, 89.0, 65.0, 56.1, 49.9, 36.8, 27.5, 26.1, 24.7; LRMS
(CI) m/z 390.2 (MH)+; HRMS (CI) exact mass calc’d for (C26H31NO2) requires m/z
389.2354, found m/z 390.2432.
The diastereomer ratio was determined by derivitization of the product to benzyl
(2E,4R*,5R*)-4-methyl-5-phenylhepta-2,6-dienoate according to general procedure C
and analysis by 1H NMR.   
Benzyl (2E,4R*,5S*)-4,5,9-Trimethyl-3-pyrrolidinohepta-5-vinyldeca-2,8-dienoate:
Prepared according to general procedure A from geranyl pyrrolidine (178 mg, 0.86
mmol), benzyl penta-2,3-dienoate (108 mg, 0.57 mmol), and Zn(OTf)2 (10 mg, 0.03
mmol).  The crude residue was purified by silica gel chromatography (10%
54
EtOAc:hexanes) to provide the title compound as a yellow
oil in 94% yield (214 mg, 0.54 mmol), >98:2 syn:anti, 2:3
E:Z.  Syn isomer:  IR (thin film) 2971, 2876, 1681, 1561,
1454, 1414, 1397, 1378, 1345, 1320, 1263, 1161, 1129,
1093, 1026 cm-1; 1H NMR (300 MHz, CDCl3) d 7.25-7.40
(m, 5H, ArH), 5.84 (dd, J = 11.0, 17.6, Hz, 1H, CH2=CH Z isomer), 5.74 (dd, J = 11.0,
17.6 Hz, 1H, CH2=CH E isomer), 4.91-5.17 (m, 6H, CH2=CH, CH2Ph, (CH3)2C=CH E
and Z isomer; and CHCH3 Z isomer), 4.63 (s, 1H, NC=CH  E  isomer), 4.57 (s, 1H,
NC=CH Z isomer), 3.59-3.67 (m, 2H, N(CH3)2 Z isomer), 3.43-3.48 (m, 2H, N(CH3)2 E
isomer), 3.24-3.29 (m, 2H, N(CH3)2 Z isomer), 3.10-3.18 (m, 2H, N(CH3)2 E isomer),
2.69 (q, J = 7.1 Hz, 1H, CHCH3 E isomer), 1.74-1.95 (m, 6H, N(CH2CH2)2 and CHCH2 E
and Z isomer), 1.67 (s, 3H, CH 3), 1.57 and 1.56 (s, 3H, CH3), 1.37-1.49 (m, 2H,
CHCH2CH2 E  and Z isomer), 1.17 (d, J = 7.7 Hz, 3H, CHCH3 E  isomer), 1.12 (s, 3H,
CH3 E isomer), 1.05-1.07 (m, 6H, CH3 E and Z isomer); 13C NMR (75 MHz, CDCl3) d
168.8, 166.1, 164.9, 164.8, 144.9, 143.6, 138.2, 138.0, 131.5, 130.8, 128.6, 128.5, 128.0,
128.0, 127.7, 127.7, 125.6, 124.9, 113.8, 113.8, 88.4, 85.6, 64.7, 64.5, 52.3, 50.6, 45.0,
44.1, 44.0, 39.8, 39.2, 39.1, 26.1, 26.1, 26.0, 25.0, 23.7, 23.5, 20.9, 20.4, 18.1, 18.1, 16.3,
14.2;  LRMS (CI) m/z 396.3 (MH)+; HRMS (CI) exact mass calc’d for (C26H37NO2)
requires m/z 396.2902, found m/z 396.2899.
The diastereomer ratio was determined by derivitization of the product to benzyl
(2E,4R*,5R*)-4,5,9-Trimethyl-5-vinyldeca-2,6-dienoate according to general procedure
C and analysis by 1H NMR.  1H NMR (300 MHz, CDCl3) d 7.32-7.37 (m, 5H, ArH), 7.01
(dd, J = 8.5, 15.6 Hz, 1H CH=CHCO2), 5.83 (d, J = 15.4 Hz, 1H, CH=CHCO2), 5.71 (dd,
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J = 11.0, 17.6 Hz, 1H, CH2=CH), 5.18 (s, 2H, CH2Ph), 5.04-5.13 (m, 2H, CH2=CH and
(CH3)2=CH), 4.95 (d, J = 17.0 Hz, 1H, CH2=CH), 2.26 (dq, J = 7.1, 7.4 Hz, 1H, CHCH3),
1.84-1.87 (m, 2H, C=CHCH2), 1.67 (s, 3H, CH3), 1.57 (s, 3H, CH3), 1.33 (t, J = 8.5 Hz,
2H, C=CHCH2CH2), 1.00 and 0.97 (d and s, 6H, CHCH3 and CCH3); LRMS (CI) m/z
327.2 (MH)+; HRMS (CI) exact mass calc’d for (C22H31O2) requires m/z 327.2324, found
m/z 327.2326.
Benzyl (2E,4R*,5R*)-4,5,9-Trimethyl-3-pyrrolidinohepta-5-vinyldeca-2,8-dienoate:
Prepared according to general procedure A from neryl
pyrrolidine (178 mg, 0.86 mmol), benzyl penta-2,3-
dienoate (108 mg, 0.57 mmol), and Zn(OTf)2 (10 mg, 0.03
mmol).  The crude residue was purified by silica gel
chromatography (10% EtOAc:hexanes) to provide the title
compound as a yellow oil in 93% yield (211 mg, 0.53 mmol), >98:2 syn:anti, 1:1.  IR
(thin film) 2970, 2876, 1680, 1560, 1455, 1413, 1398, 1376, 1344, 1319, 1264, 1161,
1130, 1091, 1026 cm-1; 1H NMR (300 MHz, CDCl3) d 7.24-7.39 (m, 5H, ArH), 5.95 (dd,
J = 11.0, 17.6 Hz, 1H, CH2=CH), 5.72 (dd, J = 11.0, 17.6 Hz, 1H, CH2=CH), 4.91-5.19
(m, 6H, CH2=CH, CH2Ph, (CH3)2C=CH and CHCH3), 4.61 (s, 1H, NC=CH), 4.59 (s, 1H,
NC=CH), 3.09-3.62 (m, 4H, N(CH3)2), 2.68 (q, J = 7.1 Hz, 1H, CHCH3), 1.74-1.97 (m,
6H, N(CH2CH2)2 and CHCH2), 1.67 (s, 3H, CH3), 1.57 and 1.56 (s, 3H, CH3), 1.26-1.50
(m, 2H, CHCH2CH2), 1.03-1.21 (m, 6H, 2CH3); 13C NMR (75 MHz, CDCl3) d 168.8,
166.1, 165.2, 164.7, 145.4, 144.5, 138.3, 138.0, 131.4, 131.0, 128.5, 128.5, 128.1, 128.0,
127.7, 127.6, 125.3, 124.9, 114.3, 113.1, 87.5, 84.2, 64.6, 64.5, 52.3, 50.5, 45.2, 43.9,
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42.8, 40.2, 40.1, 38.5, 26.1, 26.1, 26.0, 25.1, 23.3, 23.3, 19.9, 19.5, 18.1, 18.1, 16.3, 13.4;
LRMS (CI) m/z 396.3 (MH)+; HRMS (CI) exact mass calc’d for (C26H37NO2) requires m/z
396.2902, found m/z 396.2901.
The diastereomer ratio was determined by derivitization of the product to benzyl
(2E,4R*,5S*)-4,5,9-Trimethyl-5-vinyldeca-2,6-dienoate according to general procedure C
and analysis by 1H NMR.  1H NMR (300 MHz, CDCl3) d 7.33-7.37 (m, 5H, ArH), 6.98
(dd, J = 9.3, 15.9 Hz, 1H CH=CHCO2), 5.85 (d, J = 15.9 Hz, 1H, CH=CHCO2), 5.67 (dd,
J = 11.0, 17.3 Hz, 1H, CH2=CH), 5.18 (s, 2H, CH 2Ph), 5.12 (d, J = 11.0 Hz, 1H,
CH2=CH), 5.06 (t, J = 6.9 Hz, 1H, (CH3)2=CH), 4.95 (d, J = 17.6 Hz, 1H, CH2=CH),
2.24 (dq, J = 7.1, 7.7 Hz, 1H, CHCH3), 1.85 (dt, J = 7.4, 8.2 Hz, 2H, C=CHCH2), 1.67 (s,
3H, CH3), 1.57 (s, 3H, CH3), 1.25-1.37 (m, 2H, C=CHCH2CH2), 0.97 and 0.95 (d and s,
6H, CHCH3 and CCH3); LRMS (CI) m/z 327.2 (MH)+; HRMS (CI) exact mass calc’d for
(C22H31O2) requires m/z 327.2324, found m/z 327.2318.
Methyl (2E,4R*,5R*)-4-Phenyl-5-methyl-3-pyrrolidinohepta-2,6-dienoate:  Prepared
according to general procedure A from crotyl pyrrolidine (118
mg, 0.94 mmol), methyl 4-phenylbuta-2,3-dienoate (82 mg, 0.47
mmol), and Zn(OTf)2 (17 mg, 0.05 mmol).  The crude residue
was purified by silica gel chromatography (5% EtOAc:hexanes)
to afford the title compound as a crystalline solid in 86% yield (121 mg, 0.40 mmol),
97:3 syn:anti, 10:1 E/Z.  Syn, E  isomer:  IR (thin film) 2973, 2869, 1675, 1561, 1496,
1449, 1422, 1385, 1345, 1281, 1141 cm-1; 1H NMR (300 MHz, CDCl3) d 7.14-7.36 (m,
5H, ArH), 6.15 (brd, J = 9.9 Hz, 1H, CHPh), 5.85 (ddd 9.6, 9.6, 17.1 Hz, CH2=CH), 4.96
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(dd, J = 1.8, 17.1 Hz, 1H, CH2=CH), 4.87 (dd, J = 2.0, 10.1 Hz, 1H, CH2=CH), 4.57 (s,
1H, NC=CH), 3.67 (s, 3H, OCH3), 2.90-3.21 (m, 5H, CHCH3 and N(CH2CH2)2), 1.61-
1.71 (m, 4H, N(CH2CH2)2), 1.28 (d, J = 6.3 Hz, 3H, CHCH3);  13C NMR (75 MHz,
CDCl3) d 169.9, 164.0, 142.7, 139.4, 128.4, 128.4, 126.0, 112.8, 85.7, 50.4, 49.1, 47.0,
37.9, 25.3, 21.5; LRMS (CI) m/z 299 (M)+; HRMS (CI) exact mass calc’d for
(C19H25NO2) requires m/z 299.1885, found m/z 299.1878.
The diastereomer ratio was determined by derivitization of the product to methyl
(2E,4R*,5R*)-5-methyl-4-phenylhepta-2,6-dienoate according to general procedure C
and analysis by 1H NMR.  1H NMR (300 MHz, CDCl3) d 7.10-7.35 (m, 6H, ArH and
CH=CHCO2), 5.67-5.79 (m, 2H, CH=CHCO2 and CH2=CH), 5.07 (d, J = 5.5 Hz, 1H,
CH2=CH), 5.03 (s, 1H, CH2=CH), 3.69 (s, 3H, CO2CH3), 3.20 (t, J = 8.8 Hz, 1H, PhCH),
2.54-2.67 (m, 1H, CHCH3), 0.89 (d, J = 6.6 Hz, 3H, CHCH3); LRMS (CI) m/z 231.1
(MH)+; HRMS (CI) exact mass calc’d for (C15H19O2) requires m/z 231.1385, found m/z
231.1382.
Methyl (2E , 4R*,5R*)-4,5-Diphenyl-3-pyrrolidinohepta-2,6-dienoate:  Prepared
according to general procedure A from cinnamyl pyrrolidine (108
mg, 1.15 mmol), methyl 4-phenylbuta-2,3-dienoate (100 mg,
0.57 mmol), and Zn(OTf)2 (20 mg, 0.06 mmol).  The crude
residue was purified by silica gel chromatography (5%
EtOAc:hexanes) to afford the title compound as a colorless oil in
94% yield (196 mg, 0.54 mmol), 94:6 syn:anti.  Syn isomer:  IR (thin film) 2974, 2944,
1671, 1562, 1495, 1448, 1422, 1384, 1345, 1280, 1180, 1141 cm-1; 1H NMR (300 MHz,
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CDCl3) d 7.02-7.59 (m, 11H, ArH and NCCHPh), 5.98 (ddd, J = 9.8, 9.8, 16.6 Hz, 1H,
CH2=CH), 4.95 (d, J = 17.1 Hz, 1H, CH2=CH), 4.84 (dd, J = 1.2, 9.9 Hz, 1H, CH2=CH),
4.72 (s, 1H, NC=CH), 4.14 (dd, J = 10.1, 10.0 Hz, 1H, CH2=CHCH), 3.73 (s, 3H,
OCH3), 2.99-3.29 (m, 4H, N(CH2CH2)2), 1.66-1.75 (m, 4H, N(CH2CH2)2); 13C NMR (75
MHz, CDCl3) d 170.0, 163.1, 143.2, 141.7, 139.3, 129.1, 128.6, 128.2, 128.1, 126.6,
125.9, 113.1, 86.8, 51.2, 50.6, 49.3, 44.4, 25.4; LRMS (CI) m/z 361 (M)+; HRMS (CI)
exact mass calc’d for (C24H27NO2) requires m/z 361.2042, found m/z 361.2041.
The diastereomer ratio was determined by derivitization of the product to methyl
(2E,4R*,5R*)-4,5-diphenylhepta-2,6-dienoate according to general procedure C and
analysis by 1H NMR.  1H NMR (300 MHz, CDCl3) d 7.02-7.28 (m, 11H, ArH and
CH=CHCO2), 6.07 (ddd, J = 8.2, 10.4, 17.0 Hz, 1H, CH2=CH), 5.82 (d, J = 15.9 Hz, 1H,
CH=CHCO2), 5.08-5.16 (m, 2H, CH2=CH), 3.68-3.82 (m, 2H, 2CHPh), 3.72 (s, 3H,
CH3); LRMS (CI) m/z 293.2 (MH)+; HRMS (CI) exact mass calc’d for (C20H21O2)
requires m/z 293.1541, found m/z 293.1543.
(E)-Benzyl 5-Phenyl-3-Pyrrolidinohepta-2,6-dienoate:  Prepared according to general
procedure A from cinnamyl pyrrolidine (108 mg, 0.57 mmol),
benzyl buta-2,3-dienoate (100 mg, 0.57 mmol), and Zn(OTf)2 (10
mg, 0.03 mmol) to afford the title compound as a clear oil in 84%
yield (174 mg, 0.48 mmol).  The material was homogeneous by
1H NMR and 13C NMR analysis.  IR (thin film) 3062, 3029,
2973, 2950, 2871, 1678, 1562, 1495, 1483, 1449, 1387, 1345, 1182, 1128, 1056, 1037,
916 cm-1; 1H NMR (300 MHz, CDCl3) d 7.18-7.42 (m, 10H, ArH), 6.17 (ddd, J = 6.6,
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10.4, 17.0, 1H, CH2=CH), 5.09-5.18 (m, 4H, CH2Ph, CH2=CH), 4.58 (s, 1H, NC=CH),
3.76-3.80 (m, 2H, CHCH2), 2.84-3.12 (brm, 5H, CHCH2 and N(CH2CH2)2), 1.73 (brs,
4H, N(CH2CH2)2); 13C NMR (75 MHz, CDCl3) d 168.3, 162.0, 143.6, 140.5, 138.1,
128.6, 128.5, 128.2, 128.2, 127.8, 126.7, 115,0, 84.0, 64.6, 49.2, 48.5, 36.5, 25.4; LRMS
(CI) m/z 361 (M)+; HRMS (CI) exact mass calc’d for (C24H27NO2) requires m/z 361.2042,
found m/z 361.2042.
B e n z y l  ( 2E,4R*,5S*)-4-Isopropyl-5-phenyl-3-pyrrolidinohepta-2,6-dienoate:
Prepared according to general procedure A from cinnamyl
pyrrolidine (216 mg, 1.15 mmol), benzyl 5-methylhexa-2,3-
dienoate (125 mg, 0.58 mmol), and Zn(OTf)2 (20 mg, 0.06
mmol).  The crude residue was purified by silica gel
chromatography to afford the title compound as a yellow oil in
94% yield (219 mg, 0.54 mmol), 94:6 syn/anti, 7:1 E/Z.     Syn, E isomer:  IR (thin film)
3028, 2961, 2870, 1675, 1559, 1454, 1396, 1344, 1316, 1128, 1059, 1028 cm-1; 1H NMR
(300 MHz, CDCl3) d 7.14-7.52 (m, 10H, ArH), 5.93 (ddd, J = 9.9, 9.9, 17.0 Hz, 1H,
CH2=CH), 5.31 (dd, J = 9.9, 9.9 Hz, 1H, CHCH(CH3)2), 5.21 (d, J = 12.6 Hz, 1H,
CH2Ph), 5.16 (d, J = 12.6 Hz,  1H, CH2Ph), 4.85 (d, J = 17.0 Hz, 1H, CH2=CH),  4.75
(dd, J = 1.4, 10.2 Hz, 1H CH2=CH), 4.67 (s, 1H, NC=CH), 3.26-3.57 (m, 5H, PhCH and
N(CH2)2), 1.80-2.01 (m, 5H, CH(CH3)2 and N(CH2CH2)2), 0.85 (d, J = 6.59 Hz, 3H,
CH3), 0.53 (d, J = 6.59 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) d 169.2, 164.1, 146.0,
142.6, 138.0, 128.7, 128.6, 128.6, 128.2, 128.1, 127.8, 126.4, 112.1, 87.2, 64.7, 55.3,
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50.1, 48.7, 31.7, 25.5, 23.9, 22.6; LRMS (CI) 404.3 (MH)+; HRMS (CI) exact mass
calc’d for (C27H34NO2) requires m/z 404.2589, found m/z 404.2594.
The diastereomer ratio was determined by derivitization of the product to benzyl
(2E,4R*,5R*)-4-isopropyl-5-phenylhepta-2,6-dienoate according to general procedure C
and analysis by 1H NMR.  1H NMR (300 MHz, CDCl3) d 7.16-7.40 (m, 10H, ArH), 6.88
(dd, J = 10.4, 15.4 Hz, 1H, CH=CHCO2), 5.80-5.92 (m, 1H, CH2=CH), 5.81 (d, J = 15.4
Hz, 1H, CH=CHCO2), 5.20 (s, 2H, CH2Ph), 5.00 (d, J = 4.4 Hz, 1H, CH2=CH), 4.95 (d, J
= 11.0 Hz, 1H, CH2=CH), 3.44 (dd, J = 9.1, 9.1 Hz, 1H, CHPh), 2.41 (ddd, J = 10.2, 4.1,
10.1 Hz, 1H, iPrCH), 1.54-1.64 (m, 1H, (CH3)2CH), 0.83 (d, J = 4.4 Hz, 3H, (CH3)2CH),
0.81 (d, J = 4.4 Hz, 3H, (CH3)2CH); LRMS (CI) 335.2 (MH)+; HRMS (CI) exact mass
calc’d for (C23H25O2) requires m/z 335.2010, found m/z 335.2016.
Benzyl (2E,4S*,5S*)-4-Chloro-5-phenyl-3-pyrrolidinohepta-2,6-dienoate:  Prepared
according to general procedure A from cinnamyl pyrrolidine (180
mg, 1.00 mmol), benzyl 4-chlorobuta-2,3-dienoate (100 mg, 0.48
mmol), and Zn(OTf)2 (17 mg, 0.05 mmol).  The crude residue
was purified by silica gel chromatography to afford the title
compound as a yellow oil in 84% yield (160 mg, 0.40 mmol),
93:7 syn:anti, 7:1 E:Z.  Syn, E isomer:  IR (thin film) 3503, 1670, 1570, 1456, 1395,
1345, 1133 cm-1; 1H NMR (300 MHz, CDCl3) d 7.30-7.52 (m, 11H, ArH and CHCl),
6.02 (ddd, J = 9.1, 9.1, 17.6 Hz, 1H, CH2=CH), 5.25 (d, J = 12.6 Hz, 1H, CH2Ph), 5.19
(d, J = 12.0 Hz, 1H, CH2Ph), 5.03 (d, J = 16.5 Hz, 1H, CH2=CH), 5.02 (d, J = 9.9 Hz, 1H
CH2=CH), 4.71 (s, 1H, NC=CH), 3.92 (dd, J = 10.2, 10.2 Hz, 1H, PhCH), 3.72 (brs, 2H,
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N(CH2)2), 3.41-3.44 (m, 2H, N(CH2)2, 1.90-1.97 (m, 4H, N(CH2CH2)2); 13C NMR (75
MHz, CDCl3) d 168.6, 157.4, 141.3, 138.1, 137.4, 129.1, 128.7, 128.3, 128.3, 128.1,
127.4, 116.6, 87.4, 65.3, 56.5, 56.1, 50.0, 25.6; LRMS (CI) 395.1 (M)+; HRMS (CI) exact
mass calc’d for (C24H24ClNO2) (M-H)+ requires m/z 394.1574, found m/z 394.1569.
The diastereomer ratio was determined by derivatization of the product to benzyl
(2E,4R*,5S*)-4-chloro-5-phenylhepta-2,6-dienoate according to general procedure C and
analysis by 1H NMR.  1H NMR (300 MHz, CDCl3) d 7.23-7.40 (m, 10H, ArH), 7.00 (dd,
J = 8.2, 15.4 Hz, 1H, CH=CHCO2), 5.89-6.22 (m, 1H, CH2=CH), 6.08 (d, J = 15.4 Hz,
1H, CH=CHCO2), 5.09-5.25 (m, 2H, CH2=CH), 5.21 (s, 2H, CH2Ph), 4.73 (t, J = 7.7 Hz,
1H, CHCl), 3.72 (t, J = 8.0 Hz, 1H, CHPh). LRMS (CI) 327.0 (MH)+; HRMS (CI) exact
mass calc’d for (C20H20ClO2) requires m/z 327.1152, found m/z 327.1148.
B e n z y l  ( 2E,4S*,5S*)-5-Phenyl-4-phthalimido-3-pyrrolidinohepta-2,6-dienoate:
Prepared according to general procedure A from cinnamyl
pyrrolidine (64 mg, 0.34 mmol), benzyl 4-phthalimidobuta-2,3-
dienoate (91 mg, 0.28 mmol), and Zn(OTf)2 (10 mg, 0.03 mmol).
The crude residue was purified by silica gel chromatography
(20% EtOAc:hexanes) to afford the title compound as a yellow
solid in 75% yield (108 mg, 0.21 mmol) 91:9 syn/anti, 1:1 E:Z.  The (E)-product isomer
was recrystallized from EtOAc/hexanes.  Syn isomer:  IR (thin film) 3062, 3030, 2975,
2871, 1773, 1715, 1676, 1571, 1456, 1379, 1346, 1320, 1133 cm-1; E isomer:  1H NMR
(300 MHz, CDCl3) d 7.93 (d, J = 11.5 Hz, 1H, CHN), 7.10-7.69 (m, 14H, ArH), 6.04
(ddd, J = 9.3, 9.3, 16.9 Hz, 1H, CH2=CH), 5.29 (s, 2H, CH 2Ph), 4.90-5.14 (m, 3H,
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CH2=CH and PhCH), 4.83 (s, 1H, NC=CH), 3.63-3.68 (m, 2H, N(CH2)2), 3.16-3.18 (m,
2H, N(CH2)2), 1.74-2.05 (m, 4H, N(CH2CH2)2); 13C NMR (75 MHz, CDCl3) d 168.7,
168.7, 168.3, 166.6, 158.5, 156.9, 141.6, 139.9, 139.5, 137.9, 137.7, 137.5, 134.5, 134.4,
134.1, 131.6, 131.4, 128.9, 128.8, 128.6, 128.5, 128.3, 128.2, 128.0, 127.8, 127.7, 127.2,
126.9, 123.4, 123.3, 118.4, 115.5, 89.2, 85.9, 65.2, 65.0, 56.3, 54.2, 52.4, 51.9, 50.1, 49.0,
26.2, 25.7.  LRMS (CI) 506 (M)+; HRMS (CI) exact mass calc’d for (C32H30N2O4)
requires m/z 506.2206, found m/z 506.2206.
The diastereomer ratio was determined by derivitization of the product to benzyl
(2E,4R*,5S*)-5-phenyl-4-phthalimidohepta-2,6-dienoate according to general procedure
C and analysis by 1H NMR.  1H NMR (300 MHz, CDCl3) d 7.59-7.69 (m, 4H,
phthalimide H), 7.28-7.42 (m, 6H, ArH and CH=CHCO2), 7.02-7.16 (m, 5H, ArH), 5.91-
6.03 (m, 2H, CH2=CH and CH=CHCO2), 5.15-5.26 (m, 5H, CH2=CH and CH2Ph and
CHN), 4.38 (dd, J = 8.8, 11.5 Hz, 1H, CHPh).  LRMS (EI) 460.1 (MNa)+; HRMS (EI)
exact mass calc’d for (C28H23NO4Na)  requires m/z 460.1525, found m/z 460.1541.
Benzyl (2E , 4R*, 5S*)-4-Allyl-5-phenyl-3-pyrrolidinohepta-2,6-dienoate:  Prepared
according to general procedure A from cinnamyl pyrrolidine (216
mg, 1.15 mmol), benzyl 2,3,6-heptatrienoate (122 mg, 0.58
mmol), and Zn(OTf)2 (20 mg, 0.06 mmol).  The crude residue
was purified by silica gel chromatography (5% EtOAc:hexanes)
to afford the title compound as a yellow oil in 96% yield (219 mg, 0.55 mmol), 95:5
syn:anti, 2:1 E:Z.   Syn isomer:  IR (thin film) 3064, 3029, 2974, 2869, 1676, 1561, 1493,
1483, 1454, 1400, 1345, 1128, 1081, 1067, 1039, 1027 cm-1; 1H NMR (300 MHz, CDCl3)
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d 7.17-7.49 (m, 10H, ArH), 6.09 (ddd, J = 9.3, 10.0, 16.9 Hz, 1H, CH2=CHCHPh, E
isomer), 5.96 (ddd, J = 8.2, 10.4, 17.0 Hz, 1H, CH2=CHCHPh, Z isomer), 5.56-5.69 (m,
2H, CHallyl and CH2=CHCH2), 5.19 (s, 2H, CH2Ph, E isomer), 5.17 (s, 2H, CH2Ph, Z
isomer), 4.82-4.95 (m, 4H, CH2=CHCHPh and CH2=CHCH2), 4.72 (s, 1H, NC=CH, Z
isomer), 4.70 (s, 1H, NC=CH, Z isomer), 3.37-3.52 (m, 4H, N(CH2)2), 3.07-3.13 (m, 1H,
CHPh), 2.09-2.28 (m, 2H, CH2=CHCH2), 1.86-1.93 (m, 4H, N(CH2CH2)2; 13C NMR (75
MHz, CDCl3) d 169.2, 167.3, 165.0, 162.9, 143.5, 143.2, 141.2, 140.8, 138.2, 138.0,
136.7, 136.7, 129.1, 129.0, 128.8, 128.7, 128.6, 128.3, 128.1, 128.0, 127.8, 127.7, 126.8,
126.6, 116.0, 115.9, 115.4, 114.1, 87.8, 84.4, 64.7, 64.7, 54.7, 50.8, 49.9, 49.8, 48.4, 42.5,
35.2, 34.4, 25.7, 25.6; LRMS (CI) 402.2 (MH)+; HRMS (CI) exact mass calc’d for
(C27H32NO2) requires m/z 402.2433, found m/z 402.2428.
The diastereomer ratio was determined by derivitization of the product to benzyl
(2E,4S*,5S*)-4-allyl-5-phenylhepta-2,6-dienoate according to general procedure C and
analysis by 1H NMR.  1H NMR (300 MHz, CDCl3) d 7.19-7.41 (m, 10H, ArH), 6.91 (dd,
J  = 9.3, 15.9 Hz, 1H, CH = C H C O2), 5.96 (ddd, J  = 8.8, 10.0, 17.1 Hz, 1H,
CH2=CH CHPh), 5.85 (d, J  = 15.4 Hz, 1H, CH=CH CO2), 5.61-5.75 (m, 1H,
CH2=CHCH2), 5.21 (s, 2H, CH2Ph), 4.93-5.11 (m, 4H, 2CH2=CH), 3.37 (t, J = 8.5 Hz,
1H, CHPh), 2.67 (ddd, J = 4.7, 8.8, 17.3 Hz, 1H, CHCH2CH=CH2), 1.98-2.23 (m, 2H,
CH2CH=CH2); LRMS (CI) 333.2 (MH)+; HRMS (CI) exact mass calc’d for (C23H24O2)
requires m/z 333.1854, found m/z 333.1854.
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Benzyl (4S*, 5R*)-4-Acetoxy-5-methyl-3-pyrrolidinohepta-2,6-dienoate:  Prepared
according to general procedure A from crotyl pyrrolidine (100
mg, 0.80 mmol), benzyl 4-acetoxybuta-2,3-dienoate (278 mg,
1.20 mmol), and Zn(OTf)2 (29 mg, 0.08 mmol).  The crude
residue was purified by silica gel chromatography (10%
EtOAc:hexanes) to afford the title compound as a yellow oil in
29% yield (83 mg, 0.23 mmol).  IR (thin film) 1749, 1681, 1572, 1454, 1402, 1370, 1346,
1229, 1129, 1026 cm-1; 1H NMR (300 MHz, CDCl3) d 7.26-7.39 (m, 6H, ArH and
CHOAc), 5.71-5.83 (m, 1H, CH2=CH), 5.10 (s, 2H, CH2Ph), 4.91-4.98 (m, 2H,
CH2=CH), 4.57 (s, 1H, CHCO2), 3.35 (brs, 4H, N(CH2)2), 2.04-2.10 (m, 1H, CHCH3),
2.07 (s, 3H, C(O)CH3), 1.81-1.93 (m, 4H, O(CH2)2), 1.15 (d, J = 6.6 Hz, 3H, CHCH3);
HRMS (FAB) (MH)+ exact mass calc’d for (C21H28NO4) requires m/z 358.2018, found
m/z 358.2012.
Benzyl Buta-2,3-dienoate:  In a 500 mL round-bottomed flask, benzyl
(triphenylphosphoranylidene)acetate (20.5 g, 50.0 mmol) was
dissolved in CH2Cl2 (150 mL), and Et3N (7.0 mL, 50 mmol) in CH2Cl2
(50 mL) was added over 5 min.  Acetyl chloride (3.6 mL, 50 mmol) in
CH2Cl2 (50 mL) was added over 15 min.  After stirring for 1h at room temperature, the
solvent was removed, and the remaining yellow slurry was triturated with Et2O (400 mL)
and filtered through a pad of Celite.  The filtrate was concentrated, and the residue was
purified by silica gel chromatography (7% EtOAc:hexanes) to afford the title compound
as a clear colorless oil in 64% yield (5.6 g, 32 mmol.)  IR (thin film) 3068, 3034, 2992,
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2956, 2893, 1970, 1941, 1720, 1259, 1155, 1082 cm–1; 1H NMR (300 MHz, CDCl3) d
7.32-7.38 (m, 5H, ArH), 5.69 (dt, J = 1.1, 6.6 Hz, 1H, CHCO2), 5.25 (s, 1H, CH2), 5.23
(s, 1H, CH2), 5.20 (s, 2H, CH2Ph); 13C NMR (75 MHz, CDCl3) d 216.0, 165.7, 136.0,
128.7, 128.4, 128.3, 88.1, 79.8, 77.8, 76.9, 66.9; LRMS (CI) 173.1 (M-H)+; HRMS (CI)
exact mass calc’d for (C11H9O2) [M-H]+ requires m/z 173.0603, found m/z 173.0605.
Benzyl Penta-2,3-dienoate:  Prepared according to the procedure given for the
preparation of benzyl buta-2,3-dienoate from benzyl
(triphenylphosphoranylidene)acetate (13.0 g, 31.7 mmol),
propionyl chloride (2.8 mL, 31.7 mmol), and Et3N (4.4 mL, 31.7
mmol) to provide, after silica gel chromatography, the title compound as a clear, colorless
oil in 43% yield (2.6 g, 13.7 mmol).  IR (thin film) 3066, 3034, 2981, 2956, 2928, 1964,
1721, 1498, 1456, 1411, 1372, 1285, 1258, 1152, 1002 cm–1; 1H NMR (300 MHz, CDCl3)
d 7.32-7.38 (m, 5H, ArH), 5.58-5.65 (m, 2H, CH=C=CH), 5.19 (s, 2H, CH2Ph), 1.77-
1.81 (m, 3H, CH3); 13C NMR (75 MHz, CDCl3) d 213.3, 166.1, 136.2, 128.8, 128.7,
128.4, 128.3, 90.7, 87.8, 66.7, 13.2; LRMS (CI) 189.1 (MH)+; HRMS (CI) exact mass
calc’d for (C12H11O2) (M-H)+ requires m/z 187.0759, found m/z 187.0752.
Benzyl 5-Methylhexa-2,3-dienoate:  Prepared according to the procedure given for the
preparation of benzyl buta-2,3-dienoate from benzyl
(triphenylphosphoranylidene)acetate (13.0 g, 31.7 mmol),
isovaleryl chloride (3.9 mL, 31.7 mmol), and Et3N (4.4 mL, 31.7
mmol) to provide, after silica gel chromatography, the title compound as a clear colorless
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oil in 50% yield (3.5 g, 16.0 mmol).  IR (thin film) 3034, 2963, 2872, 1958, 1722, 1498,
1456, 1414, 1383, 1320, 1251, 1150, 1003 cm–1; 1H NMR (300 MHz, CDCl3) d 7.31-7.37
(m, 5H, ArH), 5.63-5.69 (m, 2H, HC=C=CH), 5.22 (d, J = 12.6 Hz, 1H, CH2), 5.14 (d, J
= 12.6 Hz, 1H, CH2), 2.42-2.54 (m, 1H, CH(CH3)2), 1.08 (d, J = 7.1 Hz, 6H, (CH3)2); ;
13C NMR (75 MHz, CDCl3) d 211.7, 166.2, 136.3, 128.7, 128.3, 128.2, 102.9, 89.4, 66.7,
28.1, 22.7, 22.6; LRMS (CI) 217.1 (MH)+; HRMS (CI) exact mass calc’d for (C14H17O2)
requires m/z 217.1228, found m/z 217.1235.
Benzyl 2,3,6-heptatrienoate:  Prepared according to the procedure given for the
preparation of benzyl buta-2,3-dienoate from benzyl
(triphenylphosphoranylidene)acetate  (13.0 g, 31.7 mmol), 4-
pentenoyl chloride (3.5 mL, 31.7 mmol), and Et3N (4.4 mL, 31.7
mmol) to provide, after silica gel chromatography, the title
compound as a clear colorless oil in 76% yield (5.1 g, 24.0 mmol).  IR (thin film) 3034,
1961, 1721, 1640, 1498, 1456, 1419, 1374, 1259, 1151, 996 cm–1; 1H NMR (300 MHz,
CDCl3) d 7.31-7.38 (m, 5H, ArH), 5.79-5.92 (m, 1H, CH2=CH), 5.62-5.70 (m, 2H,
CH=C=CH), 5.07-5.25 (m, 4H, CH2Ph and CH2=CH), 2.87-2.93 (m, 2H, CHCH2); 13C
NMR (75 MHz, CDCl3) d 212.9, 165.9, 136.2, 134.9, 128.7, 128.4, 128.3, 116.8, 94.0,
88.8, 66.8, 32.0; LRMS (CI) 215.1 (MH)+; HRMS (CI) exact mass calc’d for (C14H15O2)
requires m/z 215.1072, found m/z 215.1066.
Benzyl 4-Chlorobuta-2,3-dienoate:  Prepared according to the procedure given for the
preparation of benzyl buta-2,3-dienoate from benzyl (triphenylphosphoranylidene)acetate
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(5.0 g, 12.2 mmol), chloroacetyl chloride (1.0 mL, 12.2 mmol), and
Et3N (1.7 mL, 12.2 mmol).  The crude residue was purified by
silica gel chromatography (10% EtOAc:hexanes) to provide the
title compound as a clear colorless oil in 32% yield (0.8 g, 4.0
mmol).  IR (thin film) 3053, 1719, 1456, 1388, 1361, 1262, 1162 cm–1; 1H NMR (300
MHz, CDCl3) d 7.34-7.40 (m, 5H, ArH), 6.47 (d, J = 5.9 Hz, 1H, CHCO2), 6.00 (d, J =
5.9 Hz, 1H, CHCl), 5.25 (d, J = 12.6 Hz, 1H, CH2Ph), 5.20 (d, J = 12.3 Hz, 1H, CH2Ph);
13C NMR (75 MHz, CDCl3) d 211.7, 163.3, 135.6, 128.8, 128.7, 128.5, 95.9, 93.3, 67.5.
LRMS (CI) 209.3 (MH)+; HRMS (CI) exact mass calc’d for (C11H10ClO2) requires m/z
209.0369, found m/z 209.0366.
Benzyl 4-Phthalimidobuta-2,3-dienoate:  Prepared according to the procedure given for
the preparation of benzyl buta-2,3-dienoate from benzyl
(triphenylphosphoranylidene)acetate (10.0 g, 24.4 mmol),
phthalylglycyl chloride (5.5 g, 24.4 mmol), and Et3N (3.4 mL, 24.4
mmol).  The crude residue was purified by silica gel
chromatography (35% EtOAc:hexanes) to provide the title compound as a yellow oil in
20% yield (1.6 g, 5.0 mmol).  The compound was unstable and was used immediately
after purification.  IR (thin film) 3030, 2955, 1784, 1725, 1437, 1380, 1261, 1209, 1157
cm–1; 1H NMR (300 MHz, CDCl3) d 7.85 (dd, J = 3.3, 5.5 Hz, 2H, NPhthH), 7.73 (dd, J =
3.3, 5.5 Hz, 2H, NPhthH), 7.29-7.38 (m, 6H, ArH and CHCO2), 6.30 (d, J = 6.0 Hz, 1H,
CHCN), 5.24 (d, J = 12.6 Hz, 1H, CH2Ph), 5.19 (d, J = 12.6 Hz, 1H, CH2Ph); 13C NMR
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(75 MHz, CDCl3) d 210.4, 164.9, 164.1, 135.8, 134.9, 132.0, 128.7, 128.5, 128.4, 124.0,
97.2, 92.2, 67.3.
Benzyl 2,4-dimethylbuta-2,3-dienoate: Prepared according to the procedure given for
the preparation of benzyl buta-2,3-dienoate from benzyl 2-
(triphenylphosphoranylidene)propionate (13.0 g, 23.5 mmol),
propionyl chloride (2.2 g, 23.5 mmol), and Et3N (6.6 mL, 47.0
mmol).  The crude residue was purified by silica gel chromatography (5%
EtOAc:hexanes) to provide the title compound as a colorless oil in 50% yield (2.36 g,
11.7 mmol). 1H NMR (300 MHz, CDCl3) d 7.30-7.37 (m, 5H, ArH), 5.40-5.50 (m, 1H,
C=CH), 5.19 (s, 2H, CH2Ph), 1.88 (d, J = 3.3 Hz, 3H, CH3), 1.76 (d, J = 7.1 Hz, 3H,
CH3).
Benzyl 4-Acetoxybuta-2,3-dienoate:  A solution of freshly distilled acetoxyacetyl
chloride in CH2Cl2 (1.2 M, 2.5 mL, 2.9 mmol) was added dropwise
to a solution of benzyl (triphenylphosporanylidene)acetate (1.17 g,
2.9 mmol) and Et3N (0.29 g, 2.9 mmol) in CH2Cl2 (11.5 mL) at 0
°C.  After stirring for 30 min. hexanes (20 mL) was added and the mixture was filtered
through a Celite plug.  The filtrate was concentrated to an oily yellow solid.  This crude
material was triturated with hexanes (10 mL), filtered, and concentrated (three times)
until only a clear, colorless oil remained.  This material was unstable and was used
without further purification (66 mg, 0.28 mmol, 10% yield).
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(E)-3-Methyl Cinnamyl Pyrrolidine:  (E)-3-phenyl-2-buten-1-ol was prepared using a
modification of the procedure outlined by Corey and coworkers:4
To a solution of copper(I)iodide (2.9 g, 15.4 mmol) and methyl
lithium (23.0 mL of 1.3 M solution in Et2O, 29.9 mmol) in Et2O (10
mL) at 0 °C was added a solution of 3-iodo-3-phenyl-2-propen-1-ol
(1.0 g, 3.8 mmol) in Et2O (3 mL).  The reaction mixture was stirred at 0 °C for 87 h and
then washed with sat. aq. NH4Cl (200 mL), dried (Na2SO4), and concentrated.  The crude
residue was purified by silica gel chromatography to provide (E)-3-phenyl-2-buten-1-ol
in 69% yield (390 mg, 2.6 mmol).  Spectroscopic data of this material were in complete
agreement with reported literature values5.
The allyl pyrrolidine was prepared using a modification of the procedure outlined
by Froyen and coworkers.6  To a solution of 3-phenyl-2-buten-1-ol (280 mg, 1.9 mmol)
and PPh3 (0.51 g, 1.9 mmol) in THF (3 mL) at 0 °C was added N-bromosuccinimide
(0.35 g, 1.9 mmol) portionwise.  After 15 min pyrrolidine (0.32 mL, 3.9 mL) was added
at the reaction mixture was allowed to warm to room temperature.  After 30 min 1N HCl
(3 mL) was added and the layers were separated.  The aqueous layer was extracted with
Et2O  (3 x 2 mL) and then basified to pH = 10 with 1N NaOH (4 mL).  The aqueous layer
was extracted with Et2O  (3 x 2 mL) and the combined organic extracts were dried
(Na2SO4) and concentrated.  The crude residue was purified by silica gel chromatography
to provide the title compound as a yellow oil in 53% yield (208 mg, 1.0 mmol).  IR (thin
film) 3082, 3057, 3030, 2966, 2874, 2780, 1599, 1494, 1458, 1445, 1376, 1348, 1315,
                                                 
4 Corey, E. J.; Chen, H. K. Tetrahedron Lett., 1973, 18, 1611.
5 Bussas, R.; Münsterer, H.; Kresze, G. J. Org. Chem., 1983, 48, 2828.
6 Froyen P.; Juvvik, P. Tetrahedron Lett. 1995, 36, 9555.
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1290, 1276, 1242, 1200, 1140 cm–1; 1H NMR (300 MHz, CDCl3) d 7.23-7.43 (m, 5H,
ArH), 5.97 (t, J = 7.4 Hz, 1H, C=CH), 3.30 (d, J = 6.6 Hz, 2H, CHCH2), 2.56-2.61 (m,
4H, N(CH2CH2)2), 2.08 (s, 3H, CH3), 1.79-1.83 (m, 4H, N(CH2CH2)2); 13C NMR (75
MHz, CDCl3) d 143.6, 136.4, 128.4, 127.0, 125.9, 125.9, 54.5, 54.5, 23.9, 16.6; LRMS
(CI) 201.2 (M)+; HRMS (CI) exact mass calc’d for (C14H18N) (M-H)+ requires m/z
200.1439, found m/z 200.1431.
Geranyl Pyrrolidine:  Prepared from geraniol (4.3 mL, 25.0 mmol) according to the
procedure outlined for the preparation of (E )-3-methyl
cinnamyl pyrrolidine to provide the title compound as a yellow
oil in 23% yield (1.2 g, 5.7 mmol).  IR (thin film) 2967, 2927,
2778, 1445, 1377, 1348, 1140 cm–1; 1H NMR (300 MHz,
CDCl3) d 5.24 (t, J = 7.1, 1H, CHCH2N), 5.01 (t, J = 6.0 Hz, 1H, (CH3)2C=CH), 2.99 (d,
J  = 7.1 Hz, 2H, CHCH2N), 2.40-2.42 (m, 4H, N(CH 2CH2)2), 1.89-2.02 (m, 4H,
CHCH2CH2), 1.69-1.71 (m, 4H, N(CH2CH2)2), 1.59 (s, 3H, CH3), 1.56 (s, 3H, CH3), 1.51
(s, 3H, CH3); 13C NMR (75 MHz, CDCl3) d 137.4, 131.4, 124.3, 122.0, 54.2, 53.6, 40.0,
26.7, 26.0 23.7, 18.0, 16.6; LRMS (CI) 208.2 (MH)+; HRMS (CI) exact mass calc’d for
(C14H26N) requires m/z 208.2065, found m/z 208.2060.
Neryl Pyrrolidine:  Prepared from nerol (4.5 mL, 25.0 mmol) according to the procedure
outlined for the preparation of (E)-3-methyl cinnamyl pyrrolidine to provide the title
compound as a yellow oil in 24% yield (1.3 g, 6.0 mmol).  IR (thin film) 2966, 2928,
2778, 1447, 1377, 1344, 1140 cm–1; 1H NMR (300 MHz, CDCl3) d 5.19-5.25 (m, 1H,
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CHCH2N), 5.00-5.04 (m, 1H, (CH3)2C=CH), 2.97 (d, J = 7.1
Hz, 2H, CHCH2N), 2.38-2.42 (m, 4H, N(CH2CH2)2), 1.97 (brs,
4H, N(CH2CH2)2), 1.65-1.70 (m, 4H, CHCH2CH2), 1.62 (s, 3H,
CH3), 1.58 (s, 3H, CH3), 1.51 (s, 3H, CH 3); 13C NMR (75
MHz, CDCl3) d 137.4, 131.6, 124.2, 123.0, 54.3, 53.5, 32.4, 26.8, 26.0, 23.8, 23.7, 17.9;
LRMS (CI) 208.2 (MH)+; HRMS (CI) exact mass calc’d for (C14H26N) requires m/z
208.2065, found m/z 208.2061.
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CHAPTER 3
Investigations of Enantioselective Catalysis of the Allenoate-Claisen Rearrangement
Reaction Design
In contemplating asymmetric catalysis of the allenoate-Claisen rearrangement, we
recognized several unusual features of this protocol that we felt distinguished our
endeavor from most other enantioselective catalytic investigations.1  First, one readily
recognizes that in the allenoate-Claisen transition state 2, the Lewis acid binding site is
significantly far removed from the sigmatropic event (Figure 1).  As compared to the
acyl-Claisen protocol (1), this binding point is further by two carbon atoms.  Such an
increase in distance obviously places significant demands on a chiral catalyst to impart
asymmetry to the pro-stereogenic domain.  Fortunately, however, variation of the allenic
carbonyl component, particularly in regards to bidentate chelating moieties (for example
3) should provide advantageous possibilities for organizational control.
Figure 1. Lewis acid binding site considerations.
Second, we recognized that addition of allyl amine 5 to allene conformational
isomers 4A and 4B could potentially result in either of two geometric enolate isomers 6
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and 7 (Figure 2).  Further, each of these isomers could undergo Claisen rearrangement via
either of two orbital-aligned conformational isomers 6A and 6B or 7A and 7B.  Almost
assuredly, the asymmetric influence of a chiral catalyst on these isomeric pairs would be
nondegenerate.  That is to say, these isomers would lead to opposite enantiomers 8 and 9.
Although it seems likely that one of the intermediate isomers will be favored, competitive
rearrangement via an isomeric transition state could lead to significant degradation of
reaction enantioselectivity.
Figure 2. Potential complication of conformational / geometric intermediate isomers.
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Finally, we recognized that because we would be employing racemic allene
starting material, the initial chiral Lewis acid-bound allenic substrate would be a
diastereomeric complex (Figure 3).  Although this should not have an effect on
enantioselectivity since the cumulenic chirality is destroyed upon addition of the amine,
conversion rates could be impacted if the diastereomeric complexes 10 and 11 react at
significantly different rates.
Figure 3. Consequence of racemic allene.
Despite these potentially complicating factors, we felt confident that an
enantioselective catalytic allenoate-Claisen protocol could be devised.
Results and Discussion
To begin our investigation, we chose for our catalyst screening the reaction of
cinnamyl pyrrolidine (12) and benzyl 2,3-pentadienoate (13) (Scheme 1).  This system
was selected for its reasonable reaction rate and the high stability of Claisen product 14
towards silica gel hydrolysis.2
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Scheme 1. System for initial enantioselective catalytic investigations.
Our intitial studies involved a broad screen of chiral ligand and Lewis acid
combinations.  Notable among these were common bisoxazoline-based ligand systems
such as Box (15) and PyBox (16) (Figure 4).3  In addition, a number of arylBox systems
(17, 18, and 19) such as those that were found to be effective for the enantioselective
acyl-Claisen reaction were tested.4  Regardless of the Lewis acid employed, none of these
ligands provided an enantioselectivity for the reaction shown in Equation 1.
Figure 4. Bisoxazoline-based catalyst systems.
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We also gave significant attention to the boron diamine catalyst systems (for
example 20 and 21) that were shown by Yoon in our laboratories to catalyze the acyl-
Claisen rearrangement of non-bidentate chelating substrates (Figure 5).5  Despite
significant variation is steric size of these catalyst systems, in no case was any
enantioselection observed.
Figure 5. Boron diamine catalyst systems.
Our first enantioselective result came with the use of binaphthol (BINOL) based
titanium catalysts (Table 1).6,7  While the parent catalyst system, Ti(BINOL)2 22,
provided only barely detecTable enantioselectivity (entry 1, 9% ee), 3-phenyl
Ti(BINOL)2 23 gave rise to product with significant enantioselectivity (entry 2, 25% ee).
We hypothesized that substitution of the 3 position of the BINOL framework was
required due to the large spatial separation of the catalyst binding site and the sigmatropic
event.  As such we anticipated that substituents that could provide further extension
might have a greater impact on reaction selectivity.  To test this theory, we employed 3-
biphenyl Ti(BINOL)2 24 but, unfortunately, found no increase in enantioselectivity (entry
3, 19% ee).
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Table 1. First enantioselective results using titanium BINOL catalysts.
Although we were encouraged by this first enantioselective result, we were also
wary of attempting to optimize a system of low enantiomeric excess with such a narrow
catalyst requirement.  As such, we decided to investigate the use of a bidentate chelating
substrate.8
Bidentate Chelating Allene
It has been thoroughly established in the field of enantioselective catalysis that
substrates that are capable of binding at two points to a metal center (bidentate) provide
greatly enhanced organizational control over those that bind in a monodentate fashion.
As such, substrates are often designed to incorporate an auxiliary capable of offering this
two-point binding.  We felt this strategy could be advantageous for the allenoate-Claisen
reaction.
In this context we were pleased to find that the allenic oxazolidinone substrate 25
participated readily in the allenoate-Claisen process, providing Claisen adduct 26 in 76%
yield with only 10 mol% Zn(OTf)2 catalyst (Scheme 2).
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Scheme 2. Allenoate-Claisen rearrangement of a bidentate chelating substrate.
We began our catalyst screen for this reaction with bisoxazoline-based ligand
systems as these have been proven to be very effective for a broad range of
transformations using bidentate substrates.  Unfortunately, although a diverse range of
ligands (15-19) and Lewis acids were tested, no enantioselectivity was observed (Figure
6).   Particularly noteworthy is the absence of enantioselection using the highly extended
biphenylbisoxazoline ligand 15.
Figure 6. Bisoxazoline-based catalyst systems.
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Again we turned our attention to chiral diamine catalyst systems (27-32) (Figure
7).  In this case we broadened our screen to include a wider range of sulfonamide
substituents and Lewis acids (B, Mg, Zn, Al).  However, as before, no enantioselectivity
was observed in any case.
Figure 7. Boron diamine catalysts.
Many other catalyst systems not shown here were investigated for this
transformation, however none of them resulted in any enantioselectivity.  As with the
ester allene, success using oxazolidinone allene 25 was found with BINOL-based
titanium complexes.  As shown in Scheme 3, 10 mol% of Ti(BINOL)2 (22) at –15 °C
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catalyzed the formation of Claisen adduct 26 with 21% ee.  It was clear to us at this point
that there was something unique about the titanium–BINOL system for our Claisen
method, and we decided to focus our subsequent studies in this area.
To begin with, we surveyed a range of solvents using 10 mol% Ti(BINOL)2 as
catalyst (Table 2).  While chloroform (entry 2, 17% ee) and THF (entry 3, 17% ee)
offered no advantage over CH2Cl2 (entry 1, 20% ee), we were encouraged to find that
enantioselectivity could be increased somewhat in Et2O and toluene (entries 4 and 5, 27%
ee and 29% ee, respectively).  Most significant was the reaction performed in
chlorobenzene, which proceeded in 40% ee (entry 6).  Reactions in highly polar solvents
such as acetonitrile and DMF resulted in drastically reduced selectivities (entries 7 and 8,
11% ee and 9% ee, respectively).  Based on this study, we chose chlorobenzene as the
solvent in our subsequent experiments.
Scheme 3. Ti(BINOL)2 catalyzed Claisen rearrangement.
In the course of our studies, we came to find that the 40% ee result shown in entry
6 of Table 2 was highly irreproducible.  As this finding coincided with the use of a newly
prepared batch of Ti(BINOL)2, we assumed that catalyst purity was to blame.
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Table 2. Solvent screen with Ti(BINOL)2.
Titanium bisBINOL (22) is prepared by mixing two equivalents of BINOL with
one equivalent of Ti(OiPr)4 in CH2Cl2 and then azeotropically removing isopropanol
(Scheme 4).  We found it exceedingly difficult to remove all traces of iPrOH and we felt
perhaps this was the cause of our irreproducible results.  With this line of thinking, we
decided that a study of catalyst preparation methods would be most worthwhile.
Scheme 4. Preparation of Ti(BINOL)2.
It is a well-known aspect of titanium alkoxide complexes that the titanium center
has a high preference for full occupation of its octahedral coordination sphere.7a  This fact
readily explains the difficulty of fully removing all isopropanol from our catalyst.  We
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reasoned, however, that if the Ti(BINOL)2 was prepared in a coordinating solvent such as
THF, then residual iPrOH might be readily displaced from the metal center and removed
in vacuo (Scheme 5).  Indeed this proved to be the case, and the catalyst could be isolated
as the bis THF complex 33 with no trace of iPrOH.
Scheme 5. Alternative catalyst preparation.
The results of our investigation of the use of this catalyst complex are shown in
Table 3.  We were pleased to find that using stoichiometric 33 in PhCl, Claisen adduct 26
was obtained in 40% ee (entry 1).  Unfortunately, however, while reducing the amount of
catalyst to 50 mol% provided essentially the same result (entry 2), lower catalyst loadings
of 20 and 10 mol% resulted in drastically reduced selectivities (entries 3 and 4, 25% ee
and 15% ee, respectively).  The same pattern was observed in other solvents such as
CH2Cl2, toluene, and THF (entries 5-12).  Notably, using100 mol% 33 in THF, a 48% ee
was observed, our highest to date (entry 9).  Unfortunately reducing catalyst loading
produced an even more dramatic reduction in enantioselectivity that with other solvents.
The reaction in THF was also more sluggish such that 10 mol% catalyst did not produce
observable product (entry 12).
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Table 3. Asymmetric Claisen using Ti(BINOL)2•2THF.
The results shown in Table 3 supported our hypothesis that residual isopropanol
had a detrimental effect on enantioselectivity.  To be thorough, however, we wished to
examine catalyst that did not have iPrOH removed.  To accomplish this the catalyst
complex was prepared in situ by mixing together BINOL and Ti(OiPr)4 in a 2:1 ratio
(Table 4).  To our surprise, the enantioselectivity of reaction products using this protocol
was not diminished.  In fact, at stoichiometric catalyst loadings, a 48% ee was observed,
matching our previous best (entry 1).  Unfortunately, lower catalyst loadings resulted
again in descreased selectivities, with 10 mol% producing only 13% ee (entry 3).
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Table 4. In situ formation of Ti(BINOL)2.
In the course of further optimization studies of this in situ catalyst preparation
protocol, we again found a disturbing lack of reproducibility of enantioselectivity.  The
fortuitous discovery was made, however, that allene starting material that was purified by
silica gel chromatography immediately before use in the Claisen reaction provided
consistently high selectivities.  As shown in Table 5, allene that was not purified
immediately beforehand resulted in 34% ee when employing stoichiometric catalyst
(entry 1), while the same sample of allene, when purified, resulted in 47% ee (entry 2).
Encouragingly, the same %ee was observed when only 50 mol% catalyst was employed
(entry 3).  Unfortunately, purified allene did not solve the problem of reduced
enantioselectivity at lower catalyst loadings (entries 4 and 5).
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Table 5. Effect of allene purification.
Confident we had discovered the root of our irreproducibility problems, we
returned to the use of preformed Ti(BINOL)2 (22) with newly purified allene (Table 6).
Gratifyingly, stoichiometric use of this catalyst in chlorobenzene resulted in product with
45% ee, in line with our previous observations (entry 1).   To our surprise, when 50 mol%
catalyst was employed, our best result to date (50% ee) was observed (entry 2).
Nonetheless, reducing catalyst loading to 20 mol% again led to a decrease in selectivity,
down to 25% ee (entry 3).
It seems clear that there is some contaminant present with the allene or catalyst or
both that has a detrimental effect on enantioselectivity.  Although moisture might seem to
be a likely culprit, rigorous exclusion of water has not correlated to improved results.9  It
is possible that the contaminant is a decomposition product of the allene formed in the
reaction pot, although no such materials have yet been identified.  It also remains to be
seen if this contaminant is responsible for reduced selectivities at low catalyst loadings.
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Table 6. Purified allene with Ti(BINOL)2 catalyst.
Concluding Remarks
We have successfully identified a highly promising Ti(BINOL)2 catalyst system
for the enantioselective allenoate-Claisen rearrangement.  Surprisingly, of the chiral
Lewis acids investigated, the titanium bisbinaphtholate complexes are uniquely effective
for imparting asymmetry in this reaction manifold.  In a limited sense, we have achieved
up to 40% ee using only 10 mol% Ti(BINOL)2 for the reaction of a bidentate allenic
partner.  In a more reproducible manner, we have identified conditions for the allenoate-
Claisen rearrangement with up to 50% ee using only 50 mol% catalyst.  We feel
confident that these studies have provided a strong platform for the successful
development of a highly enantioselective catalytic Claisen rearrangement.
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Experimental Section
General Information.  All reactions were performed using oven-dried glassware under
an atmosphere of dry argon.  Non-aqueous reagents were transferred under argon by
syringe.  Organic solutions were concentrated under reduced pressure using a Buchi
rotary evaporator.  Chlorobenzene was distilled from CaH2 prior to use.  Methylene
chloride was distilled from CaH2 or filtered through a column charged with Al2O3
(solvent purification system) immediately prior to use.  Tetrahydrofuran and diethyl ether
were distilled from sodium benzophenone ketyl immediately prior to use.  Propionyl
chloride was distilled immediately prior to use.  All other commercial reagents were used
as provided.  Air sensitive solids were dispensed in an inert atmosphere glovebox.
Chromatographic purification of products was accomplished using forced-flow
chromatography on ICN 60 32-64 mesh silica gel 63 according to the method of Still.1
Thin-layer chromatography (TLC) was performed on EM Reagents 0.25 mm silica gel
60-F plates.  Visualization of the developed chromatogram was performed by
fluorescence quenching, or KMnO4 or p-anisaldehyde stain.
1H and 13C NMR were recorded on Mercury 300 (300 MHz and 75 MHz) as
noted, and are internally referenced to residual protio solvent signals.  Data for 1H NMR
are reported as follows:  chemical shift (d ppm), multiplicity (s = singlet, brs = broad
singlet, d = doublet, t = triplet, q = quartet, m = multiplet), integration, coupling constant
(Hz) and assignment.  Data for 13C NMR are reported in terms of chemical shift.  IR
spectra were recorded on a Perkin-Elmer 1600 Series spectrometer using NaCl salt plates,
and are reported in terms of frequency of absorption (cm-1).  Mass spectra were obtained
                                                 
1 Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923.
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from the Caltech Mass Spectral Facility.  Optical rotations were recorded on a Jasco P-
1010 polarimeter (WI lamp, 589 nm, 25 °C).  HPLC analysis was performed on Hewlett-
Packard 1100 series HPLC at 254 nm a Chiralcel AS (25 cm) and AS guard (cm) column.
3-Penta-2,3-dienoyloxazolidin-2-one.  To 3-[(triphenyl-phosphoranylidene)-
acetyl]oxazolidin-2-one2 (3.00 g, 7.7 mmol) in CH 2Cl2 (50
mL) was added Et3N (1.07 mL, 7.7 mmol) followed by a 1.0
M soln of freshly distilled propionyl chloride in CH2Cl2 (7.7
mL, 7.7 mmol) dropwise over 20 min.  After stirring at room
temperature for 1h, the solvent was removed in vacuo resulting in an orange solid.  The
crude residue was dissolved in a minimal amount of CH2Cl2 and then loaded onto a silica
gel column.  The column was run with 40% EtOAc : hexanes to provide the title
compound as a mixture of the title compound and isomeric 3-pent-2-ynoyloxazolidin-2-
one as a viscous yellow oil (0.52 g, 3.1 mmol, 40% yield). IR (thin film) 3630, 3532,
3059, 2984, 2924, 2860, 1960, 1774, 1708, 1676, 1522, 1478, 1412, 1388, 1317, 1264,
1227, 1111, 1037, 1016, 966 cm-1; 1H NMR (300 MHz, CDCl3) d 7.02-7.07 (m, 1H,
C(O)CH=C), 5.63-5.72 (m, 1H, C=CHCH3), 4.38-4.45 (m, 2H, OCH2), 4.00-4.11 (m,
2H, NCH2), 3.83-3.85 (m, 2H, CH2CH3), 1.77-1.83 (m, 3H, CH3); 13C NMR (75 MHz,
CDCl3) d 214.5, 168.4, 164.4, 153.8, 153.6, 90.7, 87.1, 80.2, 70.3, 62.6, 62.3, 43.0, 42.8,
27.5, 12.7, 3.8; HRMS (EI)  m/z 167.0589 (M, 167.0582 calcd for C8H9NO3).
                                                 
2 Cardillo, G.; Gentilucci, L.; Matteis, V. D. J. Org. Chem. 2002, 5957.
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3-(4(R*)-Methyl-5(R*)-phenyl-3-pyrolidin-1-ylhepta-2,6-dienoyl)oxazolidin-2-one.
To a 2 dram vial charged with Zn(OTf)2 (18 mg, 0.05
mmol) was added 3-Penta-2,3-dienoyloxazolidin-2-one (84
mg, 0.5 mmol) in CH2Cl2 (2 mL) followed by cinnamyl
pyrrolidine (0.16 g, 0.85 mmol) in CH2Cl2 (2 mL).  After
the allene was consumed as judged by TLC analysis (1 h),
the reaction mixture was diluted with Et2O and flushed through a short silica gel plug.
The filtrate was concentrated and the crude residue was purified by silica gel
chromatography using 35% EtOAc : hexanes to provide the title compound as a yellow
foamy solid (135 mg, 0.38 mmol, 76% yield) as an approximately 3:1 E:Z enamine
isomer ratio.  IR (thin film) 3060, 2973, 2918, 2872, 1758, 1637, 1547, 1480, 1455, 1417,
1384, 1308, 1218, 1195, 1174 cm-1; 1H NMR (300 MHz, CDCl3) d 7.15-7.41 (m, 5H,
ArH ), 5.86-6.11 (m, 1H, CHCH3), 6.00 (s, 1H, C=CHC(O)), 5.39-5.50 (m, 1H,
CH2=CH), 4.80-5.00 (m, 2H, CH2=C), 4.25-4.30 (m, 2H, OCH2), 4.03-4.09 (m, 2H,
NCH2), 3.34-3.54 (m, 5H, N(CH2)2 and CHPh), 1.87-1.96 (m, 4H, O(CH2)2), 0.99 (d, J =
7.1 Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) d 169.1, 167.8, 165.6, 163.2, 154.9,
154.6, 143.6, 143.2, 141.3, 141.0, 129.0, 128.8, 128.7, 128.3, 126.9, 126.8, 126.5, 126.2,
115.7, 114.1, 87.1, 85.0, 61.4, 61.3, 57.2, 54.9, 50.6, 50.3, 43.7, 43.6, 43.5, 37.9, 25.7,
25.3, 15.9, 14.2; HRMS (FAB)  m/z 355.2016 (MH, 355.2022 calcd for C21H27N2O3).
General Procedure A:  A 2 dram vial was charged with the appropriate amount of
catalyst and the vial was placed under an atmosphere of argon. 3-Penta-2,3-
dienoyloxazolidin-2-one (24 mg, 0.14 mmol) in solvent (1.0 mL) was added and the vial
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was cooled to –40 °C.  Cinnamyl amine (40 mg, 0.21 mmol) in solvent (1.0 mL) was
added slowly over 5 min after which time the vial was allowed to warm to –20 °C.   After
the desired reaction time (typically 48 h) the reaction mixture was loaded rapidly onto a
silica gel column (2 x 14 mm) and eluted with 35% EtOAc : hexanes.  The fractions
containing product (typically contaminated with ligand) were combined, concentrated,
and then purified by silica gel chromatography using 35% EtOAc : hexanes to provide
pure product.
Enantiomeric product ratios were determined by HPLC with a Chiralcel AS
column and AS guard column (2.5% iPrOH/hexanes, 1 mL/min flow rate); tr = 51.4 min.
and 67.4 min.  Material of 40% ee:  [a]D = +14.9 ° (c = 0.2, CHCl3).
Preparation of Ti(BINOL)2:  A 20 mL Schlenk flask was charged with (R)-2-binaphthol
(BINOL) (0.75 g, 2.6 mmol) in an inert atmosphere glovebox.  Under positive argon
pressure, degassed solvent (CH2Cl2, toluene, or THF) (13 mL) was added to the flask
followed by freshly distilled Ti(OiPr)4 (0.37 g, 1.3 mmol).  The resulting dark red
solution was stirred for 24 h after which time solvent was removed in vacuo.  After
remaining under high vacuum (1 mm Hg) for 24 h, solvent (13 mL) was added again to
the flask and the mixture was stirred an additional 2 h.  Solvent was again removed in
vacuo and the flask was placed under high vacuum (1 mm Hg) for 48 h to provide the
title material as a dark red solid.  Catalyst prepared in this manner invariably contained
small amounts of iPrOH as judged by 1H NMR except with the use of THF as solvent,
which instead contained approx. 2 equivalents of THF.
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In Situ Preparation of Ti(BINOL)2:  A 2 dram vial was charged with (R)-binaphthyl
(BINOL) (2 eq.) under an inert atmosphere.  Solvent (1 mL) was added followed by
freshly distilled Ti(OiPr)4 (1 eq.).  The resulting dark red solution was allowed to stir at
room temperature for 1 h before allene and amine were added in the manner described
above.
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CHAPTER 4
Progress Towards the Total Synthesis of Erythrolide E
Briarane Diterpenes
Briarane diterpenes are a class of marine metabolites isolated from coelenterates
of Mediterranean, Atlantic, and Pacific waters.1  The first member of the family, briarane
A (1), was isolated in 1977 by Burks et al., and its structure was determined by X-ray
analysis (Figure 1).2  Since this initial report, more than 200 members of the briarane
family have been reported including excavatolides A-Z,3 milolides A-N,4 and erythrolides
A-V.5  The common distinguishing feature of the briaranes is a highly functionalized
bicyclo[8.4.0] ring system (2).
Figure 1.  Briarane A and common briarane structural features.
As a subclass of the briarane family, the erythrolides are characterized by a highly
oxidized tri- or tetracyclic framework.  In 1984 Fenical, Clardy and coworkers isolated
erythrolides A (3) and B (4) from Erythropodium caribaeorum, a gorgonian coral found
off the coast of Belize (Figure 2).5a  Erythrolide A was unique in that it was the first
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natural product identified that presumably arises via a di-p-methane rearrangement.
Erythrolide B, the most abundant metabolite of E. caribaeorum (comprising as much as
30% of the organic extract and 0.5% of the wet weight of the organism), was shown to
posess the prototypical erythrolide framework described by structure 5.
Figure 2.  Erythrolides A and B and common erythrolide structural features.
In 1991 Schmitz, van der Helm, and coworkers isolated erythrolides C-I from
Erythropodium caribaeorum.5b  Subsequently, Mootoo and coworkers reported
erythrolides J-Q5c-e and, recently, Roberge and Andersen et al. reported erythrolides R-V5f
from the same species.  The structures of these compounds were determined by X-ray
analysis, mass spectrometry, NMR spectroscopy, and by comparison to the known
erythrolides.
Of the new compounds, five were shown to possess 2,3-epoxy functionality
(Figure 3).  Erythrolides C (6), D (7), and U (8) vary only in the identity of the acyloxy
group at C-9.  Erythrolide T (9) possesses an additional acyloxy group at C-4 and is
likely the direct epoxidation product of erythrolide B (4).  Erythrolide H (10) lacks allylic
chloride functionality and instead displays a primary allylic alcohol, the apparent result of
an SN2’ displacement of erythrolide C (6) with hydroxide ion.
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Figure 3. 2,3-Epoxy erythrolides:  erythrolides C, D, H, T, and U.
Six erythrolides have been shown to possess a bridging pyran ring (Figure 4).  As
with the epoxy compounds, three of the pyranyl erythrolides, E (11), F (12), and I (13),
result only from variation of the C-9 acyl functionality.  Erythrolides G (14), P (15), and
Q (16) differ from the other pyranyl erythrolides in the oxidation pattern of C-12, C-13,
or C-3.  Although other briarane metabolites that incorporate cyclic ether functionality
have been reported, the erythrolides are the only members that possess the C-2 to C-8
pyran linkage.1
Figure 4. Pyranyl erythrolide:  erythrolides E, F, G, I, P, and Q.
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In addition to erythrolide H (10), four other erythrolide members lack the allylic
chloride functionality (Figure 5).  Erythrolide N (17) possesses an allylic hydroxyl group,
while C-16 of erythrolides J (18), S (19), and O (20) exists in the ester oxidation state.
Although common among other briarane families, the C-16 methyl group of erythrolide
M (21) is unique within the erythrolide class.
Figure 5. Deschloro erythrolides:  erythrolides J, M, N, O, and S.
Four erythrolides possess skeletally rearranged carbon frameworks (Figure 6).  As
noted earlier, erythrolide A (3) contains a [3.1.0] bicyclic system that has been shown to
arise from a di-p-methane rearrangement of erythrolide B (4).  Erythrolide L (22) is a C-9
acyloxy analogue of erythrolide A(3), while erythrolide V (23) varies at C-4.  Erythrolide
K (24), which contains a bicyclo [9.2.1] system, is presumably derived from erythrolide
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A (3) via  [1,5]-sigmatropic hydrogen shift / acetic acid elimination and has, in fact, been
synthesized by this route.5d
Figure 6. Skeletally rearranged erythrolides:  erythrolides A, L, K, V.
Proposed Biosynthesis of the Erythrolides
Although a detailed study of the biosynthesis of the erythrolides has not been
reported, several key steps have been proposed (Figure 7).  The cembrene (26) skeleton,
which arises from cyclization of geranyl geraniol (25), is the biosynthetic precursor to a
number of natural product frameworks.6  Ksebati and Schmitz have suggested that the
briarane skeleton 27 results from 1,10 cyclization (briarane numbering) of cembrene
(26).7
Figure 7. Proposed biosynthetic origin of the briarane skeleton.
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It seems most probable that the pyranyl erythrolides arise from internal ring
opening of the 2,3-epoxy erythrolides (Figure 8).8  Credence is lent to this claim by
noting that the stereochemical configuration at C-2 of the 2,8-ether bridged compounds is
opposite that present in the other members of the briarane family.  Thus erythrolide E
(11) is regarded as the direct biogenetic product of epoxide opening product of
erythrolide C (6).
Figure 8. Biosynthetic origin of the pyranyl erythrolides.
As noted earlier, it has been shown that erythrolide A (3) can be obtained
synthetically via photochemical di-pi-methane rearrangement of erythrolide B (4), though
this does not necessarily rule out an enzymatic bioorigin (Figure 9).5a  Mootoo and
coworkers have demonstrated that erythrolide A (3) is the progenitor of erythrolide K
(24), having effected this conversion by way of a thermal [1,5]-sigmatropic hydrogen
shift followed by silica gel promoted loss of acetic acid.5d  Finally, a related compound,
aquariolide A, presumably arise from the erythrolide A (3) skeleton by way of a vinyl
cyclopropane rearrangement, although this proposal has yet to succumb to synthetic
demonstration.8
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Figure 9. Biosynthesis of erythrolides A and K and aquariolide A from erythrolide B.
Biological Activity of the Erythrolides
A very limited biological activity study of several of the erythrolides has been
disclosed by Roberge and Andersen et al.5f  In an in vitro cytotoxicity assay against the
MCF-7 human breast cancer cell line, erythrolides P (15) and J (18) were found to have
IC50 values of less than 4 mg/mL.  Erythrolide D (7) showed only modest activity (IC50 >
10 mg/mL), while erythrolide T (9) displayed absolutely no activity at the concentrations
tested.  The authors of the study have suggested that the fully reduced cyclohexane ring
systems of erythrolides P (15) and J (18) might be an important motif for optimal
cytotoxicity.
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Erythrolide E
Our interest in the erythrolide diterpenes stemmed from identification of two key
structural issues that we felt our acyl-Claisen rearrangement9 technology would be
particularly well suited to address.  As shown in Figure 10, the vicinal oxy-chloro and
vicinal quaternary carbon-oxy substitution patterns incorporate two structurally and
stereochemically challenging acyl-Claisen retrons.  Our chosen target, erythrolide E (11),
also possesses significant additional elements of complexity including a total of ten
stereocenters, a ten-membered medium ring, and a bridging pyran ring.  Because of the
distinct synthetic challenges posed by the erythrolide E (11) framework, we felt that a
total synthetic effort toward this target would entail a suitable platform for the
demonstration of the utility of the acyl-Claisen rearrangement.
Figure 10. Synthetically challenging structural features of erythrolide E.
Synthetic Plan
Our strategy toward erythrolide E is shown in retrosynthetic format in Scheme 1.
We reasoned that complex tricycle 30 could provide access to the target structure (11) via
hetero-Michael addition. Medium ring 30 should be accessible by way of a Nozaki-
Kishi10 cyclization of tethered bicycle 31.  In turn, scission of the C(3)-C(4) bond of 31
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via Sakurai11 disconnection reveals cyclohexenyl aldehyde 32 and methallyl silane-
lactone 33.
Scheme 1. Retrosynthetic analysis of erythrolide E.
Our first generation retrosynthetic analysis of the core coupling fragment 32 is
outlined in Scheme 2.  Cyclohexenyl aldehyde 32 could be derived from morpholine
amide 34–an ideal Claisen rearrangement retron.  Acyl-Claisen reaction of
cyclohexenylamine 35 with an appropriate acid chloride should thus provide facile access
to the complex core fragment 34.  We reasoned that amine 35 could be constructed by
appropriate functionalization of 1,4-diene 36, a substrate that should be readily derived
from aromatic acid or ester 37 via Birch reduction.
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Scheme 2. Retrosynthetic analysis of the core coupling fragment 32.
Our synthetic plan to construct the lactone coupling fragment 33 is shown in
Scheme 3.  The enol triflate moiety of fragment 33 should be readily prepared from the
corresponding b-keto ester 38 by standard methods.  Lactone 38 should be available by
elaboration of amide 39 via addition of a propionate enolate equivalent followed by
lactone ring closure.  Vicinal oxy-chloro amide 39 represents our second acyl-Claisen
rearrangement retron.  Thus 39 could be prepared rapidly from the relatively simple allyl
amine 40.
Scheme 3. Retrosynthetic analysis of the acyclic fragment 33.
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Model Studies
Before embarking on the total synthesis of erythrolide E, we wished to test the
feasibility of our acyl-Claisen key steps.  Shown in Equation 1 is our model study of the
cyclohexenyl core rearrangement.  Treatment of 3-methylcyclohexenylmorpholine 41
with benzyloxyacetyl chloride in the presence of iPr2NEt and one equivalent of Lewis
acid provided the rearrangement product 42 as a single diastereomer.  Although the yield
of this unoptimized reaction was low, we felt confident that our reaction technology
allowed for the generation of the required functionality in the confines of a cyclic system.
Our model of the second fragment of erythrolide E is shown in Equation 2.  In a
reaction performed by Yoon and Dong,9  (Z)-3-chloroallyl morpholine (43) was
converted to the complex amide 44 in good yield and with high diastereoselectivity by
treatment with benzyloxyacetyl chloride and catalytic Lewis acid in the presence of
Hunig’s base.  Amide 44 displays the desired stereochemical architecture required by the
erythrolide framework.
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With the results of these successful model studies in hand, we turned our efforts
towards construction of the appropriately functionalized fragments for our total synthetic
effort.
Reductive Amination Route to the Cyclohexenyl Core
Our initial studies toward the cyclohexenyl core are shown in Scheme 4.  Birch
reduction12 of commercially available methyl 2,6-dimethylbenzoate (45) proceeded in
modest yield to provide the 1,4-diene 46.  Dihydroxylation of 46 with catalytic osmium
tetroxide then provided the diol 47 in 84% yield as a single diastereomer in which the
carbomethoxy substituent directed reaction exclusively from the opposite pi face.  The
diol 47 was bisacetylated using standard conditions13 to provide bisacetate 48.
At this stage we required the installation of functionality at the allylic methylene
that would provide access to requisite acyl-Claisen substrate 51.  Very quickly we found
that the allylic position could be oxidized with sodium chromate in AcOH / Ac2O, albeit
in low yield.14  In analogy to our preparation of the model amine 41, we anticipated that
reductive amination of the ketone 49  would provide the desired acyl-Claisen
rearrangement substrate 51.
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Scheme 4. Reductive amination route to the cyclohexenyl core.
Unfortunately, when ketone 49 was treated with morpholine and Ti(OiPr)4
followed by Na(CN)BH3 in EtOH,15 no desired product was observed, nor was starting
material recovered.  Instead, a new compound was isolated that had a 1H NMR spectrum
consistent with aromatic compound 50.
We rationalized that the C(2) substituted acetate as well as the carboxylate ester
moiety rendered the C(2) and C(4) protons sufficiently acidic to undergo soft enolization
under the reductive amination conditions.  We therefore modified our strategy to
diminish the capacity for soft enolization by replacing the carboxylate ester moiety and
the acetate protecting group with functionality of a less electron-withdrawing nature.
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Scheme 5. Modified reductive amination strategy.
This modified strategy commenced with Birch reduction16 of 2,6-dimethylbenzoic
acid (52) using lithium metal to generate diene acid 53 in 87% yield (Scheme 5).
Reduction of 53 with LiAlH4 proceeded smoothly to give the alcohol 54 in similarly high
yield, before protection with TBDPSCl furnished the silyloxy diene 55.  Treatment of 55
with NMO and catalytic OsO4 then provided the vicinal diol 56 in 64% yield as a single
diastereomer.  Selective protection of the secondary alcohol moiety of 56 was achieved
by treatment with NaH in THF followed by PMBBr to afford the benzylic ether 57,
which, upon exposure to Ac2O and catalytic TMSOTf, provided the protected triol 58.
Unfortunately, all attempts to access the desired ketone 59 by way of allylic
oxidation resulted in removal of the PMB group and subsequent substrate decomposition.
Mindful that the bisacetate of 56 should be suitable for allylic oxidation, we
decided to investigate whether the ketone derived from 56 ( see 61 in Scheme 6) would
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be stable to the reductive amination conditions.  It was reasoned that the acidity of the
allylic proton in this case should be relatively diminished and therefore less susceptible to
soft enolization in comparison to 49.
Scheme 6. Modified reductive amination strategy.
Treatment of the diol 56 with Ac2O and catalytic TMSOTf provided the bisacetate
60, and allylic oxidation with Na2CrO4 proceeded as expected to afford the ketone 61.
Unfortunately, treatment of 61 under the reductive amination conditions involving either
morpholine or pyrrolidine resulted in a complex mixture of aromatic products.  The
desired amine 62 was not observed.
It was apparent that a reductive amination strategy involving a substrate with a b-
leaving group would be untenable.  We therefore decided to modify our approach by
preparing a Claisen substrate lacking the offending acetoxy moiety.
Towards this end we began by hydrogenating the 1,4-diene 55 using palladium on
carbon (Scheme 7).  The yield of cyclohexene 63 was expectedly low, no doubt due to
overhydrogenation.  Allylic oxidation proceeded as expected to provide the ketone 64.
When subjected to our standard reductive amination conditions, 64 was converted to allyl
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morpholine 65 in 39% yield as a single diastereomer.  NOE coupling of the C(1) and
C(3) protons, however, revealed that the stereochemistry at the amine bearing carbon was
the opposite of what we desired.
Scheme 7.  Hydrogenation route to the cyclohexenyl core.
The rationale for the observed reduction stereoselectivity is straightforward
(Figure 11).  Iminium ion intermediate 66 is expected to exist predominantly in the
conformation shown, which minimizes the number of unfavorable diaxial interactions.  In
this conformation the axial methyl group would block hydride attack from the top face
resulting in the observed all cis product 65.
Figure 11. Stereoselectivity of the reductive amination.
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We decided to utilize this high diastereoselectivity to our advantage by employing
a reduction/inversion strategy (Scheme 8).  Ketone 64 was reduced with NaBH4 in nearly
quantitative yield to provide the allylic alcohol 67.  Complete diastereoselectivity was
observed congruent with our reductive amination results.  Mitsunobu inversion17 of
alcohol 67 with phthalimide resulted in the allylic phthalimide substrate 68.  Deprotection
of the phthalimide group with hydrazine followed by morpholine ring formation
(bromoethyl ether) then provided our desired acyl-Claisen substrate 69.
Scheme 8. Reduction/inversion strategy.
Acyl-Claisen rearrangement of amine 69  proved successful (Scheme 9).
Treatment of 69 with benzyloxyacetyl chloride in the presence of Hunig’s base and one
equivalent of TiCl4 produced Claisen rearrangement product 70 as a single diastereomer
in 41% yield.  Although our low yielding route to Claisen precursor 69 did not allow for
sufficient optimization studies of the rearrangement step, we were confident a suitably
high yield was possible.  In any case we were highly encouraged by the successful
reaction of this complex acyl-Claisen substrate.
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Scheme 9. Acyl-Claisen rearrangement of cyclohexenyl amine 69.
The stereochemistry of the Claisen product was determined by NOE analysis of
the bicyclic lactone 71 obtained from iodolactonization of 70.
Scheme 10. Iodolactonization of the acyl-Claisen rearrangement product 70.
Our rationale for the observed diastereoselectivity of the acyl-Claisen reaction is
based on well-established precedent of the Claisen rearrangement of cyclic substrates18
(Figure 12).  The acyl-Claisen rearrangement of amine 69 could proceed through either a
chair-like (72) or boat-like (73) transition state to provide products epimeric at the a-
position.  In the chair conformation, however, the titanium-bound acyl-enolate moiety
would experience an unfavorable steric interaction with the axial methine proton.  In the
boat conformation this interaction is absent, and, congruent with Claisen precedent, the
observed product (70) is that resulting from the boat-like transition state.
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Figure 12. Stereochemical rationale for the formation of 70.
We next turned our attention to the development of a synthetic strategy that would
allow facile production of significant quantities of the cyclohexenyl core bearing
appropriate functionality.
Based on our rationale of the reduction of iminium 66, we hypothesized that the
reduction stereoselectivity might be reversed for a substrate such as iminium 75 in which
the axial methyl group is absent (Figure 13).
Figure 13. Proposed substrate for reversal of reduction selectivity.
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Our synthetic strategy incorporating this hypothesis is outlined in antithetic
format in Scheme 11.  Ketone 77, which would serve as precursor to the acyl-Claisen
substrate 76, should be readily accessible from enol ether-aldehyde 78 .  We were
intrigued by the possibility of preparing 78 via another methodology developed in the
MacMillan laboratories, namely the organocatalyzed Diels-Alder reaction.
Scheme 11. Retrosynthetic analysis of Claisen substrate 76.
Organocatalysis
The MacMillan group has developed a research program directed at utilizing
purely organic molecules as enantioselective reaction catalysts.  With this aim, Ahrendt,
Borths, and MacMillan reported the LUMO-lowering activation of a,b-unsaturated
aldehydes 80  with chiral secondary amines in the first highly enantioselective
organocatalytic Diels-Alder reaction19a (Figure 14).  This organocatalytic protocol is
predicated on (1) the reversibility of iminium ion formation 81 between an aldehyde and
a secondary amine and (2) the selective reaction of the LUMO-lowered unsaturated
iminium ion.
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Indeed, the authors reported that imidazolidinone catalyst 84 was efficient at
catalyzing the Diels-Alder reaction of a range of unsaturated aldehydes and dienes in a
highly enantioselective fashion.
Figure 14. Organocatalyzed Diel-Alder reaction.
This LUMO-lowering catalysis strategy has since been extended to a number of
different reaction technologies including [3+2]-nitrone cycloadditions,19b Friedel-Crafts
alkylations,19c,d intramolecular Diels-Alder reactions,19e and Michael reactions.19f
Organocatalysis Strategy Towards the Cyclohexenyl Core
We were pleased to find that the organocatalyzed Diel-Alder methodology
developed by Ahrendt and Borths proved suitable for our desired transformation.  Shown
in Table 1 is the condition screen that was performed to optimize this reaction.  Thus
cycloaddition of 2-acetoxy-1,3-pentadiene (85) with acrolein in the presence of 20 mol%
imidazolidinone catalyst 84 at 0 °C proved facile with a range of solvents and acid
cocatalysts.  The optimal combination proved to be perchloric acid in THF which
provided the cycloadduct as a 7.8 to 1 endo:exo mixture of diastereomers in 91% ee.  In
all cases the reactions proceeded to completion.
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The organocatalytic preparation of aldehyde 86 can be performed on large-scale
with no loss in selectivity (Scheme 12).  Although the yield upon scale-up is somewhat
low (44%) due to presumed polymerization of acrolein, the desired adduct 86 can be
accessed readily on a 20 gram scale.
Table 1.  Organocatalyzed Diels-Alder reaction towards the cyclohexenyl core.
Our studies aimed at the elaboration of aldehyde 86 are presented in Scheme 13.
While NaBH4 proved too harsh for the reduction of 86 and resulted in cleavage of the
vinyl acetate moiety, treatment of 86 with excess Na(CN)BH3 provided the alcohol 87
cleanly in 73% yield.  After protection with TIPSCl, vinyl acetate 88 was then converted
to a ,b-unsaturated ketone 89 via a Saegusa-type oxidation according to a modified
procedure of Tsuji.20
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Scheme 12. Large-scale organocatalyzed Diels-Alder reaction.
Unfortunately, when ketone 89 was subjected to the standard reduction amination
conditions, allylic morpholine 90  was produced in low yield with almost no
diastereoselectivity.  Alteration of the reducing agent had no effect on this ratio.
Scheme 13. Elaboration of aldehyde 86.
To address the issue of poor selectivity, we decided to install the C(2)
oxygenation required of the erythrolide E framework.  Our expectation was that this
stereocenter would direct the facial selectivity of reduction in the desired sense
(Figure"15).
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Figure 15. Proposed reduction selectivity with C(2) stereocenter.
To install the requisite oxygen stereocenter, we decided to utilize the well-known
strategy of silyl enol ether oxidation21 (Table 2).  As such, ketone 89 was subjected to
enolization with LDA at low temperature followed by TMSCl quench.  Although used as
a crude isolate, the intermediate siloxy diene 94 was pure as judged by 1H NMR
spectroscopy.
Table 2. Oxidation of ketone 89.
A number of conditions for the oxidation of silyl enol ether 94 were screened
including mCPBA, dimethyldioxirane, and OsO4. However all of these reagents resulted
in at best a 4:1 diastereoselectivity.  To address this issue, we decided to employ
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Sharpless’ chiral dihydroxylating system,22 the commercially available AD-mix a, which
provided the desired hydroxy ketone 93 as a 9:1 trans:cis mixture of diastereomers.
We were somewhat disappointed with the low yield of this transformation (34%,
52% based on recovered starting material) (Scheme 14).  We hypothesized that the low
mass recovery might be a consequence of over oxidation since such highly polar products
would tend to remain in the aqueous layer during workup.  Nonetheless, this procedure
allowed us to access sufficient quantities of hydroxyketone 93 with which to continue our
investigations.
Scheme 14. Optimal hydroxylation procedure.
After protection of the newly formed hydroxyl group with TIPSCl to provide
ketone 95, we were ready for the reductive amination step (Scheme 15).  Unfortunately
95 was completely unreactive to the reductive amination conditions and no products
involving incorporation of morpholine were observed.  The reason for the complete
failure of this transformation is almost surely due to the very high steric demands of
forming the tetrasubstituted iminium ion intermediate.
Given our inability to convert ketone 95 into the appropriate acyl-Claisen
substrate, we decided to continue with our synthetic efforts by accessing the
cyclohexenyl core fragment by way of an Ireland Claisen rearrangement23  (Scheme 16).
As such, ketone 95 was reduced with NaBH4 to provide allylic alcohol 97 as a single
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diastereomer.  Acylation with tert-butyldiphenylsiloxyacetyl chloride then provided
Ireland Claisen substrate 98.
Scheme 15. Attempted reductive amination of ketone 95.
Unfortunately, when subjected to standard Ireland-Claisen conditions (LDA,
TMSCl, -78 °C, then warming) substrate 98 failed to produce more than trace amounts of
Claisen adduct 99 .  We hypothesized that this lack of reactivity was due to the
extraordinarily large size of the TBDPS protecting group.  Therefore, we decided to
prepare a less sterically demanding substrate.
Scheme 16. Preparation of Ireland-Claisen substrate 98.
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As shown in Scheme 17, allylic alcohol 97 was acylated with benzyloxyacetyl
chloride to provide Ireland-Claisen substrate 100.  When subjected to the appropriate
Ireland-Claisen conditions, 100 underwent reaction to provide the cyclohexenyl core acid
101 in 58% yield based on recovered starting material as a 9:1 mixture of diastereomers.
Scheme 17. Ireland-Claisen rearrangement of acyloxy substrate 100.
It should be noted that our acyl-Claisen methodology has been shown to provide
much greater diastereoselectivity (>99:1) than the Ireland-Claisen rearrangement with
similar substrates.  The drawback to the acyl-Claisen approach is thus merely a lack of
suitable reaction technology to prepare the appropriate acyl-Claisen substrate.
Although use of the Ireland-Claisen protocol was a departure from our outlined
goals, it allowed us to access the desired core fragment with which to investigate the later
stages of our synthetic plan.
In order to complete the synthesis of the requisite aldehyde coupling partner, acid
101 was methylated with TMSCH2N2, reduced (DIBALH), and oxidized (TPAP)24 to
provide the complex fragment 104 in 91% yield over 3 steps (Scheme 18).
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Scheme 18. Completion of the synthesis of coupling fragment 104.
Synthesis of the Acyclic Fragment
With a suitable route in place to access core fragment 104, we turned our attention
to the synthesis of the second coupling partner, methallyl silane 33 (Scheme 19).  To
reiterate, we felt confident that compound 33 could be prepared from the complex amide
39, which in turn should be readily prepared with our acyl-Claisen methodology.  Thus to
begin our studies of this phase of our total synthetic effort, we required a facile synthesis
of the Claisen precursor, allyl amine 107.
Scheme 19. Strategy for the preparation of coupling fragment 33.
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Although preparation of substrate 107 proved much more straightforward than the
cyclohexenyl Claisen precursor, we investigated several unsuccessful routes before
success was found.  As most simple allyl morpholines used in the acyl-Claisen studies
were prepared from the corresponding allylic alcohols, we intitially sought to prepare
amine 107 by way of alcohol 105 (Eq. 3).  Attempted trimethylsilylmethylation of
propargyl alcohol followed by halogen quenching, however, provided only a complex
mixture of products.
Alternatively, we investigated Wittig olefination of ketone 106  with
chloromethyltriphenylphosphonium chloride.  Unfortunately, this reaction was
unsuccessful as well, resulting only in recovered starting material (Eq. 4).
Finally, we were unsuccessful in functionalizing the methallyl position of amine
108, undoubtedly due to the incompatibility of the vinyl halide moiety and the alkyl
lithium species (Eq. 5).
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Success came by application of methodology reported by Lambert et al. (Scheme
20).25  Treatment of propargyl morpholine hydrochloride with iodine monochloride in
refluxing THF provided the bishalogenated substrate 110 in 87% yield as a readily
separable 11:1 mixture of regioisomers.  The regioselectivity of this reaction is due to the
electron withdrawing nature of the ammonium chloride functionality.  Completion of the
synthesis of allyl amine 107 was accomplished by transition metal coupling of vinyl
iodide 110 with TMSCH2MgCl.  A screen of palladium and nickel reagents identified
Pd2(dba)3 as the optimal catalyst for this transformation, providing the amine 107 in 88%
yield.
Scheme 20. Preparation of the acyclic acyl-Claisen substrate.
When allyl amine 107 was treated with benzyloxyacetyl chloride in the presence
of iPr2NEt and one equivalent of TiCl4, Claisen product 111 was produced with a very
poor diastereoselectivity (1.4:1 anti:syn) (Scheme 21).  We were pleased to find, however
that with the use of AlCl3, the diastereoselectivity could be increased to 9:1 anti:syn.
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Scheme 21. Acyl-Claisen rearrangement of allyl amine 107.
The reason for the disparity between the two Lewis acids in this reaction is
unclear.  Given the known high levels of (Z)-enolate formation in the addition of
nucleophiles to ketenes and barring enolate equilibration, the two diastereomers must
arise from competition between chair-like 112 and boat-like 113 transition states (Figure
16).  In both transition states, however, several transannular interactions exist between
the chloro, trimethylsilylmethyl, morpholine, and metal-bound enolate moieties.   It
might be proposed that dative bonding between the chloro group and the aluminum metal
center enforces the chair-like transition state thus leading to the anti product 111.
Figure 16. Transition states for acyl-Claisen rearrangement of amine 107.
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Notably, acyl-Claisen technology allowed for the facile preparation of adduct 115
that incorporates a-silyloxy substitution in good yield and with diastereoselectivity equal
to the alkoxy substituted case (Scheme 22).  This fact represents an important point of
flexibility in anticipation of synthetic elaboration of this coupling fragment.
Scheme 22. Alternative acyl-Claisen rearrangement of allyl amine 107.
Asymmetric Synthesis of the Acyclic Fragment
Motivated by our success in accessing this complex fragment 111 of the
erythrolide architecture in a racemic fashion, we turned our attention to preparing
enantiomerically enriched material as required by our coupling strategy.  To accomplish
this goal, we anticipated employing the enantioselective acyl-Claisen protocol developed
by Tehshik Yoon in our laboratories (see chapter 1).26
To restate, Yoon developed a protocol for the enantioselective acyl-Claisen
rearrangement of allyl amines with a-benzyloxyacetyl chloride (Figure 17).  By
employing two equivalents of the magnesium aryl-Box complex 116, a diverse range of
Claisen adducts could be accessed in good yield and with excellent enantioselectivities.
Of primary significance to our studies was the reaction of cis-chloro substrate 43 which,
in the presence of 116, produced the anti Claisen adduct 44 in 91% ee.  Notably, amide
44 differs from our desired synthetic fragment 111 by only a trimethylsilylmethyl
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substituent.  Further, it was shown that methallyl substitution was well tolerated in the
asymmetric Claisen reaction, with methallyl morpholine (117) providing adduct 118 with
similarly high enantioenrichment.
Figure 17. Enantioselective acyl-Claisen method.
Unfortunately, when allyl amine 107 was subjected to Yoon’s optimal conditions
using 300 mol% of chiral promoter 116, the Claisen adduct 111 was produced in only
44% ee and with very low conversion (Scheme 23).  It would seem that the demands
imposed by incorporating both the cis electron- withdrawing chloro substituent and the
bulky methallyl substituent are too severe.
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Scheme 23.  Asymmetric rearrangement of amine 107.
To address the problem of reactivity, we decided to employ a catalyst system that
Yoon had found to be somewhat more reactive, namely, complex 119.  We were
encouraged to find that with 300 mol% of 119 the Claisen adduct 111 could be obtained
with 50% enantioselectivity and in 56% isolated yield at room temperature (Scheme 23).
The result shown in Equation 9 is our best to date.  Though certainly not optimal,
the 3:1 enantiomeric ratio achieved with chiral promoter 119 must be viewed as very
promising.
Scheme 24.  Asymmetric rearrangement of amine 107.
Concluding Remarks
Our principal goal of demonstrating the utility of the acyl-Claisen rearrangement
for the rapid and selective generation of complex architecture in a natural product setting
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has been achieved with the preparation of fragments 70 and 111 (Figure 18).  Further, we
have developed a concise route to access enantioenriched coupling fragment 104 using as
key steps a novel organocatalytic Diels-Alder reaction and an Ireland-Claisen
rearrangement.
Our broader goal of accomplishing a total synthesis of erythrolide E remains a
challenge.  In particular, suitable technologies for the asymmetric preparation of the core
acyl-Claisen substrate must be developed.  In addition, optimization of the
enantioselective acyl-Claisen construction of fragment 111  is required.  Finally,
investigations of fragment coupling and subsequent elaboration parameters are requisite
for a successful total synthetic achievement.
Figure 18. Summary of progress.
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Experimental Section
General Information. All reactions were performed using oven-dried glassware under
an atmosphere of dry argon.  Non-aqueous reagents were transferred under argon or
nitrogen by syringe.  Organic solutions were concentrated under reduced pressure using a
Buchi rotary evaporator.  Methylene chloride (CH2Cl2), diisopropylethylamine (iPr2NEt),
and triethylamine (Et3N) were distilled under N2 from calcium hydride immediately prior
to use.  Tetrahydrofuran (THF) and ether were distilled under N2 from sodium /
benzophenone immediately prior to use.  Acetic anhydride, 2-(benzyloxy)acetyl chloride,
titanium (IV) tetraisopropoxide (Ti(OiPr)4), and trimethylsilyltrifluoromethane-sulfonate
(TMSOTf) were distilled under reduced pressure and stored under N2 in sealed Schlenk
flasks.  Sodium and lithium metals were washed with hexane followed by THF
immediately prior to use.  All other commercial reagents were used as provided.  Air
sensitive solids were dispensed in an inert atmosphere glovebox.  Chromatographic
purification of products was accomplished using forced-flow chromatography on ICN 60
32-64 mesh silica gel 63 according to the method of Still.1  Thin-layer chromatography
(TLC) was performed on EM Reagents 0.25 mm silica gel 60-F plates.  Visualization of
the developed chromatogram was performed by fluorescence quenching, or KMnO4 or p-
anisaldehyde stain.
1H and 13C NMR were recorded on Mercury 300 (300 MHz and 75 MHz) or
Bruker AMX-400 or AMX-300 spectrometers as noted, and are internally referenced to
residual protio solvent signals.  Data for 1H NMR are reported as follows:  chemical shift
(d ppm), multiplicity (s = singlet, brs = broad singlet, d = doublet, t = triplet, q = quartet,
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m = multiplet), integration, coupling constant (Hz) and assignment.  Data for 13C NMR
are reported in terms of chemical shift.  IR spectra were recorded on a Perkin-Elmer 1600
Series spectrometer using NaCl salt plates or with a ASI ReactIr system and are reported
in terms of frequency of absorption (cm-1).  Mass spectra were obtained from the Mass
Spectral Facility at the University of California at Berkeley or at Caltech.  Gas
chromatography was performed on Hewlett-Packard 6890 Series gas chromatograph
equipped with split-mode capillary injection system and flame ionization detector using a
C&C Column Technologies CC-1701 (30 m x 0.25 mm).
3-Methyl-1-morpholino-2-cyclohexene (41).  A modified procedure of Mattson et al.
was employed.2  To a solution of 3-methyl-2-cyclohexen-1-one
(1.50 g, 13.7 mmol) and morpholine (3.57 g, 41.0 mmol) in
CH2Cl2 (120 mL) was added Ti(OiPr)4 (14.59 g, 51.4 mmol)  The
reaction was monitored by react IR for disappearance of the
ketone stretch.  After 6 h the solution was concentrated, and EtOH (45 mL) was added,
followed by Na(CN)BH3 (1.81 g, 28.8 mmol).  The solution was stirred for 1 h, before 1
N NaOH (30 mL) was added.  The resulting mixture was extracted with EtOAc (3 x 50
mL), and the combined organic extracts were dried over Na2SO4 and concentrated.  The
crude residue was purified by silica gel chromatography using EtOAc to furnish amine 41
as a brown oil in 19% yield (0.47 g, 2.6 mmol).  The spectral data for 41 were identical to
that for the previously reported compound.3
                                                                                                                                                                               
1 Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923.
2 Mattson, R. J.; Pham, K. M.; Leuck, D. J.; Cowen, K. A. J. Org. Chem. 1990, 55, 2552.
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Morpholine-2-(1-methyl-2-cyclohexenyl)-2-benzyloxy-ethanamide (42).  To amine 41
(0.05 g, 0.3 mmol), iPr2NEt (0.07 g, 0.6 mmol) and TiCl4⋅THF2
(0.09 g, 0.3 mmol) in CH2Cl2 (3 mL) was added 2-
benzyloxyacetyl chloride (0.41 mL, 1.0 M in CH2Cl2) over 4 h by
syringe pump.  The resulting solution was diluted with Et2O (10
mL) and 1 N NaOH (2 mL) was added.  The resulting mixture
was stirred for 5 min before the layers were separated and the organic layer was washed
with brine, dried over Na2SO4, and concentrated.  The crude residue was purified by silica
gel chromatography using 35% EtOAc:hexanes to provide amide 42 as a yellow oil in
33% yield (0.03 g, 0.09 mmol).  IR (CH2Cl2) 3053, 3030, 2968, 2926, 2864, 1644, 1455,
1436 cm-1; 1H NMR (400 MHz, CDCl3) d  7.33 (m, 5H, ArH ), 5.69 (m, 2H,
CCHCHCH2), 4.64 (d, J = 12.1 Hz, 1H, OCH (H)Ph), 4.42 (d, J = 12.1 Hz, 1H,
OCH(H)Ph), 4.00 (s, 1H, CCH(O)), 3.49-3.71 (m, 8H, N(CH2)2 and O(CH2)2), 1.38-1.96
(m, 6H, CHCH2CH2CH2C), 1.09 (s, 3H, CH3); 13C NMR (100 MHz, CDCl3) d 169.0,
137.5, 132.6, 128.4, 127.9, 127.9, 127.3, 72.7, 67.2, 66.7, 50.2, 46.7, 42.6, 39.3, 32.4,
24.9, 24.5, 19.0; HRMS (FAB) m/z 330.2072 (MH, 330.2069 calcd for C20H27NO3H).
Methyl 2,6-dimethylbenzoate (45).  To 2,6-dimethylbenzoic acid (6.38 g, 42.5 mmol) in
MeOH (100 mL) was added 1,3-dicyclohexylcarbodiimide (DCC)
(8.76 g, 42.5 mmol).  After stirring for 9 h solid was removed by
filtration and H2O (100 mL) was added to the filtrate to produce a
white precipitate.  The resulting mixture was filtered and the
                                                                                                                                                                               
3 Birch, A. J. et al. J. Chem. Soc. C 1971, 2409.
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filtrate was extracted with CH2Cl2 (3 x 100 mL).  The organic layer was dried over
Na2SO4 and concentrated to give a yellow semi-solid.  The residue was purified by silica
gel chromatography using 20% EtOAc:hexane to provide methyl 2,6-dimethylbenzoate
(45) as a colorless oil in 87% yield (6.04 g, 36.8 mmol). The spectral data for 45 was
identical to that for the previously reported compound.4
Methyl 2,6-dimethyl-2,5-cyclohexadiene-1-carboxylate (46).  To methyl 2,6-
dimethylbenzoate (45) (9.41 g, 57.4 mmol) and tert-BuOH (4.25
g, 57.4 mmol) in THF (30 mL) and NH3 (60 mL) at –78 ºC was
added sodium metal (8.0 g, 35 mmol) resulting in a yellow liquid
covered by a brown oil.  The mixture was stirred for 0.5 h before
NH4Cl (10 g) was added, and the flask was warmed to room temperature to remove NH3.
The resulting residue was dissolved in H2O (100 mL) and extracted with Et2O (3 x 50
mL).  The organic extracts were dried over Na2SO4 and concentrated.  The crude residue
was purified by silica gel chromatography using 10% EtOAc:hexane to provide diene 46
as a clear, yellow oil in 50% yield (4.78 g, 28.8 mmol).  The product was determined
pure by 1H NMR and TLC analysis and was used without further purification.  IR
(CH2Cl2) 2937, 2918, 2864, 1733, 1436 cm-1; 1H NMR (300 MHz, CDCl3) d 5.56 (brs,
2H, CCHCH2), 3.64 (s, 3H, C(O)OCH3), 3.42 (t, J = 6.6 Hz, 1H, CHC(O)OCH3), 2.76 (d,
J = 16.0 Hz, 1H, CHCH(H)CH), ), 2.62 (d, J = 16.0 Hz, 1H, CHCH(H)CH), 1.64 (s, 6H,
CH3); 13C NMR (100 MHz, CDCl3) d 173.2, 128.6, 121.8, 52.3, 52.1, 27.5, 21.7; HRMS
(EI) m/z 166.0994 (M, 166.0994 calcd for C10H14O2).
                                                           
4  Jung, M. E.; Hagenah, J. A. J. Org. Chem. 1987, 52, 1889.
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Methyl (1R*, 2S*, 3R *)-2,3-dihydroxy-2,6-dimethyl-5-cyclohexene-1-carboxylate
(47).  To a mixture of tert-BuOH (140 mL) and H2O (140 mL) was
added AD-Mix b (Aldrich Chemical Co.) (40.75 g). The mixture
was stirred until two distinct layers were visible, with the bottom
layer appearing bright orange.  Methanesulfonamide (2.27 g, 23.9
mmol) was added, the flask was cooled to 0 ºC, and diene 46 (4.78 g, 23.9 mmol) was
added with vigorous stirring.  After stirring at 0 ºC for 67 h, Na2SO3 (36 g) was added and
the flask was allowed to warm to room temperature.  EtOAc (100 mL) was added and the
layers were separated.  The aqueous layer was extracted with EtOAc (3 x 100 mL) and
the combined organic extracts were washed with 2 N KOH (200 mL), dried over Na2SO4,
and concentrated.  The crude residue was purified by silica gel chromatography using
85% EtOAc:hexane to provide diol 47 as a glassy solid in 85% yield (4.06 g, 20.3 mmol).
IR (CH2Cl2) 3567, 3451, 2980, 2953, 2918, 2860, 1733, 1436, 1320 cm-1; 1H NMR (400
MHz, CDCl3) d 5.42 (brs, 1H, CCHCH2), 3.89 (dd, J = 6.0, 6.0 Hz, 1H, CHOH), 3.69 (s,
3H, C(O)OCH3), 3.20 (s, 1H, CHC(O)OCH3), 2.87 (brs, 2H, CHOH and COH), 2.36 (d,
J = 18.0 Hz, 1H, CHCH(H)CH), 2.11 (d, J = 18.0 Hz, 1H, CHCH(H)CH), 1.63 (s, 3H,
CCH3), 1.19 (s, 3H, C(OH)CH3); 13C NMR (100 MHz, CDCl3) d 172.9, 129.1, 121.7,
72.3, 70.4, 57.2, 52.0, 31.1, 22.4, 21.7; ; HRMS (FAB) m/z 201.1130 (MH, 201.1127
calcd for C10H16O4H).
Methyl (1R*, 2S*, 3R*)-2,3-diacetoxy-2,6-dimethyl-5-cyclohexene-1-carboxylate
(48).  To diol 47 (4.06 g, 20.3 mmol) and 4-(dimethylamino)pyridine (DMAP) in Et3N (5
mL) was added acetic anhydride (6.22 g, 60.9 mmol).  After stirring for 58 h the solution
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was acidified with 2 N HCl to pH <2 and then diluted with Et2O
(10 mL).  The layers were separated and the organic layer was
washed with saturated NaHCO3, dried over Na2SO4, and
concentrated.  The crude residue was purified by silica gel
chromatography using 35% EtOAc:hexane to furnish bisacetate 48 as a white solid in
58% yield (3.33 g, 11.7 mmol).  IR (CH2Cl2) 1737, 1436, 1370, 1239 cm-1; 1H NMR (400
MHz, CDCl3) d  5.47 (m, 2H, CCHCH2 and CH(OC(O)CH3)), 4.11 (s, 1H,
CHC(O)OCH3), 3.71 (s, 3H, C(O)OCH3), 2.42 (d, J = 17.4 Hz, 1H, CH(H)), 2.25 (d, J =
17.4 Hz, 1H, CH(H)), 2.07 (s, 3H, C(O)CH3), 1.98 (s, 3H, C(O)CH3), 1.62 (s, 3H CCH3),
1.55 (s, 3H, C(OC(O)CH3)CH3); 13C NMR (100 MHz, CDCl3) d 171.6, 170.3, 170.2,
128.5, 121.8, 80.2, 71.5, 53.2, 52.1, 28.1, 22.2, 21.7, 21.1, 19.4; HRMS (FAB) m/z
285.1338 (MH, 285.1338 calcd for C14H20O6H).
(1R*, 2S*, 3R*)-2,3-diacetoxy-3,5-dimethyl-4-methylcarboxylate-5-cyclohexen-1-one
(49).  To ester 48 (1.29 g, 4.5 mmol) in AcOH (10.6 mL) and
acetic anhydride (6.4 mL) was added solid Na2CrO4 (2.93, 18.1
mmol).  The mixture was observed to change from orange to dark
green over the course of the reaction.  After stirring for 65 h the
solution was poured onto saturated NaHCO3 (50 mL) overlaid with Et2O (20 mL), stirred
for 1 h, and then diluted with H2O (20 mL).  The aqueous layer was extracted with Et2O
(3 x 50 mL) and the combined extracts were dried over Na2SO4 and concentrated to a
white solid.  The residue was purified by silica gel chromatography using 35%
EtOAc:hexane to furnish ketone 49 as a white solid in 23% yield (0.31 g, 1.0 mmol).  IR
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(CH2Cl2) 1741, 1702, 1498, 1436, 1374, 1227; 1H NMR (400 MHz, CDCl3) d 6.02 (s, 1H,
CH(OC(O)CH3)), 5.96 (s, 1H, CCHCH2), 4.67 (s, 1H, CHC(O)OCH3), 3.78 (s, 3H,
C(O)OCH3), 2.22 (s, 3H, CH(O)CH3), 1.95 (s, 3H, C(O)CH3), 1.92 (s, 3H, CCH3), 1.64
(s, 3H, C(OC(O)CH3)CH3); 13C NMR (100 MHz, CDCl3) d 190.3, 170.4, 170.1, 168.9,
152.0, 126.7, 83.6, 76.0, 54.4, 53.1, 22.9, 22.1, 20.6, 19.6; LRMS (FAB) m/z 299 (MH)+.
2,4-dimethyl-3-hydroxymethyl-1,4-cyclohexadiene (54).  To a solution of 2,6-
dimethylbenzoic acid (52) (20.40 g, 135.8 mmol) in NH3 (1000
mL) and EtOH (134 mL) at –40 ºC (±5 ºC) was added lithium
metal (4.70 g, 677 mmol).  The deep blue solution was stirred for
several minutes until a white suspension was observed.  At this
point NH4Cl (50 g) was added and the flask was allowed warmed to room temperature to
remove NH3.  The resulting solid residue was dissolved in H2O (300 mL) and then
acidified with 1 N HCl to pH <2.  The resulting solution was extracted with EtOAc (3 x
250 mL), dried over Na2SO4, and concentrated to provide the acid 53 as a white solid in
87% yield (18.06 g).  The spectral data for acid 53 was identical to that for the previously
reported compound.5  Acid 53 was used without further purification.
To a solution of LiAlH4 (6.50 g, 171 mmol) in Et2O (140 mL) at 0 ºC was added a
solution of acid 53 (17.50 g, 115.0 mmol) in Et2O (100 mL) and the flask was allowed to
warm to 23 ºC over 1 h where it was maintained for a further 10 h.  At this point the
solution was adjusted to pH <2 with 1 N HCl and the layers were separated.  The aqueous
layer was extracted with Et2O (3 x 100 mL) and the combined organic extracts were dried
over Na2SO4 and concentrated to give alcohol 54 as a yellow oil in 87% yield (13.79 g,
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99.8 mmol) which was determined to be pure by 1H NMR and 13C NMR analysis.
Alcohol 54 was used without further purification.  IR (CH2Cl2) 3570, 2968, 2937, 2918,
2887, 2860, 2826, 1447, 1386 cm-1; 1H NMR (300 MHz, CDCl3) d 5.71 (brs, 2H,
CCHCH2), 3.76 (brm, 2H, CH2OH), 2.66 (m, 3H, CHCH2CH and CCH(CH2OH)C), 1.76
(s, 6H, CCH3), 1.23 (t, J = 6.1 Hz, 1H, OH); 13C NMR (75 MHz, CDCl3) d 131.7, 123.3,
60.8, 47.8, 28.0, 21.6; HRMS (EI) m/z 138.1042 (M, 138.1045 calcd for C9H14O).
2,4-dimethyl-3-(tert-butyldiphenylsiloxy)methyl-1,3-cyclohexadiene (55).  To a
solution of alcohol 5 4  (7.00 g, 50.7 mmol), 4-
(dimethylamino)pyridine (DMAP) (0.49 g, 4.0 mmol), and Et3N
(8.5 mL) in CH2Cl2 (100 mL) was added t e r t -
butyldiphenylchlorosilane (TBDPSCl) (13.92 g, 50.7 mmol).
After stirring for 20 h the resulting white precipitate was filtered off through a Celite pad
and washed with CH2Cl2 (20 mL).  The filtrate was then washed with saturated NH4Cl
(150 mL) followed by brine (150 mL), dried over Na2SO4, and then concentrated to
provide the silyl ether 55 as a white solid in 88% yield (16.71 g, 44.4 mmol).  Silyl ether
55 was determined pure by 1H NMR and TLC analysis.  IR (CH2Cl2) 2964, 2934, 2883,
2860, 1475, 1428 cm-1; 1H NMR (400 MHz, CDCl3) d  7.72 (d, J = 9.5 Hz, 4H,
SiC(CH)2), 7.45 (m, 6H, SiCCH(CH)2 and SiCCHCHCH), 5.63 (brs, 2H, CCHCH2),
3.76 (d, J = 3.8 Hz, 2 H, CH2OSi), 2.72 (d, J = 16.2 Hz, 1H, CHCH(H)CH), 2.60 (d, J =
16.2 Hz, 1H, CHCH(H)CH),  2.58 (m, 1H, CCH(CH2OSi)C), 1.76 (s, 6H, CCH3), 1.07
(s, 9H, SiC(CH3)3); 13C NMR (100 MHz, CDCl3) d 135.7, 134.0, 133.3, 129.6, 127.6,
                                                                                                                                                                               
5 Grossel, M. C. J. Chem. Soc., Perkin Trans. 2 1975, 1544.
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121.6, 64.0, 47.9, 27.8, 26.8, 22.1, 19.3; HRMS (FAB) m/z 383.2398 (M+Li, 383.2382
calcd for C25H32OSiLi).
(1R *, 2S *, 3R*)-3-(tert-butyldiphenylsiloxy)methyl-1,2-dihydroxy-2,4-dimethyl-4-
cyclohexene (56).  To a mixture of OsO4 in tert-BuOH (0.04 M,
18.0 mL) and N-methylmorpholine oxide monohydrate (NMO)
(3.42 g, 25.3 mmol) in acetone (50 mL) and H2O (11 mL) was
added silyl ether 55 (0.79 g, 2.1 mmol).  The flask was warmed
with a heat gun until a homogeneous solution was observed.  The resulting solution was
maintained at 23 ºC for 13 h before a slurry of NaHSO3 (0.06 g) and Florisil (7.25 g) in
H2O (100 mL) was added.  The Florisil was removed by filtration and then washed with
EtOAc (20 mL).  The layers of the combined filtrates were separated, and the aqueous
layer was neutralized with 1 N H2SO4 before NaCl (5 g) was added.  The aqueous layer
was then extracted with EtOAc (2 x 100 mL), and the combined organic extracts were
dried over Na2SO4 and concentrated.  The crude residue was purified by silica gel
chromatography using a solvent gradient (10:90 EtOAc:hexane to 50:50 EtOAc:hexane)
to furnish diol 56 as a viscous oil in 64% yield (0.55 g, 13.4 mmol).  IR (CH2Cl2) 3567,
3486, 2964, 2934, 2891, 2860, 1471, 1428 cm-1; 1H NMR (400 MHz, CDCl3) d 7.71 (m,
4H, SiC(CH)2), 7.45 (m, 6H, SiCCH(CH)2 and SiCCHCHCH), 5.31 (brs, 1H, CCHCH2),
4.25 (s, 1H, CHOH), 4.10 (dd, J = 10.6, 4.9 Hz, 1H, CH2CH(OH)C), 3.80 (d, J = 10.1
Hz, 2H, CHCH2OSi), 2.85 (bs, 1H, C(CH3)OH), 2.72 (brs, 1H, CHCH2OSi), 2.31 (d, J =
16.9 Hz, 1H, CHCH(H)CH(OH)), 2.20 (d, J = 16.9 Hz, 1H, CHCH(H)CH(OH)), 1.44 (s,
3H, CCH3), 1.25 (s, 3H, C(OH)CH3), 1.09 (s, 9H, SiC(CH3)3);  13C NMR (100 MHz,
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CDCl3) d 135.6, 135.5, 132.4, 130.8, 130.1, 128.0, 120.4, 74.5, 72.5, 63.7, 30.5, 26.8,
21.1, 21.0, 19.0; HRMS (FAB) m/z 411.2357 (MH, 411.2355 calcd for C25H34O3SiH).
(1R*, 2S*, 3R*)-3-(tert-butyldiphenylsiloxy)methyl-2,4-dimethyl-2-hydroxy-1-(4-
methoxy)benzyloxy-4-cyclohexene (57). para-Methoxybenzyl
bromide (PMBBr) was prepared immediately before use by
mixing equal volumes (5 mL) of p-methoxybenzyl alcohol with
48% HBr.  The mixture was stirred for 0.5 h before Et2O (10
mL) was added.  The layers were separated and the organic layer was washed with
saturated NaHCO3 (5 mL) followed by brine (5 mL), dried over Na2SO4 and concentrated
to provide the PMBBr as a yellow oil which was >95% pure by 1H NMR.  The product
was used immediately in the next step without purification.
To diol 56 (6.50 g, 15.9 mmol) in THF (60 mL) was added NaH (1.52 g, 63.4
mmol) followed by PMBBr (6.00 g, 29.9 mmol).  After stirring for 5 h saturated NH4Cl
(50 mL) was added followed by Et2O (50 mL).  The layers were separated and the
organic layer was dried over Na2SO4 and concentrated.  The crude residue was purified
by silica gel chromatography using 20% EtOAc:hexane to give alcohol 57 as a viscous
oil in 60% yield (5.04 g, 9.5 mmol).  IR (CH2Cl2) 3570, 2964, 2934, 2891, 2860, 1613,
1513, 1471, 1428 cm-1; 1H NMR (300 MHz, CDCl3) d 7.69 (m, 4H, SiC(CH)2), 7.43 (m,
6H, SiCCH(CH)2 and SiCCHCHCH), 7.31 (d, J = 8.7 Hz, 2H, CH3OC(CH)2), 6.90 (d, J
= 8.7 Hz, 2H, CH3OC(CH(CH))2), 5.45 (brs, 1H, CCHCH2), 4.65 (d, J = 11.5, 1H,
CHOCH(H)C), 4.53 (d, J = 11.5, 1H, CHOCH(H)C), 3.85 (m, 3H, CHCH2OSi and
CH2CH(OCH2)C), 3.81 (s, 3H, COCH3), 2.61 (s, 1H, C(CH3)OH), 2.44 (d, J = 16.0 Hz,
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1H, CHCH(H)CH(OH)), 2.26 (brs, 1H, CHCH2OSi), 2.24 (d, J = 16.0 Hz, 1H,
CHCH(H)CH(OH)), 1.59 (s, 3H, CCH3), 1.38 (s, 3H, C(OH)CH 3), 1.08 (s, 9H,
SiC(CH3)3); 13C NMR (75 MHz, CDCl3) d  159.5, 136.1, 136.0, 133.7, 133.4, 132.4,
131.4, 130.1, 130.1, 129.6, 128.1, 128.0, 121.0, 114.1, 78.7, 74.1, 71.8, 62.3, 55.6 52.4,
29.4, 27.2, 23.5, 22.2, 19.6; HRMS (FAB) m/z 537.3013 (M+Li, 537.3012 calcd for
C33H42O4SiLi).
(1R*, 2S*, 3R*)-2-Acetoxy-3-(tert-butyldiphenylsiloxy)-methyl-2,4-dimethyl-1-(4-
methoxy)benzyloxy-4-cyclohexene (58).  To alcohol 57 (0.20
g, 0.4 mmol) in CH2Cl2 (1.0 mL) was added acetic anhydride
(0.19 g, 1.9 mmol) followed by a 1.0 M solution of
trimethylsilyltrifluoromethanesulfonate (TMSOTf) in CH2Cl2
(20 mL).  After stirring for 0.5 h MeOH (0.5 mL) was added and the solution was washed
with saturated NaHCO3 (3 mL).  The organic layer was dried over Na2SO4 and
concentrated.  The crude residue was purified by silica gel chromatography using 10%
EtOAc:hexane to provide acetate 58 as a colorless oil in 38% yield (0.08 g, 0.1 mmol).
IR (CH2Cl2) 3073, 3049, 2961, 2934, 2860, 1722, 1613, 1513, 1370 cm-1; 1H NMR (400
MHz, CDCl3) d 7.65 (m, 4H, SiC(CH)2), 7.42 (m, 6H, SiCCH(CH)2 and SiCCHCHCH),
7.27 (d, J = 6.4 Hz, 2H, CH3OC(CH)2), 6.86 (d, J = 8.6 Hz, 2H, CH3OC(CH(CH))2), 5.46
(brs, 1H, , CCHCH2), 4.59 (d, J = 11.6 Hz, 1H, CHOCH(H)C), 4.49 (d, J = 11.6 Hz, 1H,
CHOCH(H)C),  4.17 (t, J = 6.6 Hz, 1H, CH2CH(OCH2)C), 3.83 (m, 2H, CHCH2OSi),
3.79 (s, 3H, COCH3), 3.11 (brs, 1H, CHCH2OSi), 2.34 (brm, 2H, CHCH2CH(OH)), 1.94
(s, 3H, C(O)CH3), 1.69 (s, 3H, CCH 3), 1.58 (s, 3H, , C(OOCH3)CH3), 1.05 (s, 9H,
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SiC(CH3)3); 13C NMR (100 MHz, CDCl3) d 171.0, 159.1, 135.8, 135.7, 133.5, 133.2,
131.1, 129.7, 129.2, 127.7, 127.6, 113.7, 84.8, 71.8, 61.4, 55.3, 48.1, 31.6, 28.9, 26.9,
25.3, 22.7, 22.6, 21.8, 19.8, 19.3, 14.2; ; HRMS (FAB) m/z 579.3136 (M+Li, 579.3118
calcd for C35H44O5SiLi).
( 1R *, 2S *, 3R *)-3-(tert-butyldiphenylsiloxy)methyl-1,2-diacetoxy-2,4-dimethyl-4-
cyclohexene (60).  To diol 56 (1.00 g, 2.4 mmol) in CH2Cl2 (5
mL) was added acetic anhydride (2.49 g, 24.4 mmol) followed by
a 1.0 M solution of trimethylsilyltrifluoromethanesulfonate
(TMSOTf) (240 mL) resulting in a red solution.  After stirring for
2 h, MeOH (1 mL) was added and the solution was washed with saturated NaHCO3 (5
mL).  The organic layer was dried over Na2SO4 and concentrated.  The crude residue was
purified by silica gel chromatography using 10% EtOAc:hexane to furnish bisacetate 60
as a colorless oil in 35% yield (0.44 g, 0.9 mmol).  IR (CH2Cl2) 2934, 2860, 1729, 1471,
1428, 1370 cm-1; 1H NMR (400 MHz, CDCl3) d 7.67 (m, 4H, SiC(CH)2), 7.39 (m, 6H,
SiCCH(CH)2 and SiCCHCHCH), 5.58 (t, J = 7.5 Hz, 1H, CH2CH(OOCH3)), 5.44 (s, 1H,
CCHCH2), 3.81 (dd, J = 11.3, 3.3 Hz, 1H, CHCH(H)OSi), 3.70 (dd, J = 11.3, 3.3 Hz, 1H,
C H C H (H)OSi), 3.09 (brs, 1H, CH C H2OSi), 2.42 (d, J = 16.8 Hz, 1H,
CHCH(H)CH(OH)), 2.28 (d, J = 16.8 Hz, 1H, CHCH(H)CH(OH)),  2.12 (s, 3H,
CH(OC(O)CH3)), 1.96 (s, 3H, C(OC(O)CH 3)), 1.65 (s, 3H, CCH 3), 1.47 (s, 3H,
C(OC(O)CH3)CH3), 1.06 (s, 9H, SiC(CH3)3); 13C NMR (100 MHz, CDCl3) d 170.6,
170.5, 135.9, 135.8, 133.3, 133.0, 131.0, 129.7, 127.7, 127.6, 120.8, 83.1, 77.4, 73.2,
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61.1, 48.4, 28.5, 26.7, 22.4, 21.7, 21.2, 19.5, 19.1; HRMS (FAB) m/z 501.2646 (M+Li,
501.2649 calcd for C29H38O5SiLi).
(2S*, 3S*, 4S*)-4-(tert-butyldiphenylsiloxy)methyl-2,3-diacetoxy-3,5-dimethyl-5-
cyclohexen-1-one (61).  To bisacetate 60 (0.44 g, 0.8 mmol) in
AcOH (2.4 mL) and acetic anhydride (1.6 mL) was added
Na2CrO4 (0.54, 3.3 mmol).  The mixture was observed to
change from orange to dark green over the course of the
reaction.  After stirring for 14 h the mixture was diluted with Et2O (2 mL) and basified
with 1 N NaOH to pH >10.  The aqueous layer was extracted with Et2O (3 x 5 mL) and
the combined organic extracts were dried over Na2SO4 and concentrated.  The crude
residue was purified by silica gel chromatography using 20% EtOAc:hexane to afford
ketone 61 as a clear, colorless oil in 23% yield (0.11 g, 0.2 mmol).  IR (CH2Cl2) 3073,
2953, 2891, 2860, 1749, 1733, 1691, 1471, 1428, 1374 cm-1; 1H NMR (400 MHz, CDCl3)
d 7.64 (m, 4H, SiC(CH)2), 7.41 (m, 6H, SiCCH(CH)2 and SiCCHCHCH), 6.21 (s, 1H,
CH(OOCH3)), 6.06 (s, 1H, CCHC(O)), 4.06 (dd, J = 11.7, 2.9 Hz, 1H, CHCH(H)OSi),
3.89 (dd, J = 11.7, 2.9 Hz, 1H, CHCH(H)OSi),  3.53 (brs, 1H, CHCH2OSi), 2.28 (s, 3H,
CH(OC(O)CH3)), 1.93 (s, 3H, C(OC(O)CH 3)), 1.75 (s, 3H, CCH 3), 1.62 (s, 3H,
C(OC(O)CH3)CH3), 1.03 (s, 9H, SiC(CH3)3); 13C NMR (100 MHz, CDCl3) d 191.6,
170.8, 170.4, 157.3, 135.9, 135.7, 134.3, 132.5, 130.1, 130.0, 127.9, 127.8, 126.9, 86.3,
77.6, 60.9, 50.0, 26.7, 22.5, 22.2, 20.6, 19.6, 19.0; HRMS (FAB) m/z 515.2454 (M+Li,
515.2441 calcd for C29H36O6SiLi).
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(3S*, 4S*)-3-(tert-butyldiphenylsiloxy)methyl-2,4-dimethyl-cyclohexene (63).  The
diene 55 (1.19 g, 3.2 mmol) and 10% Pd/C (1.3 g) in EtOH (10
mL) were stirred under an atmosphere of H2 for 2 h.  The reaction
mixture was filtered through a silica gel plug with hexanes and
the filtrate was concentrated.  The crude residue was purified by
silica gel chromatography using hexanes to provide the alkene 63 as a colorless oil (0.38
g, 1.0 mmol, 34% yield, 43% based on recovered starting material).  IR (thin film) 3445,
3071, 3050, 2958, 2929, 2858, 1652, 1472, 1462, 1428, 1389, 1112, 1072, 998 cm-1; 1H
NMR (300 MHz, CDCl3) d 7.79-7.81 (m, 4H, ArH), 7.45-7.48 (m, 6H, ArH), 5.52 (s, 1H,
C=CH), 3.79 (d, J = 3.8 Hz, 2H, CH2O), 1.52-2.16 (m, 6H, CH2CH2CH(CH3)CH), 1.65
(s, 3H, CCH3), 1.15-1.17 (m, 12H, C(CH3)3 and CHCH3); 13C NMR (75 MHz, CDCl3) d
136.1, 136.0, 134.5, 129.8, 127.9, 123.8, 63.1, 46.6, 31.6, 27.5, 27.2, 25.5, 23.0, 19.5,
18.8; HRMS (FAB) m/z 377.2308 (M–H, 377.2301 calcd for C25H33OSi).
(4S*, 5S*)-4-(tert-butyldiphenylsilyloxy)methyl-3,5-dimethyl-cyclohex-2-enone (64).
The alkene 63 (1.72 g, 4.6 mmol) in AcOH (10.7 mL) and
Ac2O (6.6 mL) was cooled to 0°C and Na2CrO4 was added.
After stirring for 19 h at 23 °C, the dark green mixture was
poured into a vigorously stirred 1:1 mixture of 1 N NaOH :
Et2O (100 mL).  The layers were separated and the aqueous layer was extracted with Et2O
(3 x 100 mL).  The combined organic extracts were dried (Na2SO4) and concentrated.
The crude residue was purified by silica gel chromatography using 10% EtOAc : hexanes
to provide ketone 64 as a colorless oil in 45% yield (0.82 g, 2.1 mmol).  IR (thin film)
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2958, 2931, 2857, 2361, 1663, 1428, 1112, 1088 cm-1; 1H NMR (300 MHz, CDCl3) d
7.60-7.66 (m, 4H, ArH), 7.34-7.43 (m, 6H, ArH), 5.95 (s, 1H, C=CH), 3.91 (dd, J = 3.8,
11.0 Hz, 1H, CH2O), 3.75 (dd, J = 4.4, 11.0 Hz, 1H, CH2O), 2.58 (dd, J = 12.4, 16.2 Hz,
1H, C(O)CH2), 2.33-2.42 (m, 1H, CHCH3), 2.27 (dd, J = 4.4, 15.9 Hz, 1H, CH2C(O)),
2.19 (dd, J = 4.4, 8.2 Hz, 1H, CHCH2O), 1.81 (s, 3H, C=CCH3), 1.10 (d, J = 6.6 Hz, 3H,
CHCH3), 1.00 (s, 9H, C(CH3)3); 13C NMR (75 MHz, CDCl3) d 200.4, 163.1, 135.9, 135.8,
133.2, 133.0, 130.1, 130.1, 128.5, 128.0, 128.0, 61.7, 47.5, 42.8, 32.4, 27.0, 23.6, 19.3,
18.5; HRMS (FAB) m/z 377.1939 (M–CH3, 377.1937 calcd for C24H29O2Si).
( 1 R *, 4S *, 5S*)-4-(tert-butyldiphenylsiloxy)methyl-2,4-dimethyl-1-morpholino-
cyclohex-2-ene (65).  To ketone 64 (50.0 mg, 0.13
mmol) in CH2Cl2 (1.5 mL) was added morpholine (33
mg, 0.38 mmol) followed by Ti(OiPr)4 (136 mg, 0.48
mmol).  After 2.5 h CH2Cl2 was removed in vacuo.  The
residue was dissolved in EtOH (1.0 mL) and Na(CN)BH3 (17 mg, 0.27 mmol) was added.
After stirring for 1 h 1 N NaOH (1.0 mL) was added and the mixture was filtered through
a Celite plug.  The filtrate was extracted with EtOAc (3 x 20 mL) and the combined
organic extracts were dried (Na2SO4) and concentrated.  The crude residue was purified
by silica gel chromatography using 50% EtOAc : hexanes to provide amine 65 as a clear
colorless oil in 30% yield (18 mg, 0.04 mmol).
(1R*, 4S*, 5S*)-4-(tert-butyldiphenylsilyloxy)methyl-2,4-dimethyl-cyclohex-2-en-1-ol
(67).  To ketone 64 (0.82 g, 2.1 mmol) in MeOH (40 mL) was added NaBH4 (0.40 g, 10.5
147
mmol).  After 2.5 h MeOH was removed in vacuo. The
residue was dissolved in CH2Cl2 (50 mL) and washed with
H2O (2 x 50 mL), dried (Na2SO4), and concentrated to provide
alcohol as a clear oil in 98% yield (0.81 g, 2.1 mmol) that was
homogeneous by TLC and 1H NMR analysis.  IR (thin film) 3332, 3071, 2959, 2930,
2858, 1659, 1472, 1428, 1112, 1084, 997, 824 cm-1; 1H NMR (300 MHz, CDCl3) d 7.70-
7.73 (m, 4H, ArH), 7.38-7.47 (m, 6H, ArH), 5.51 (s, 1H, C=CH), 4.20-4.25 (m, 1H,
CHOH), 3.78 (dd, J = 4.9, 11.0 Hz, CH2OSi), 3.71 (dd, J = 3.3, 10.0 Hz, 1H, CH2OSi),
1.56-1.97 (m, 5H, OH  and C(OH)CH2 and CHC H3 and CHC H2OSi), 1.61 (s, 3H,
C=CCH3), 1.12, d, J = 6.6 Hz, CHCH3), 1.09 (s, 9H, C(CH3)3); 13C NMR (75 MHz,
CDCl3) d 138.2, 136.0, 133.9, 129.9, 128.3, 127.9, 68.5, 62.5, 46.8, 37.3, 31.4, 27.2, 22.6,
19.6, 19.5; HRMS (FAB) m/z 393.2239 (M–H, 393.2250 calcd for C25H33O2Si).
(1S*, 4S *, 5S *)-4-(tert-butyldiphenylsiloxy)methyl-2,4-dimethyl-1-phthalimido-
cyclohex-2-ene (68).   To alcohol 67 (0.81 g, 2.1
mmol), PPh3 (1.20 g, 4.5 mmol), and phthalimide
(0.65 g, 4.4 mmol) in THF (30 mL) at 0 °C was added
diethyldiazodicarboxylate (DEAD) in THF (1.0 M
soln., 4.7 mL, 4.7 mmol) dropwise.  The flask was
warmed to room temperature and stirred for 1 h.  Silica gel (1.0 g) was added and the
solvent was removed in vacuo.  The resulting solid was loaded onto a column using
EtOAc and the crude product was eluted with EtOAc.  Concentration of the combined
eluents followed by purification by silica gel chromatography using 10% EtOAc :
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hexanes provided the title compound  as a white solid in 49% yield (0.53 g, 1.0 mmol).
IR (thin film) 2958, 2930, 2857, 1771, 1713, 1468, 1428, 1390, 1369, 1112, 1085 cm-1;
1H NMR (300 MHz, CDCl3) d 7.65-7.81 (m, 8H, ArH), 7.39-7.45 (m, 6H, ArH), 5.29 (s,
1H, C=CH), 4.91 (s, 1H, CHN), 3.84 (dd, J = 4.7, 10.2 Hz, 1H, CH2O), 3.64 (dd, J = 7.7,
10.5 Hz, 1H, CH2O), 2.54-2.55 (m, 1H, CHCH3), 2.43 (brs, 1H, CHCH2O), 1.93-2.04 (m,
2H, NCHCH2), 1.62 (s, 3H, C=CCH3), 1.06 (s, 12H, C(CH3)3 and CHCH3); 13C NMR (75
MHz, CDCl3) d 168.6, 138.1, 135.9, 135.8, 134.0, 132.4, 129.9, 127.9, 123.2, 121.4,
62.9, 45.9, 45.1, 33.9, 28.6, 27.1, 22.4, 19.4, 15.9; HRMS (FAB) m/z 524.2627 (M+H,
524.2621 calcd for C33H38NO3Si).
(1S*,  4S *, 5S *) -4 - (tert-butyldiphenylsiloxy)methyl-2,4-dimethyl-1-morpholino-
cyclohex-2-ene (69).  To phthalimide 68 (0.43 g, 0.82
mmol) in MeOH (20 mL) was added NH2NH2•H2O (2.06
g, 41.1 mmol) and the resulting mixture was heated to
80-90 °C for 4h.  MeOH was removed in vacuo to
provide a white solid which was dissolved in CH3CN (6 mL).  Anhydrous K2CO3 (0.22 g,
1.6 mmol) was added and the mixture was stirred for 1 h.  2-Bromoethyl ether (0.23 g,
1.0 mmol) in CH3CN (2 mL) was added and the resulting mixture was heated to 90 °C for
11 h.  The mixture was diluted with CH3CN (10 mL) and Na2SO4 (5 g) was added.  The
solution was filtered and concentrated.  The crude residue was purified by silica gel
chromatography using 35% EtOAc : hexanes to provide amine 69 as a yellow oil in 27%
yield (102 mg, 0.22 mmol).  IR (thin film) 2957, 2929, 2856, 1472, 1450, 1428, 1250,
1114, 1080, 998 cm-1; 1H NMR (300 MHz, CDCl3) d 7.66-7.68 (m, 4H, ArH), 7.36-7.42
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(m, 6H, ArH), 5.45 (s, 1H, C=CH), 3.57-3.77 (m, 6H, (CH2)2N and CH2OSi), 3.12 (brs,
1H, CHN), 2.50-2.64 (m, 4H, (CH2)2O), 2.08-2.17 (m, 3H, CHCH2O and CH2CHN),
1.66-1.69 (m, 1H, CHCH3), 1.60 (s, 3H, C=CCH3), 1.04 (s, 9H, C(CH3)3), 1.00 (d, J =
7.7 Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) d 138.5, 135.9, 135.8, 134.0, 133.9,
129.8, 127.8, 124.0, 67.7, 62.8, 58.4, 49.7, 45.9, 29.2, 29.2, 27.0, 22.8, 19.4, 16.9; HRMS
(FAB) m/z 464.2965 (M+H, 464.2985 calcd for C29H41NO2Si).
Morpholine 2(S*)-benzyloxy-[1(R*),3(S*)-dimethyl-2(S*)-(tert-butyldiphenylsiloxy-
methyl)-5-cyclohexenyl]ethanamide (70).  Amine 69 (50 mg,
0.11 mmol) in CH2Cl2 (1.25 mL) followed by iPr2NEt (41 mg,
0.32 mmol) was added to TiCl4•THF2 (36 mg, 0.11 mmol).  A
1.0 M solution of freshly distilled benzyloxyacetyl chloride in
CH2Cl2 (0.21 mL, 0.21 mmol) was added via syringe pump
over 2 h.  The reaction mixture was diluted with Et2O (3 mL) and then quenched with 1 N
NaOH (2 mL).  The layers were separated and the aqeous layer was extracted with Et2O
(3 x 2 mL).  The combined organic extracts were washed with brine (2 mL), dried
(Na2SO4), and concentrated.  The crude residue was purified by silica gel
chromatography using 35% EtOAc : hexanes to provide amide 70 as a clear colorless oil
in 41% yield (27 mg, 0.04 mmol).  IR (thin film) 3028, 2959, 2929, 2893, 2857, 1630,
1454, 1428, 1390, 1361, 1300, 1270, 1244, 1114 cm-1; 1H NMR (300 MHz, CDCl3) d
7.61-7.64 (4H, m, ArH), 7.24-7.41 (m, 11H, ArH), 5.68 (dt, J = 3.9, 10.4 Hz, 1H,
C=CHCH2), 5.48 (d, J = 9.9 Hz, 1H, C(CH3)CH=C), 4.53 (d, J = 11.5 Hz, 1H, CH2Ph),
4.39 (d, J = 12.1 Hz, 1H, CH 2Ph), 4.22 (s, 1H, CHOCH2Ph), 3.46-3.76 (m, 10H,
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morpholine and CH2OSi), 1.98-2.27 (m, 2H, CHCH2OSi and CHCH3), 1.54-1.67 (m, 2H,
C=CHCH2), 1.08 (s, 3H, CCH3), 1.02 (s, 9H, tBu), 0.79 (d, J = 7.1 Hz, 3H, CHCH3); 13C
NMR (75 MHz,CDCl3) d 169.2, 137.8, 136.0, 134.1, 133.9, 132.8, 129.8, 129.8, 128.6,
128.1, 128.0, 127.9, 127.8, 126.7, 86.9, 73.2, 67.5, 67.0, 61.9, 46.8, 44.8, 43.0, 31.4, 27.9,
27.1, 21.1, 19.4, 17.4; HRMS (FAB) m/z 612.3487 (M+H, 612.3509 calcd for
C38H50NO4Si).
3(S*)-Benzyloxy-4(S*)-(tert-butyldiphenylsilyloxymethyl)-7(R*)-iodo-3a(S*), 5(S*) -
dimethylhexahydrobenzofuran-2-one (71).  To amide 70 (27
mg, 0.04 mmol) in 1:1 DME:H2O (2 mL) was added I2 (12 mg,
0.1 mmol).  After stirring for 4 h another portion of I2 (13 mg)
was added.  After an additional 2 h the reaction mixture was
diluted with Et2O (3 mL), washed with 10% Na2S2O3 (2 mL)
and brine (2 mL), dried, and concentrated to provide the title compound 71 as a colorless
oil in 81% yield (24 mg, 0.04 mmol) that was homogenous by TLC and 1H NMR
analysis.  1H NMR (300 MHz, CDCl3) d 7.63-7.67 (m, 4H, ArH), 7.23-7.46 (m, 11H,
ArH), 4.90 (d, J = 12.1 Hz, 1H, CH2Ph), 4.72 (d, J = 9.9 Hz, 1H, CHOC(O)), 4.60 (d, J =
12.1 Hz, 1H, CH2Ph), 4.30-4.40 (m, 1H, CHI), 3.93 (d, J = 11.5 Hz, 1H, CH2OSi), 3.68
(dd, J = 3.3, 11.0 Hz, 1H, CH 2OSi), 3.41 (s, 1H, CHOCH2Ph), 2.49-2.69 (m, 2H,
CH2CHI), 2.14-2.17 (m, 1H, CHCH2OSi), 1.72 (brs, 1H, CHCH3), 1.13 (s, 9H, tBu), 1.06
(s, 3H, CCH3), 0.83 (d, J = 6.6 Hz, 3H, CHCH3).
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(3S, 4S)-1-acetoxy-4-formyl-3-methylcyclohex-1-ene (86).  The reaction was divided
between three 250 mL round bottom flasks to maximize yield.
To a solution of (5S)-5-benzyl-2,2,3-trimethylimidazolin-4-
one hydroperchlorate 84 (17.70 g, 50.1 mmol, 20 mol%) in
THF (255 mL) at 0 °C was added acrolein (50.1 ml, 750
mmol) over 20 min (exotherm).  Water (12.9 ml, 720 mmol) was added followed by (E)-
2-acetoxy-1,3-pentadiene (31.50 g, 250 mmol) (Scheeren, JOC, 1985, 50, 1955).  When
the diene was consumed as determined by gas chromatography, the reaction mixture was
diluted with Et2O (300 mL) and washed with H2O (300 mL).  The layers were separated
and the aqueous layer was extracted with Et2O (3 x 200 mL).  The combined organic
extracts were dried (Na2SO4) and concentrated.  The crude residue was purified by silica
gel chromatography using 10% EtOAc : hexanes to provide aldehyde 86 as a colorless oil
in 44% yield (20.00 g, 109.7 mmol); endo:exo 5.6:1 endo 90% ee.  IR (thin film) 2963,
2938, 2875, 1753, 1723, 1367, 1213, 1127, 1094, 1018, 904 cm-1; 1H NMR (300 MHz,
CDCl3) d 9.77 (s, 1H, CHO), 5.37-5.39 (m, 1H, C=CH), 2.85-2.90 (m, 1H, CHCHO),
2.53-2.60 (m, 1H, CHCH3), 1.78-2.32 (m, 4H, CH2CH2), 2.08 (s, 3H, C(O)CH3), 0.99 (d,
J = 6.6 Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) d 204.2, 169.5, 148.3, 118.9, 49.9,
29.1, 25.8, 21.2, 18.6, 17.1; HRMS (EI) m/z 182.0938 (M, 182.0943 calcd for C10H14O3);
[a]25D = –185.4, (c = 0.3, CHCl3).  The enantiomeric purity and diastereomer ratio was
determined by GC with a Bodman G-TA Chiraldex column (70 °C with 3 °C/min, 2
mL/min); exo isomer, tr = 33.0 min and 33.5 min; endo isomer tr = 35.6 min and 36.6 min.
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(3S, 4S)-1-acetoxy-4-(hydroxymethyl)-3-methylcyclohex-1-ene (87).  To aldehyde 86
(5.19 g, 28.5 mmol) in MeOH (150 mL) was added
Na(CN)BH3 (17.9 g, 285.0 mmol) portionwise over 10 min.
After 6 h the reaction was judged to be complete by thin layer
chromatography.  MeOH was removed by rotary evaporation
and the residue was taken up in CH2Cl2 (100 mL) and washed with H2O (100 mL).  The
layers were separated and the aqueous layer was extracted with CH2Cl2 (100 mL).  The
combined organic extracts were dried (Na2SO4) and concentrated.  The crude residue was
purified by silica gel chromatography using 35% EtOAc : hexanes to provide alcohol 87
as a colorless oil in 73% yield (3.81 g, 20.7 mmol).  IR (thin film) 3419, 2960, 2933,
2875, 2360, 1755, 1689, 1455, 1435, 1371, 1222, 1127, 1091, 1040, 1012, 906 cm-1; 1H
NMR (300 MHz, CDCl3) d 5.32 (d, J = 5.0 Hz, 1H, C=CH), 3.50-3.63 (m, 2H, CH2OH),
2.48-2.54 (m, 1H, CHCH3), 1.47-2.30 (m, 5H, CH2CH2CH), 2.08 (s, 3H, C(O)CH3), 0.90
(d, J = 7.1 Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) d 169.6, 148.0, 119.8, 64.5,
39.4, 29.9, 26.7, 21.4, 21.1, 15.6; HRMS (EI) m/z 184.1098 (M, 184.1100 calcd for
C10H16O3);  [a]25D = –238.6, (c = 0.65, CHCl3).
(3S, 4S)-1-acetoxy-3-methyl-4-(triisopropylsiloxymethyl)cyclohex-1-ene (88). Alcohol
87 (6.84 g, 37.2 mmol), TIPSCl (9.32 g, 48.3 mmol), and
imidazole (6.96 g, 102.3 mmol) in DMF (150 mL) were
stirred at 23 oC for 2h after which time H2O (200 mL) was
added. The mixture was extracted with Et2O (3 x 200 mL),
and the combined organic extracts were washed with H2O (200 mL) and brine (200 mL),
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dried (Na2SO4), and concentrated.  The crude residue was purified by silica gel
chromatography using 2.5% EtOAc : hexanes to provide the title compound 88 as a
colorless oil in 76% yield (9.62 g, 28.2 mmol).  IR (thin film) 2943, 2866, 1760, 1690,
1463, 1366, 1216, 1104, 1067, 1015, 883 cm-1; 1H NMR (300 MHz, CDCl3) d 5.33 (d, J =
4.9 Hz, 1H, C=CH), 3.61 (d, J = 4.9 Hz, 1H, CH2O), 3.59 (d, J = 4.4 Hz, 1H, CH2O),
2.53 (m, 1H, C=CHCH), 1.87-2.32 (m, 3H, CH2C=CH and CHCH2O), 2.10 (s, 3H,
C(O)CH3), 1.47-1.65 (m, 2H, CH2CHCH2O), 1.04-1.07 (m, 21H, TIPS), 0.91 (d, J = 7.1
Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) d 169.6, 148.1, 120.1, 64.8, 39.4, 29.7,
26.7, 21.3, 20.8, 18.3, 15.3, 12.2; HRMS (FAB) m/z 340.2434 (M+H, 340.5728 calcd for
C19H37O3Si); [a]25D = –123.2, (c = 1.0, CHCl3).
(4S)-3-methyl-4-(triisopropylsiloxymethyl)cyclohex-2-en-1-one (89).  A modified
procedure of Siegel et al. was used.6  Vinyl acetate 88 (12.90 g,
37.9 mmol) was added to Pd(OAc)2 (0.43 g, 1.9 mmol, 5 mol%),
DIPHOS (0.76 g, 1.9 mmol, 5 mol%) and allyl methylcarbonate
(11.0 g, 94.8 mmol) in CH3CN (680 mL) in a 2L thick-walled jar
with a screwcap.  After stirring for 10 min the yellow mixture was homogeneous.
Bu3SnOMe (12.20 g, 37.9 mmol) was added and then the jar was sealed tightly and
heated to 100 oC for 6 h.  After cooling to room temperature, brine (300 mL) was added
and the mixture was filtered through a Celite pad with Et2O (3 x 100 mL) washings.  The
filtrate layers were separated and the aqueous layer was extracted with Et2O (2 x 100
mL).  The combined organic filtrate and extracts were washed with sat. NaHCO3 (100
                                                           
6 Siegel, C.; Gordon, P. M.; Uliss, D. B.; Handrick, G. R.; Dalzell, H. C.; Razdan, R. K. J. Org. Chem.
1991, 56, 6865.
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mL) and brine (100 mL), dried (Na2SO4) and concentrated.  The crude residue was
purified by silica gel chromatography using 10% EtOAc : hexanes to provide ketone 89
as a colorless oil in 87% yield (9.72 g, 32.8 mmol).  IR (thin film) 3425, 2944, 2867,
1674, 1627, 1463, 1382, 1249, 1202, 1110, 1069, 882 cm-1; 1H NMR (300 MHz, CDCl3)
d 5.85 (s, 1H, C=CH), 3.81 (d, J = 5.5 Hz, 2H, CH2O), 2.36-2.52 (m, 2H, C(O)CH2),
2.20-2.30 (m, 1H, CHCH2O), 1.98-2.13 (m, 2H, C(O)CH2CH2), 1.96 (s, 21H, TIPS); 13C
NMR (75 MHz, CDCl3) d 199.7, 162.9, 128.4, 64.2, 42.9, 34.8, 25.7, 23.3, 18.2, 12.1;
HRMS (FAB) m/z 297.2238 (M+H, 297.2250 calcd for C17H33O2Si); [a]25D = –130.3, (c =
1.1, CHCl3).
3-Methyl-1-morpholino-4(S)-(triisopropylsilyloxymethyl)cyclohex-2-ene (90).  To
ketone 89 (1.00 g, 3.3 mmol) in CH2Cl2 (2 mL) in a
React IR schlenk flask was added morpholine (0.29 mL,
3.3 mmol) followed by Ti(OiPr)4 (1.2 mL, 4.2 mmol).
After the ketone IR stretch had completely disappeared,
EtOH (3.3 mL) and NaCNBH3 (0.14 g, 2.2 mmol) were added.  The reaction mixture was
stirred for 20 h before H2O (0.67 mL) was added.  The resulting mixture was filtered
through Celite with EtOH washes (3 x 20 mL).  The combined filtrates were concentrated
and the crude residue was purified by silica gel chromatography using 20 to 30% EtOAc :
hexanes to provide amine 90 as a clear oil in 21% yield (0.27 g, 0.72 mmol); dr = 1.4 : 1.
IR (thin film) 2943, 2865, 1463, 1450, 1382, 1325, 1287, 1249, 1119, 1069, 998 cm-1; 1H
NMR (300 MHz, CDCl3) d  5.41 (s, 1H, C=CH ), 3.51-3.76 (m, 6H, N(CH2)2 and
CH2OSi), 3.07 (brs, 1H, CHN major isomer), 3.00 (brs, 1H, CHN minor isomer), 2.45-
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2.58 (m, 4H, O(CH2)2), 1.97-2.07 (m, 2H, CH2CHN), 1.69 (s, 3H, C=CCH3), 1.53-1.55
(m, 2H, CH2CH2CHN), 1.00-1.06 (m, 21H, TIPS); 13C NMR (75 MHz, CDCl3) d 138.1,
137.8, 126.0, 126.0, 67.7, 67.7, 65.4, 64.4, 61.3, 60.8, 49.6, 49.4, 42.5, 42.1, 25.4, 23.7,
22.9, 22.3, 22.0, 18.7, 18.2, 17.9, 12.2, 12.2; HRMS (FAB) m/z 366.2819 (M–H,
366.2828 calcd for C21H40NO2Si).
(4S, 6S)-6-hydroxy-3-methyl-4-(triisopropylsiloxymethyl)cyclohex-2-en-1-one (93).
To diisopropylamine (1.17 mL, 11.6 mmol) in THF (25 mL) at
–78 °C was added a 1.7 M solution of n-BuLi in hexanes (6.9
mL, 11.6 mmol).  After 10 min ketone 89 (3.15 g, 10.6 mmol)
in THF (15 mL) was added and the mixture was stirred at –78
°C for 40 min.  Freshly distilled TMSCl (2.8 mL, 22.1 mmol) was added rapidly and the
flask was removed from the cold bath.  The reaction mixture was stirred at room
temperature for 2.5 h before pentane (5 mL) was added.  The resultant mixture was
washed with cold (0 °C) sat. NaHCO3 (30 mL), and the organic layer was dried and
concentrated to provide silyl enol ether 94, which was pure as judged by 1H NMR
analysis.  Silyl enol ether 94 in 27 mL tert-BuOH was added to a vigorously stirred
mixture of AD-mix a (15.0 g) and MeSO2NH2 (1.00 g, 10.6 mmol) in H2O (54 mL) and
tert-BuOH (27 mL) at 0 °C.  The reaction mixture was stirred vigorously for 26 h at 0 °C
before Na2SO3 (10.5 g) was added.  After stirring for an additional 1 h, the reaction
mixture was diluted with CH2Cl2 (100 mL), the layers were separated, and the aqueous
layer was extracted further with EtOAc (3 x 100 mL).  The combined organic extracts
were dried and concentrated and the crude residue was purified by silica gel
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chromatography to provide starting material 89 (1.10 g) and hydroxy ketone 93 as a
colorless oil (1.13 g, 3.6 mmol, 34% yield, 52% yield based on recovered starting
material).  IR (thin film) 3484, 2943, 2867, 1678, 1628, 1463, 1382, 1250, 1106, 1029,
1014, 998, 882 cm-1; 1H NMR (300 MHz, CDCl3) d 5.95 (s, 1H, C=CH), 4.44-4.50 (m,
1H, CHOH), 3.95 (d, J = 5.5 Hz, 2H, CH2OSi), 3.53 (d, J = 1.6 Hz, 1H, OH), 2.49-2.60
(m, 2H, CH2CHOH), 1.94-2.05 (m, 1H, CHCH2OSi), 2.01 (s, 3H, CCH3), 0.96-1.15 (m,
21H, TIPS); 13C NMR (75 MHz, CDCl3) d 200.2, 164.2, 125.4, 69.0, 64.9, 44.2, 34.8,
23.8, 18.2, 12.1; HRMS (FAB) m/z 313.2198 (M+H, 313.2199 calcd for C17H33O3Si);
[a]25D = –69.3, (c = 1.0, CHCl3).
( 4 S, 6S)-3-methyl-6-triisopropylsiloxy-4-(triisopropylsiloxymethyl)cyclohex-2-en-1-
one (95).  To alcohol 93 (2.00 g, 6.4 mmol) and imidazole (1.20
g, 17.6 mmol) in DMF  (28 mL) was added TIPSCl (2.7 mL,
12.8 mmol).  When starting material was consumed as
determined by TLC analysis (12 h), H2O (30 mL) was added the
resulting mixture was extracted with Et2O (3 x 50 mL).  The combined organic extracts
were washed with brine (50 mL), dried, and concentrated.  The crude residue was
purified by silica gel chromatography to provide ketone 95 as a colorless oil in 86% yield
(2.56 g, 5.5 mmol).  IR (thin film) 2943, 2867, 1690, 1464, 1383, 1248, 1156, 1138,
1105, 1070, 1014, 997, 882 cm-1; 1H NMR (300 MHz, CDCl3) d 5.80 (s, 1H, C=CH),
4.40 (dd, J = 4.7, 9.6 Hz, 1H, CHOSi), 3.81-3.91 (m, 2H, CH2OSi), 2.55-2.60 (m, 1H,
CHCHOSi), 2.29 (app dt, J = 4.7, 13.5 Hz, 1H, CH2CHOSi), 2.11 (ddd, J = 5.2, 9.6, 13.5
Hz, CH2CHOSi), 1.94 (s, 3H, CCH3), 1.00-1.07 (m, 42H, TIPS); 13C NMR (75 MHz,
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CDCl3) d 198.0, 161.1, 127.0, 71.1, 64.5, 42.5, 36.1, 22.8, 18.2, 18.2, 12.6, 12.2; HRMS
(FAB) m/z 469.3530 (M+H, 469.3533 calcd for C26H53O3Si2); [a]22D = –39.6, (c = 1.0,
CHCl3).
(1S, 2R, 5S)-2-hydroxy-4-methyl-1-triisopropylsiloxy-5-(triisopropylsiloxymethyl)-
cyclohex-3-ene (97).  To ketone 95 (2.56 g, 5.5 mmol) in
MeOH (60 mL) was added CeCl3•7H2O (8.20 g, 22.0 mmol).
The mixture was stirred until homogeneous and then NaBH4
(0.62 g, 16.4 mmol) was added cautiously.  After stirring for
1 h, additional NaBH4 (0.62 g, 16.4 mmol) was added.  After 3 h H2O (50 mL) was added
and the resulting mixture was stirred until gas evolution ceased.  The aqueous layer was
extracted with EtOAc (3 x 100 mL) and the combined organic extracts were dried
(Na2SO4) and concentrated to provide alcohol 97 as a colorless oil in 87% yield (2.25 g,
4.8 mmol) that was pure by TLC and 1H NMR analysis.  IR (thin film) 3456, 3206, 2943,
2867, 1464, 1383, 1248, 1106, 1068, 996, 883 cm-1; 1H NMR (300 MHz, CDCl3) d 5.58-
5.60 (m, 1H, C=CH), 4.08-4.15 (m, 1H, CHOH), 3.98 (brs, 1H, OH), 3.52-3.81 (m, 3H,
CH2OSi and CHOSi), 2.28-2.32 (m, 1H, CHCH2OSi), 1.88-1.98 (m, 2H, CH2CHOSi),
1.74 (s, 3H, C=CCH3), 1.04-1.08 (m, 42H, TIPS); 13C NMR (75 MHz, CDCl3) d 139.0,
124.2, 68.0, 66.6, 64.7, 43.5, 28.7, 22.5, 18.4, 18.4, 12.7, 12.4; HRMS (FAB) m/z
469.3533 (M–H, 469.3533 calcd for C26H53O3Si2); [a]25D = 92.5, (c = 1.0, CHCl3).
(1S, 2R, 5S)-2-(2-benzyloxyacetoxy)-4-methyl-1-triisopropylsiloxy-5-(triisopropyl-
siloxymethyl)cyclohex-3-ene (100).  To alcohol 97 (1.50 g, 3.2 mmol) in pyridine (21
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mL) was added freshly distilled benzyloxyacetyl chloride
(0.88 g, 4.8 mmol) followed by DMAP (0.04 g, 0.3
mmol).  After 1.5 h the reaction mixture was diluted with
Et2O (50 mL) and washed with saturated NaHCO3
solution (50 mL) and brine (50 mL).  The organic layer was dried (Na2SO4) and
concentrated.  The crude residue was purified by silica gel chromatography using 2.5%
EtOAc : hexanes to provide ester 100 a colorless oil in 76% yield (1.48 g, 2.4 mmol).  IR
(thin film) 2943, 2866, 1753, 1464, 1384, 1248, 1197, 1118, 1070, 883 cm-1; 1H NMR
(300 MHz, CDCl3) d 7.27-7.40 (m, 5H, ArH), 5.49 (d, J = 4.4 Hz, 1H, C=CH), 5.37-5.40
(m, 1H, CHOC(O)), 4.70 (d, J = 11.5 Hz, 1H, CH2Ph), 4.63 (d, J = 11.5 Hz, 1H, CH2Ph),
4.21 (dt, J = 3.9, 10.4 Hz, 1H, CHOSi), 4.12 (s, 2H, C(O)CH2), 3.80 (dd, J = 3.9, 9.9 Hz,
1H, CH2OSi), 3.60 (dd, J = 8.8, 9.5 Hz, 1H, CH2OSi), 2.36 (brs, 1H, C=C(CH3)CH),
1.87-2.05 (m, 2H, CH2CHO), 1.74 (s, 3H, CH3), 1.05-1.09 (m, 42H, TIPS); 13C NMR (75
MHz, CDCl3) d 170.5, 141.3, 128.7, 128.6, 128.6, 128.3, 128.1, 121.2, 73.5, 70.3, 67.6,
66.2, 64.5, 43.2, 29.8, 22.2, 18.3, 18.2, 12.6, 12.2; HRMS (FAB) m/z 617.4057 (M–H,
617.4058 calcd for C35H61O5Si2); [a]25D = 26.6, (c = 1.0, CHCl3).
(2S)-2-benzyloxy-2-(1(R)-methyl-4(S)-triisopropylsiloxy-6(S)-triisopropylsiloxy-
methylcyclohex-2-enyl)acetic acid (101).   To diisopropylamine (0.72 mL, 5.1 mmol )
in THF (8 mL) at –78 °C was added a 1.85 M solution of n-
BuLi (2.8 mL, 5.1 mmol).  After 10 min.ester 100 (1.58 g, 2.6
mmol) in THF (16 mL) was added, and after an additional 0.5 h
TMSCl (1.41 g, 13.0 mmol) was added.  The cold bath was
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removed and the reaction mixture was allowed to stir at room temperature for 6h.  The
mixture was diluted with Et2O (25 mL) and acidified with 1 N HCl (25 mL).  After
stirred for 0.5 h, the layers were separated and the aqueous layer was extracted with
EtOAc (5 x 100 mL).  The combined organic extracts were dried and concentrated.  The
crude residue was purified by silica gel chromatography (20% EtOAc:Hexanes) to
provide starting material 100 (0.57 g) and acid 101 as a brown oil (0.34 g, 0.55 mmol,
22% yield, 58% yield based on recovered starting material).  IR (thin film) 3416, 2943,
2866, 1714, 1463, 1110, 1066, 882 cm-1; 1H NMR (300 MHz, CDCl3) d 8.83 (brs, 1H,
CO2H), 7.28-7.38 (m, 5H, ArH), 5.84 (d, J = 10.4 Hz, 1H, CH=CHCHOSi), 5.76 (dd, J =
3.9, 10.4 Hz, 1H, CH=CHCHOSi), 4.75 (d, J = 12.1 Hz, 1H, CH2Ph), 4.36 (d, J = 11.5
Hz, 1H, CH2Ph), 4.23-4.26 (m, 1H, CHOSi), 4.20 (s, 1H, CHOCH2Ph), 3.84 (dd, J = 7.7,
9.9 Hz, 1H, CH2OSi), 3.55 (dd, J = 6.0, 9.9 Hz, 1H, CH2OSi), 2.46-2.55 (brs, 1H,
CHCH2OSi), 1.64-1.68 (m, 2H, CH2CHOSi), 0.98-1.16 (m, 45H, CCH3 and TIPS); 13C
NMR (75 MHz, CDCl3) d 173.9, 137.5, 133.3, 129.3, 128.5, 128.2, 128.0, 84.0, 72.8,
65.1, 64.2, 42.1, 35.9, 31.9, 18.5, 18.4, 18.2, 12.7, 12.2; HRMS (FAB) m/z 617.4061
(M–H, 617.4058 calcd for C35H61O5Si2); [a]25D = 87.5, (c = 1.0, CHCl3).
Methyl  (2S ) - 2 - b e n z y l o x y - 2 - [ 1 ( R )-methyl-4(S)-triisopropylsiloxy-6(S)-
triisopropylsiloxymethylcyclohex-2-enyl]acetate (102).  To
acid 101 (100 mg, 0.2 mmol) in CH2Cl2 (1.6 mL) and MeOH
(0.3 mL) at room temperature was added a 2.0 M solution of
TMSCH2N2 in hexanes (0.1 mL) dropwise resulting in gas
evolution.  After stirring for 0.5 h, AcOH was added dropwise
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until the solution became colorless and gas evolution ceased.  The reaction was
concentrated and the crude residue was purified by silica gel chromatography to provide
ester 102 as a colorless oil in 93% yield (95 mg, 0.2 mmol).  IR (thin film) 3032, 2943,
2866, 1751, 1736, 1463, 1389, 1367, 1335, 1256, 1196, 1174, 1100, 1014, 920, 883 cm-1;
1H NMR (300 MHz, CDCl3) d 7.27-7.37 (m, 5H, ArH ), 5.80 (d, J = 9.9 Hz, 1H,
CH=CHCHOSi), 5.73 (dd, J = 3.9, 9.9 Hz, 1H, CH=CHCHOSi), 4.64 (d, J = 11.5 Hz,
1H, CH2Ph), 4.33 (d, J = 11.5 Hz, 1H, CH2Ph), 4.20-4.24 (m, 1H, CHOSi), 4.21 (s, 1H,
CHOCH2Ph), 3.82 (dd, J = 6.0, 9.6 Hz, 1H, CH2OSi), 3.69 (s, 3H, CO2CH3), 3.51 (dd, J
= 9.6, 8.0 Hz, 1H, CH2OSi), 2.27-2.36 (m, 1H, CHCH2OSi), 1.53-1.81 (m, 2H,
CH2CHOSi), 1.02-1.07 (m, 45H, CCH3 and TIPS); 13C NMR (75 MHz, CDCl3) d 171.7,
137.9, 133.9, 128.6, 128.5, 128.1, 127.9, 84.2, 72.6, 64.3, 63.9, 51.5, 42.0, 35.5, 31.4,
18.3, 18.3, 18.3, 12.5, 12.2; HRMS (FAB) m/z 469.3530 (M–H, 469.3533 calcd for
C26H53O3Si2); [a]25D = 41.9, (c = 1.1, CHCl3).
(2S)-2-Benzyloxy-2-[1(R)-methyl-4(S)-triisopropylsilyloxy-6(S)-triisopropylsilyloxy-
methylcyclohex-2-enyl]ethanol (103).  To ester 102 (107 mg,
0.17 mmol) in CH2Cl2 (1.0 mL) at –78 °C was added DIBAL-H
(0.09 mL, 0.51 mmol) dropwise.  The cold bath was removed,
and the reaction was allowed to stir at room temperature for 1h
after which time MeOH (0.1 mL) was added cautiously.  After
gas evolution ceased, the reaction mixture was diluted with CH2Cl2 (5.0 mL) and a
saturated solution of Rochelle’s salt (5.0 mL).  After stirring vigorously for 12h the layers
were separated and the aqueous layer was extracted with CH2Cl2 (3 x 10 mL).  The
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combined organic extracts were dried and concentrated to provide alcohol 103 as a
colorless oil in 100% yield (102 mg, 0.17 mmol) that was homogeneous by TLC and 1H
NMR analysis.  IR (thin film) 3566, 3453, 2942, 2866, 1463, 1388, 1367, 1335, 1248,
1210, 1084, 1065, 919, 883 cm-1; 1H NMR (300 MHz, CDCl3) d 7.27-7.41 (m, 5H, ArH),
5.88 (d, J = 9.9 Hz, 1H, CH=CHCHOSi), 5.79 (d, J = 4.4, 9.9 Hz, 1H, CH=CHCHOSi),
4.73 (d, J = 11.5 Hz, 1H, CH2Ph), 4.66 (d, J = 11.5 Hz, 1H, CH2Ph), 4.22-4.26 (m, 1H,
CHOSi), 3.67-3.90 (m, 5H, CH2OH and CH2CHOSi and CH2OSi), 3.53 (dd, J = 6.3,
10.2 Hz, 1H, CH2OSi), 2.32-2.42 (m, 1H, CHCH2OSi), 1.44-1.73 (m, 2H, CH2CHOSi),
1.06-1.09 (m, 45H, CCH3 and TIPS); 13C NMR (75 MHz, CDCl3) d 139.0, 135.8, 128.6,
128.0, 127.9, 127.8, 85.4, 74.7, 65.5, 64.0, 62.9, 42.5, 35.2, 31.7, 18.3, 18.3, 18.2, 12.5,
12.2; HRMS (FAB) m/z 603.4247 (M-H, 603.4265 calcd for C35H63O4Si2); [a]25D = 16.4,
(c = 1.0, CHCl3).
(2S)-2-Benzyloxy-2-[1(R)-methyl-4(S)-triisopropylsilyloxy-6(S)-triisopropylsilyloxy-
methylcyclohex-2-enyl]acetaldehyde (104).  Alcohol 103 (95
mg, 0.16 mmol), N-methylmorpholine-N-oxide (NMO) (81 mg,
0.31 mmol), and 5Å mol sieves (20 mg) were stirred in CH2Cl2
(3.0 mL) for 15 min before tetrapropylammoniumperruthenate
(TPAP) (8 mg, 0.02 mmol) was added.  After 15 minutes the
reaction was judged to be complete by thin layer chromatography.  The reaction mixture
was flushed through a silica plug with CH2Cl2 and the filtrate was concentrated to provide
aldehyde 104 colorless oil in 98% yield (93 mg, 0.15 mmol) that was homogeneous by
TLC and 1H NMR analysis.  IR (thin film) 2943, 2866, 1731, 1463, 1386, 1255, 1211,
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1083, 1066, 1013, 997, 919, 883 cm-1; 1H NMR (300 MHz, CDCl3) d 9.69 (d, J = 3.3 Hz,
1H, CHO), 7.27-7.35 (m, 5H, ArH), 5.87 (d, J = 9.9 Hz, 1H, CH=CHCHO), 5.82 (dd, J =
3.9, 10.2 Hz, 1H, CH=CHCHO), 4.67 (d, J = 12.1 Hz, 1H, CH2Ph), 4.41 (d, J = 11.5 Hz,
1H, CH2Ph), 4.22-4.26 (m, 1H, CHOSi), 4.05 (d, J = 3.3 Hz, 1H, CHOCH2Ph), 3.78 (dd,
J = 7.1, 9.9 Hz, 1H, CH2OSi), 3.54 (dd, J = 6.6, 9.9 Hz, 1H, CH2OSi), 2.28-2.37 (m, 1H,
CHCH2OSi), 1.48-1.71 (m, 2H, CH2CHOSi), 1.04-1.06 (m, 45H, CCH3 and TIPS); 13C
NMR (75 MHz, CDCl3) d 203.1, 138.0, 133.5, 129.7, 128.6, 128.1, 128.0, 87.5, 73.1,
64.9, 63.8, 42.0, 35.5, 31.4, 18.3, 18.3, 17.6, 12.5, 12.1; HRMS (FAB) m/z 601.4103 (M-
H, 601.4108 calcd for C35H61O4Si2); [a]25D = 29.3, (c = 1.0, CHCl3).
(E)-3-chloro-1-morpholino-2-iodoprop-2-ene (110).  The procedure of Lambert was
used.7  To a solution of iodine monochloride (8.05 g, 49.5 mmol)
in THF (190 mL) was added N-propargyl morpholine
hydrochloride (109) (5.00 g, 31.0 mmol).  The reaction mixture
was heated to reflux for 2h, cooled to room temperature, and
partitioned between 1 N NaOH (200 mL) and CH2Cl2 (200 mL).  The organic layer was
washed with 10% Na2S2O3 aqueous solution (100 mL), dried (Na2SO4), and concentrated.
1H NMR analysis revealed an 11:1 E:Z mixture of isomers.  The desired isomer was
easily separated by silica gel chromatography using 5% EtOAc : hexanes to provide vinyl
iodide 110 as a yellow oil in 87% yield (7.76 g, 27.0 mmol).  IR (thin film) 3073, 2959,
2856, 2813, 1606, 1452, 1346, 1331, 1292, 1268, 1236, 1115, 1070, 1032, 1008 cm-1; 1H
NMR (300 MHz, CDCl3) d 6.64-6.65 (m, 1H, ClCH=C), 3.67 (m, 4H, O((CH)2)2), 3.19-
                                                           
7  Lambert, S. J.; Kabalka, G. W.; Knapp, Jr., F. F.; Srivastava, P. C. J. Org. Chem. 1991, 56, 3707.
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3.20 (m, 2H, CCH2), 2.43-2.46 (m, 4H, N(CH2)2); 13C NMR (75 MHz, CDCl3) d 122.0,
100.8, 67.2, 61.6, 53.1; HRMS (FAB) m/z 287.9641 (M+H, 287.9652 calcd for
C7H12NOClI).
(E)-3-chloro-1-morpholino-2-(trimethylsilylmethyl)prop-2-ene (107).  To Pd2(dba)3
(80 mg, 0.09 mmol, 2.5 mol%) was added a freshly prepared 1 M
trimethylsilylmethylmagnesium chloride solution in Et2O (7.0 mL,
7 mmol) followed by vinyl iodide 110 (1.00 g, 3.5 mmol) in Et2O
(1.4 mL).  After 22 h the reaction mixture was diluted with Et2O
(20 mL) and washed with saturated aqueous NH4Cl (20 mL).  The organic layer was
separated, dried (Na2SO4), and concentrated.  The crude residue was purified by silica gel
chromatography using 5% EtOAc : hexanes to provide amine 107 as a clear, colorless oil
in 88% yield (0.76 g, 3.1 mmol).  IR (thin film) 3067, 2957, 2893, 2854, 2809, 1455,
1398, 1349, 1332, 1294, 1248, 1182, 1120, 1071, 1035, 1011, 992 cm-1; 1H NMR (300
MHz, CDCl3) d 5.71 (s, 1H, ClCH=C), 3.65-3.68 (m, 4H, O(CH2)2), 3.03 (s, 2H, CCH2),
2.37-2.40 (m, 4H, N(CH2)2), 1.67 (s, 2H, CH2Si), 0.01 (s, 9H, Si(CH3)3); 13C NMR (75
MHz, CDCl3) d 137.8, 111.6, 67.3, 58.3, 53.8, 23.9, -0.8; HRMS (FAB) m/z 246.1087
(M–H, 246.1081 calcd for C11H21NOClSi).
 (2R*, 3 R*)-Morpholine 2-( tert-butyldiphenylsiloxy)-3-chloro-4-trimethylsilyl-
methyl)pent-4-enamide (115).  Amine 107 (1.18 g, 4.8 mmol) in CH2Cl2 (100 mL) was
added to AlCl3 (0.64 g, 4.8 mmol).  The resulting mixture was treated with iPr2NEt (3.1
mL, 19.1 mmol) followed by a 1.0 M solution of 2-(tert-butyldiphenylsilyloxy)acetyl
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chloride in CH2Cl2 (14.3 mL, 14.3 mmol) via syringe pump
over 15 h.  The reaction mixture was diluted with Et2O
(100 mL) and 1 N NaOH (100 mL) and the layers were
separated.  The aqueous layer was extracted with EtOAc (3
x 100 mL) and the combined organic extracts were washed with brine (100 mL), dried,
and concentrated.  The crude residue was purified by silica gel chromatography (10%
EtOAc : hexanes) to provide amide 115 as a yellow oil in 73% yield (1.90 g, 3.5 mmol);
syn:anti 1:9.  IR (thin film) 3073, 3050, 2958, 2932, 2896, 2858, 1655, 1461, 1428, 1361,
1248, 1113, 1031 cm-1; 1H NMR (300 MHz, CDCl3) d 7.64-7.72 (m, 4H, ArH), 7.33-7.44
(m, 6H, ArH), 5.17 (s, 1H, C=CH2), 4.95 (s, 1H, C=CH2), 4.61 (d, J = 9.1 Hz, CHCl or
CHO), 4.57 (d, J = 9.1 Hz, 1H, CHCl or CHO), 3.11-3.54 (m, 8H, morpholine), 1.36-
1.49 (m, 2H, CH2Si), 1.03 (s, 9H, tBu), 0.05 (s, 9H, TMS); 13C NMR (75 MHz, CDCl3) d
168.9, 143.5, 136.4, 136.4, 132.6, 132.6, 130.4, 130.2, 127.9, 127.7, 115.0, 71.1, 66.7,
66.4, 66.1, 46.1, 42.4, 27.2, 23.5, 19.8, –0.7; HRMS (FAB) m/z 544.2464 (M+H,
544.2470 calcd for C29H43NO3ClSi2).
(2R*, 3R*)-Morpholine 2-benzyloxy-3-chloro-4-(trimethylsilylmethyl)pent-4-
enamide (111).  Amine 107  (1.00 g, 4.0 mmol) in
CH2Cl2 (80 mL) was added to AlCl3 (0.53 g, 4.0 mmol).
The resulting mixture was treated with iPr2NEt (2.1 mL,
12.0 mmol) followed by a 1.0 M solution of 2-
benzyloxyacetyl chloride in CH2Cl2 (8.0 mL, 8.0 mmol) via syringe pump over 10 h.  The
reaction mixture was diluted with Et2O (100 mL) and 1 N NaOH (100 mL) and the layers
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were separated.  The aqueous layer was extracted with EtOAc (3 x 100 mL) and the
combined organic extracts were washed with brine (100 mL), dried, and concentrated.
The crude residue was purified by silica gel chromatography (20% EtOAc : hexanes) to
provide amide 111 as a yellow oil in 84% yield (1.33 g, 3.4 mmol); syn:anti 1:9.  IR (thin
film) 3088, 3031, 2957, 2898, 2859, 1744, 1654, 1600, 1455, 1438, 1248, 1116, 1030,
853 cm-1; 1H NMR (300 MHz, CDCl3) d 7.27-7.36 (m, 5H, ArH), 5.17 (s, 1H, C=CH2),
4.97 (s, 1H, C=CH2), 4.67 (d, J = 12.1 Hz, 1H, CH2Ph), 4.59 (d, J = 13.2 Hz, 1H), 4.59
(d, J = 12.1 Hz, 1H, CH2Ph), 4.46 (d, J = 10.4 Hz, 1H), 3.30-3.74 (m, 8H, morpholine),
1.61 (s, 2H, CH2Si), 0.08 (s, 9H, TMS); 13C NMR (75 MHz, CDCl3) d 167.8, 143.7,
137.0, 128.7, 128.4, 128.3, 114.7, 77.7, 71.9, 67.2, 66.8, 63.7, 46.3, 42.9, 22.8, –0.6;
HRMS (FAB) m/z 396.1756 (M+H, 396.1762 calcd for C20H31ClNO3Si).
























